MENU
The Electronic Scholarly Publishing Project: Providing world-wide, free access to classic scientific papers and other scholarly materials, since 1993.
More About: ESP | OUR CONTENT | THIS WEBSITE | WHAT'S NEW | WHAT'S HOT
ESP: PubMed Auto Bibliography 20 Nov 2026 at 01:46 Created:
CRISPR-Cas
Clustered regularly interspaced short palindromic repeats (CRISPR, pronounced crisper) are segments of prokaryotic DNA containing short repetitions of base sequences. Each repetition is followed by short segments of "spacer DNA" from previous exposures to foreign DNA (e.g a virus or plasmid). The CRISPR/Cas system is a prokaryotic immune system that confers resistance to foreign genetic elements such as those present within plasmids and phages, and provides a form of acquired immunity. CRISPR associated proteins (Cas) use the CRISPR spacers to recognize and cut these exogenous genetic elements in a manner analogous to RNA interference in eukaryotic organisms. CRISPRs are found in approximately 40% of sequenced bacterial genomes and 90% of sequenced archaea. By delivering the Cas9 nuclease complexed with a synthetic guide RNA (gRNA) into a cell, the cell's genome can be cut at a desired location, allowing existing genes to be removed and/or new ones added. The Cas9-gRNA complex corresponds with the CAS III crRNA complex in the above diagram. CRISPR/Cas genome editing techniques have many potential applications, including altering the germline of humans, animals, and food crops. The use of CRISPR Cas9-gRNA complex for genome editing was the AAAS's choice for breakthrough of the year in 2015.
Created with PubMed® Query: ( "CRISPR.CAS" OR "crispr/cas" ) NOT pmcbook NOT ispreviousversion
Citations The Papers (from PubMed®)
RevDate: 2026-11-19
CmpDate: 2026-11-19
Structural insights into target detection by the Serratia type III CRISPR complex and its deployment in SNP identifications.
The Journal of biological chemistry, 302(11):113595.
Type III CRISPR systems utilize a complex containing Cas10, additional Cas proteins and a crRNA to detect foreign transcripts. Upon detection, Cas10 synthesizes cyclic oligoadenylates (cOA), signaling molecules that coordinate interference by stimulating downstream enzymes with DNase, RNase, protease or other activities. Type III systems possess properties well-suited to their deployment as molecular diagnostics: specific detection and activation of a cascade of multi-turnover enzymatic reactions that can be harnessed for signal generation. We answered key questions concerning the structure and function of Serratia Cas10-Csm to facilitate its use in molecular diagnostics. We determined that Serratia Cas10-Csm (SerrCas10-Csm) synthesizes predominantly cA3 molecules and this synthesis is sensitive to mismatches in the crRNA-target RNA duplex adjacent to Cas10. To understand how Cas10 senses the presence of a bound target RNA, we determined the structure of SerrCas10-Csm unbound and bound to target RNA identifying conformational changes associated with target binding. We programmed SerrCas10-Csm with a crRNA recognizing a single nucleotide polymorphism that occurs in the human HBB transcript and is associated with sickle cell disease. We demonstrate that when the polymorphism occurs in the +1 position of the crRNA-target duplex, SerrCas10-Csm can distinguish it indicating an additional role for type III CRISPR systems in point-of-care diagnostics in low-resource settings.
Additional Links: PMID-42772556
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid42772556,
year = {2026},
author = {Perdigao, CC and Ajisafe, LO and Sunny, AT and Wu, S and Dokland, T and Dunkle, JA},
title = {Structural insights into target detection by the Serratia type III CRISPR complex and its deployment in SNP identifications.},
journal = {The Journal of biological chemistry},
volume = {302},
number = {11},
pages = {113595},
pmid = {42772556},
issn = {1083-351X},
support = {P30 CA013148/CA/NCI NIH HHS/United States ; R35 GM142966/GM/NIGMS NIH HHS/United States ; S10 OD024978/OD/NIH HHS/United States ; },
mesh = {*Polymorphism, Single Nucleotide/genetics ; *Serratia/genetics/chemistry/metabolism ; *CRISPR-Cas Systems/genetics ; *CRISPR-Associated Proteins/chemistry/metabolism/genetics ; },
abstract = {Type III CRISPR systems utilize a complex containing Cas10, additional Cas proteins and a crRNA to detect foreign transcripts. Upon detection, Cas10 synthesizes cyclic oligoadenylates (cOA), signaling molecules that coordinate interference by stimulating downstream enzymes with DNase, RNase, protease or other activities. Type III systems possess properties well-suited to their deployment as molecular diagnostics: specific detection and activation of a cascade of multi-turnover enzymatic reactions that can be harnessed for signal generation. We answered key questions concerning the structure and function of Serratia Cas10-Csm to facilitate its use in molecular diagnostics. We determined that Serratia Cas10-Csm (SerrCas10-Csm) synthesizes predominantly cA3 molecules and this synthesis is sensitive to mismatches in the crRNA-target RNA duplex adjacent to Cas10. To understand how Cas10 senses the presence of a bound target RNA, we determined the structure of SerrCas10-Csm unbound and bound to target RNA identifying conformational changes associated with target binding. We programmed SerrCas10-Csm with a crRNA recognizing a single nucleotide polymorphism that occurs in the human HBB transcript and is associated with sickle cell disease. We demonstrate that when the polymorphism occurs in the +1 position of the crRNA-target duplex, SerrCas10-Csm can distinguish it indicating an additional role for type III CRISPR systems in point-of-care diagnostics in low-resource settings.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Polymorphism, Single Nucleotide/genetics
*Serratia/genetics/chemistry/metabolism
*CRISPR-Cas Systems/genetics
*CRISPR-Associated Proteins/chemistry/metabolism/genetics
RevDate: 2026-11-19
CmpDate: 2026-11-19
A programmable aptamer-triggered B-PER/CRISPR cascade amplification platform for ultrasensitive detection of Staphylococcus aureus.
Analytical methods : advancing methods and applications, 18(44):10931-10939.
Rapid and sensitive detection of Staphylococcus aureus (S. aureus) is critical for food safety and public health. Herein, this work developed an ABC (aptamer-B-PER-CRISPR) cascade detection platform, where B-PER stands for bidirectional primer exchange reaction, that integrates aptamer-mediated target recognition, B-PER isothermal amplification, and CRISPR/Cas12a trans-cleavage for highly sensitive and specific detection of S. aureus. Upon target recognition, the trigger strand T is released from the aptamer-T duplex, initiating B-PER to generate abundant products containing sequences recognized by the guide RNA (gRNA), which activate Cas12a to cleave the reporter probe, generating a detectable fluorescence signal. Under optimized conditions, the platform exhibited a linear range of 10[2] to 10[10] CFU per mL with a regression equation of F520 nm = 575.36 log C + 3246.47 (R[2] = 0.9992) and a limit of detection of 13 CFU per mL. The assay showed excellent specificity for S. aureus, with negligible cross-reactivity toward Vibrio parahaemolyticus and Salmonella. Recovery tests in spiked milk samples yielded average recoveries of 98.9-100.7%. Overall, the ABC platform offers high sensitivity, excellent specificity, robust anti-interference capability, and operational simplicity, demonstrating great potential for rapid and reliable detection of foodborne pathogens in complex matrices.
Additional Links: PMID-42878276
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid42878276,
year = {2026},
author = {Jiang, J and Peng, Y and Ma, W and Zhang, H and Xiong, S and Fu, X and Li, J},
title = {A programmable aptamer-triggered B-PER/CRISPR cascade amplification platform for ultrasensitive detection of Staphylococcus aureus.},
journal = {Analytical methods : advancing methods and applications},
volume = {18},
number = {44},
pages = {10931-10939},
doi = {10.1039/d6ay01701k},
pmid = {42878276},
issn = {1759-9679},
mesh = {*Staphylococcus aureus/isolation & purification/genetics ; *Aptamers, Nucleotide/chemistry/genetics ; *Nucleic Acid Amplification Techniques/methods ; Limit of Detection ; *CRISPR-Cas Systems/genetics ; Milk/microbiology ; Animals ; *Biosensing Techniques/methods ; },
abstract = {Rapid and sensitive detection of Staphylococcus aureus (S. aureus) is critical for food safety and public health. Herein, this work developed an ABC (aptamer-B-PER-CRISPR) cascade detection platform, where B-PER stands for bidirectional primer exchange reaction, that integrates aptamer-mediated target recognition, B-PER isothermal amplification, and CRISPR/Cas12a trans-cleavage for highly sensitive and specific detection of S. aureus. Upon target recognition, the trigger strand T is released from the aptamer-T duplex, initiating B-PER to generate abundant products containing sequences recognized by the guide RNA (gRNA), which activate Cas12a to cleave the reporter probe, generating a detectable fluorescence signal. Under optimized conditions, the platform exhibited a linear range of 10[2] to 10[10] CFU per mL with a regression equation of F520 nm = 575.36 log C + 3246.47 (R[2] = 0.9992) and a limit of detection of 13 CFU per mL. The assay showed excellent specificity for S. aureus, with negligible cross-reactivity toward Vibrio parahaemolyticus and Salmonella. Recovery tests in spiked milk samples yielded average recoveries of 98.9-100.7%. Overall, the ABC platform offers high sensitivity, excellent specificity, robust anti-interference capability, and operational simplicity, demonstrating great potential for rapid and reliable detection of foodborne pathogens in complex matrices.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Staphylococcus aureus/isolation & purification/genetics
*Aptamers, Nucleotide/chemistry/genetics
*Nucleic Acid Amplification Techniques/methods
Limit of Detection
*CRISPR-Cas Systems/genetics
Milk/microbiology
Animals
*Biosensing Techniques/methods
RevDate: 2026-11-19
CmpDate: 2026-11-19
A self-contained ternary probe assay integrating self-priming cascade amplification with CRISPR/Cas12a for ultrasensitive detection of infant UTI-related microRNA.
Analytical methods : advancing methods and applications, 18(44):11006-11015.
Accurate quantification of infant urinary tract infection (UTI)-associated microRNAs remains challenging due to their short length, low abundance, and high sequence homology. Herein, we present a sensitive fluorescent biosensor that integrates a self-priming extension cascade with CRISPR/Cas12a-mediated signal amplification, with the core innovation being a rationally designed ternary sensing probe that consolidates all recognition and amplification elements into a single, self-contained architecture on magnetic beads. This integrated design eliminates the need for multiple exogenously added primers, offering three inherent advantages: fixed stoichiometric ratios ensure reproducible reaction initiation, the unified format simplifies the operational workflow, and stringent coupling of amplification to target recognition suppresses non-specific background. Upon target recognition, the probe undergoes programmed conformational rearrangements that trigger sequential self-priming extension events, simultaneously generating fragments that drive autocatalytic feedback and T7 promoter-containing products for downstream crRNA transcription. The transcribed crRNA activates Cas12a collateral cleavage, producing exponentially amplified fluorescence. Under optimized conditions, the assay achieves a detection limit of 0.48 fM, excellent single-base discrimination, and reliable performance in human serum. Quantification results correlate strongly with qRT-PCR. This exogenously primer-free, self-contained cascade uniquely unifies signal amplification, target regeneration, and crRNA synthesis in a single probe format, while the seamless coupling with CRISPR/Cas12a trans-cleavage ensures both ultrahigh sensitivity and exceptional specificity. The proposed strategy provides a promising platform for early diagnosis and screening of infant UTI.
Additional Links: PMID-42894985
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid42894985,
year = {2026},
author = {Deng, G and Xia, X and Li, X and Guo, J and Wei, G},
title = {A self-contained ternary probe assay integrating self-priming cascade amplification with CRISPR/Cas12a for ultrasensitive detection of infant UTI-related microRNA.},
journal = {Analytical methods : advancing methods and applications},
volume = {18},
number = {44},
pages = {11006-11015},
doi = {10.1039/d6ay01892k},
pmid = {42894985},
issn = {1759-9679},
mesh = {Humans ; *MicroRNAs/genetics/analysis ; *Urinary Tract Infections/genetics/diagnosis ; *Biosensing Techniques/methods ; *CRISPR-Cas Systems/genetics ; Infant ; *Nucleic Acid Amplification Techniques/methods ; Limit of Detection ; },
abstract = {Accurate quantification of infant urinary tract infection (UTI)-associated microRNAs remains challenging due to their short length, low abundance, and high sequence homology. Herein, we present a sensitive fluorescent biosensor that integrates a self-priming extension cascade with CRISPR/Cas12a-mediated signal amplification, with the core innovation being a rationally designed ternary sensing probe that consolidates all recognition and amplification elements into a single, self-contained architecture on magnetic beads. This integrated design eliminates the need for multiple exogenously added primers, offering three inherent advantages: fixed stoichiometric ratios ensure reproducible reaction initiation, the unified format simplifies the operational workflow, and stringent coupling of amplification to target recognition suppresses non-specific background. Upon target recognition, the probe undergoes programmed conformational rearrangements that trigger sequential self-priming extension events, simultaneously generating fragments that drive autocatalytic feedback and T7 promoter-containing products for downstream crRNA transcription. The transcribed crRNA activates Cas12a collateral cleavage, producing exponentially amplified fluorescence. Under optimized conditions, the assay achieves a detection limit of 0.48 fM, excellent single-base discrimination, and reliable performance in human serum. Quantification results correlate strongly with qRT-PCR. This exogenously primer-free, self-contained cascade uniquely unifies signal amplification, target regeneration, and crRNA synthesis in a single probe format, while the seamless coupling with CRISPR/Cas12a trans-cleavage ensures both ultrahigh sensitivity and exceptional specificity. The proposed strategy provides a promising platform for early diagnosis and screening of infant UTI.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Humans
*MicroRNAs/genetics/analysis
*Urinary Tract Infections/genetics/diagnosis
*Biosensing Techniques/methods
*CRISPR-Cas Systems/genetics
Infant
*Nucleic Acid Amplification Techniques/methods
Limit of Detection
RevDate: 2026-11-19
CmpDate: 2026-11-19
The chromatin context differently impacts prime editors and base editors and controls the fidelity and purity of base editing.
Molecular cell, 86(22):4794-4811.e7.
Base editors and prime editors allow changing specific genomic sequences without chromosomal breakage. However, the role of the chromatin environment and its underlying factors on the efficiency, product fidelity, and purity of prime editing versus base editing is unknown. Here, using human cellular systems that monitor the efficiency and fidelity of gene-editing tools at isogenic target sites controlled by specific epigenetic remodeling factors, we report that heterochromatin impinged by the Krüppel-associated box (KRAB)/KRAB-associated protein 1 (KAP-1)/heterochromatin protein-1 (HP-1) axis alone (non-heritable), or in concert with the DNA methyltransferases DNMT3A and DNMT3L (heritable), mostly hinders prime editors over base editors with the extended portions of prime-editing guide RNAs contributing to this outcome. Indeed, base editors are frequently unhindered or, strikingly, more active at heterochromatin than at euchromatin, an outcome observed neither for prime editors nor nucleases. Critically, the extent and types of byproducts accumulated upon base editing is also contingent upon the epigenetic context of target sequences.
Additional Links: PMID-42976864
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid42976864,
year = {2026},
author = {Wang, Q and Zittersteijn, H and Wang, X and Janssen, JM and Liu, J and Mei, H and Hoeben, RC and Gonçalves, MAFV},
title = {The chromatin context differently impacts prime editors and base editors and controls the fidelity and purity of base editing.},
journal = {Molecular cell},
volume = {86},
number = {22},
pages = {4794-4811.e7},
doi = {10.1016/j.molcel.2026.10.012},
pmid = {42976864},
issn = {1097-4164},
mesh = {Humans ; *Gene Editing/methods ; *Heterochromatin/genetics/metabolism ; Euchromatin/genetics/metabolism ; Epigenesis, Genetic ; DNA (Cytosine-5-)-Methyltransferases/genetics/metabolism ; *CRISPR-Cas Systems ; DNA Methyltransferase 3A ; RNA, Guide, CRISPR-Cas Systems/genetics/metabolism ; Chromosomal Proteins, Non-Histone/genetics/metabolism ; *Chromatin/genetics/metabolism ; Chromatin Assembly and Disassembly ; Epigenome Editing ; Repressor Proteins/genetics/metabolism ; },
abstract = {Base editors and prime editors allow changing specific genomic sequences without chromosomal breakage. However, the role of the chromatin environment and its underlying factors on the efficiency, product fidelity, and purity of prime editing versus base editing is unknown. Here, using human cellular systems that monitor the efficiency and fidelity of gene-editing tools at isogenic target sites controlled by specific epigenetic remodeling factors, we report that heterochromatin impinged by the Krüppel-associated box (KRAB)/KRAB-associated protein 1 (KAP-1)/heterochromatin protein-1 (HP-1) axis alone (non-heritable), or in concert with the DNA methyltransferases DNMT3A and DNMT3L (heritable), mostly hinders prime editors over base editors with the extended portions of prime-editing guide RNAs contributing to this outcome. Indeed, base editors are frequently unhindered or, strikingly, more active at heterochromatin than at euchromatin, an outcome observed neither for prime editors nor nucleases. Critically, the extent and types of byproducts accumulated upon base editing is also contingent upon the epigenetic context of target sequences.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Humans
*Gene Editing/methods
*Heterochromatin/genetics/metabolism
Euchromatin/genetics/metabolism
Epigenesis, Genetic
DNA (Cytosine-5-)-Methyltransferases/genetics/metabolism
*CRISPR-Cas Systems
DNA Methyltransferase 3A
RNA, Guide, CRISPR-Cas Systems/genetics/metabolism
Chromosomal Proteins, Non-Histone/genetics/metabolism
*Chromatin/genetics/metabolism
Chromatin Assembly and Disassembly
Epigenome Editing
Repressor Proteins/genetics/metabolism
RevDate: 2026-11-19
CmpDate: 2026-11-19
IL-15/IL-15Rα-targeted CRISPRa boosts NK cell effector function against HIV-infected cells.
Journal of leukocyte biology, 118(11):.
Like many other immune cell types, natural killer (NK) cells exhibit impaired functionality in people with HIV (PWH), limiting their ability to efficiently target and eliminate HIV-infected cells and contributing to the persistence of the HIV reservoir. Recently, adoptive NK cell therapy using activated or engineered NK cells has emerged as a promising immunotherapeutic strategy for cancer; however, its application to HIV remains in the early stages of development. NK cells primarily rely on interleukin-15 (IL-15) signaling for their development, survival, and maintenance, and dysregulated IL-15 signaling has been reported in PWH. We hypothesized that simultaneous enhancement of IL-15 and IL-15 receptor α (IL-15Rα) expression would improve NK cell effector function and promote clearance of HIV reservoir. Using dCas9-VPR-mediated multiplex CRISPR activation (CRISPRa), we successfully upregulated both IL-15 and IL-15Rα expression in the same primary NK cells without altering the genomic sequence. CRISPRa-treated NK cells had increased IL-15 and IL-15Rα transcript levels, as measured by quantitative reverse transcription polymerase chain reaction, and significantly elevated surface expression of IL-15Rα, as determined by flow cytometry. Enhanced IL-15/IL-15Rα expression increased NK cell metabolic activity and cytotoxicity against target K562 cells, a chronic myelogenous leukemia cell line, indicating improved effector function. Furthermore, in co-culture experiments using an HIV-positive T-cell line, IL-15/IL-15Rα-CRISPRa-treated NK cells demonstrated enhanced target cell elimination and increased secretion of IFN-γ. Together, these findings provide a proof of concept that multiplex CRISPRa can be used to enhance NK cell function, representing a novel strategy to improve persistence and therapeutic efficacy in HIV and other disease settings.
Additional Links: PMID-42987219
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid42987219,
year = {2026},
author = {Brancazio, S and Burdo, TH and Shan, L and Kaminski, R},
title = {IL-15/IL-15Rα-targeted CRISPRa boosts NK cell effector function against HIV-infected cells.},
journal = {Journal of leukocyte biology},
volume = {118},
number = {11},
pages = {},
doi = {10.1093/jleuko/qiag140},
pmid = {42987219},
issn = {1938-3673},
support = {//Cure Collaboratory/ ; UM1 AI164568//National Institute of Allergy and Infectious Diseases/ ; //US/ ; T32 MH079785/MH/NIMH NIH HHS/United States ; },
mesh = {Humans ; *Killer Cells, Natural/immunology ; *Interleukin-15/genetics/immunology/metabolism ; *HIV Infections/immunology/therapy/virology ; *Interleukin-15 Receptor alpha Subunit/genetics/immunology ; *CRISPR-Cas Systems ; *HIV-1/immunology ; K562 Cells ; Receptors, Interleukin-15 ; Lymphocyte Activation ; },
abstract = {Like many other immune cell types, natural killer (NK) cells exhibit impaired functionality in people with HIV (PWH), limiting their ability to efficiently target and eliminate HIV-infected cells and contributing to the persistence of the HIV reservoir. Recently, adoptive NK cell therapy using activated or engineered NK cells has emerged as a promising immunotherapeutic strategy for cancer; however, its application to HIV remains in the early stages of development. NK cells primarily rely on interleukin-15 (IL-15) signaling for their development, survival, and maintenance, and dysregulated IL-15 signaling has been reported in PWH. We hypothesized that simultaneous enhancement of IL-15 and IL-15 receptor α (IL-15Rα) expression would improve NK cell effector function and promote clearance of HIV reservoir. Using dCas9-VPR-mediated multiplex CRISPR activation (CRISPRa), we successfully upregulated both IL-15 and IL-15Rα expression in the same primary NK cells without altering the genomic sequence. CRISPRa-treated NK cells had increased IL-15 and IL-15Rα transcript levels, as measured by quantitative reverse transcription polymerase chain reaction, and significantly elevated surface expression of IL-15Rα, as determined by flow cytometry. Enhanced IL-15/IL-15Rα expression increased NK cell metabolic activity and cytotoxicity against target K562 cells, a chronic myelogenous leukemia cell line, indicating improved effector function. Furthermore, in co-culture experiments using an HIV-positive T-cell line, IL-15/IL-15Rα-CRISPRa-treated NK cells demonstrated enhanced target cell elimination and increased secretion of IFN-γ. Together, these findings provide a proof of concept that multiplex CRISPRa can be used to enhance NK cell function, representing a novel strategy to improve persistence and therapeutic efficacy in HIV and other disease settings.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Humans
*Killer Cells, Natural/immunology
*Interleukin-15/genetics/immunology/metabolism
*HIV Infections/immunology/therapy/virology
*Interleukin-15 Receptor alpha Subunit/genetics/immunology
*CRISPR-Cas Systems
*HIV-1/immunology
K562 Cells
Receptors, Interleukin-15
Lymphocyte Activation
RevDate: 2026-11-14
CmpDate: 2026-11-14
Genome Editing for Earliness and Plant Architecture in Cucurbit Crops: Recent Advances and Future Perspectives.
International journal of molecular sciences, 27(21):.
Earliness and plant architecture are major breeding targets in cucurbit crops because they influence crop duration, early yield, planting density, canopy management, and production efficiency. This review summarizes genetic, molecular, and genome-editing advances related to flowering, sex expression, fruit development, stem elongation, branching, and canopy architecture in cucumber, melon, watermelon, Cucurbita species, and other cucurbits. Current evidence shows that earlier flowering or increased femaleness does not necessarily lead to earlier commercial maturity, while compact growth must be evaluated together with yield, fruit quality, and environmental adaptation. CRISPR/Cas9 knockout remains the most established editing approach, whereas base editing, cis-regulatory editing, multiplex editing, developmental-regulator-assisted regeneration, and DNA-free RNP delivery offer promising routes toward more precise trait optimization. Major constraints include genotype-dependent transformation, pleiotropic effects, limited validation in elite germplasm, and scarce direct evidence for shortening fruit-development duration. An evidence-guided framework is proposed that links trait definition, functional genomics, target prioritization, tailored genome editing, whole-plant evaluation, and breeding deployment. Future progress will depend on quantitatively tuned alleles and coordinated optimization of reproductive timing, canopy architecture, productivity, fruit quality, and environmental stability.
Additional Links: PMID-43027944
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43027944,
year = {2026},
author = {Wan, L and Wang, Z and Ren, J and Wei, J and Zeng, H and Li, X and Qu, J and Xiong, J and Tang, M},
title = {Genome Editing for Earliness and Plant Architecture in Cucurbit Crops: Recent Advances and Future Perspectives.},
journal = {International journal of molecular sciences},
volume = {27},
number = {21},
pages = {},
pmid = {43027944},
issn = {1422-0067},
support = {2025DJA079//Science and Technology Department of Hubei Province/ ; 2025BBB020//Hubei Key Research Project of Development and Breeding of New Watermelon Cultivars with Enhanced Crack Resistance and Superior Fruit Quality/ ; },
mesh = {*Gene Editing/methods ; *Crops, Agricultural/genetics/growth & development ; *Genome, Plant ; Plant Breeding/methods ; CRISPR-Cas Systems ; *Cucurbita/genetics/growth & development ; Fruit/genetics/growth & development ; },
abstract = {Earliness and plant architecture are major breeding targets in cucurbit crops because they influence crop duration, early yield, planting density, canopy management, and production efficiency. This review summarizes genetic, molecular, and genome-editing advances related to flowering, sex expression, fruit development, stem elongation, branching, and canopy architecture in cucumber, melon, watermelon, Cucurbita species, and other cucurbits. Current evidence shows that earlier flowering or increased femaleness does not necessarily lead to earlier commercial maturity, while compact growth must be evaluated together with yield, fruit quality, and environmental adaptation. CRISPR/Cas9 knockout remains the most established editing approach, whereas base editing, cis-regulatory editing, multiplex editing, developmental-regulator-assisted regeneration, and DNA-free RNP delivery offer promising routes toward more precise trait optimization. Major constraints include genotype-dependent transformation, pleiotropic effects, limited validation in elite germplasm, and scarce direct evidence for shortening fruit-development duration. An evidence-guided framework is proposed that links trait definition, functional genomics, target prioritization, tailored genome editing, whole-plant evaluation, and breeding deployment. Future progress will depend on quantitatively tuned alleles and coordinated optimization of reproductive timing, canopy architecture, productivity, fruit quality, and environmental stability.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Gene Editing/methods
*Crops, Agricultural/genetics/growth & development
*Genome, Plant
Plant Breeding/methods
CRISPR-Cas Systems
*Cucurbita/genetics/growth & development
Fruit/genetics/growth & development
RevDate: 2026-11-14
CmpDate: 2026-11-14
Metadata-Driven Project-Level Analysis and Noise Modeling for Amplicon Sequencing Data Using CRISPResso2.
International journal of molecular sciences, 27(21):.
Here we present a lightweight workflow designed to improve the robustness and scalability of high-throughput amplicon sequencing analysis while leveraging CRISPResso2. To handle large batch processing without sensitive runtime interruptions, our pipeline processes samples sequentially, allowing the analysis to resume from the last successfully completed sample if an error occurs. The workflow implements a fallback mechanism for failed runs, automated extraction and separate processing of control samples, and a background noise model derived from control libraries within defined editing windows. Validation using spike-in datasets across Cas9, base editing, and prime editing demonstrated that our noise-adjusted estimates deviated from the ground truth by only 0.1-0.6%, whereas native CRISPResso2 caused a 1.5-3.7% overestimation. Unlike existing tools such as CRISPECTOR, which focus primarily on CRISPR-Cas9, our approach supports multiple editing modalities and enables project-level organization of large datasets. Input complexity is reduced through configurable flags and modular metadata tables, minimizing manual parameter entry. Together, these features provide a flexible, fault-tolerant, and highly accurate framework for analyzing large genome editing datasets.
Additional Links: PMID-43028057
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43028057,
year = {2026},
author = {Volodina, O and Smirnikhina, S},
title = {Metadata-Driven Project-Level Analysis and Noise Modeling for Amplicon Sequencing Data Using CRISPResso2.},
journal = {International journal of molecular sciences},
volume = {27},
number = {21},
pages = {},
pmid = {43028057},
issn = {1422-0067},
support = {//Ministry of Science and Higher Education of the Russian Federation/ ; },
mesh = {*High-Throughput Nucleotide Sequencing/methods ; *CRISPR-Cas Systems ; *Metadata ; *Software ; *Gene Editing/methods ; Workflow ; },
abstract = {Here we present a lightweight workflow designed to improve the robustness and scalability of high-throughput amplicon sequencing analysis while leveraging CRISPResso2. To handle large batch processing without sensitive runtime interruptions, our pipeline processes samples sequentially, allowing the analysis to resume from the last successfully completed sample if an error occurs. The workflow implements a fallback mechanism for failed runs, automated extraction and separate processing of control samples, and a background noise model derived from control libraries within defined editing windows. Validation using spike-in datasets across Cas9, base editing, and prime editing demonstrated that our noise-adjusted estimates deviated from the ground truth by only 0.1-0.6%, whereas native CRISPResso2 caused a 1.5-3.7% overestimation. Unlike existing tools such as CRISPECTOR, which focus primarily on CRISPR-Cas9, our approach supports multiple editing modalities and enables project-level organization of large datasets. Input complexity is reduced through configurable flags and modular metadata tables, minimizing manual parameter entry. Together, these features provide a flexible, fault-tolerant, and highly accurate framework for analyzing large genome editing datasets.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*High-Throughput Nucleotide Sequencing/methods
*CRISPR-Cas Systems
*Metadata
*Software
*Gene Editing/methods
Workflow
RevDate: 2026-11-14
CmpDate: 2026-11-14
From Nitrate Perception to Environmental Adaptation: Functional Elucidation and Regulatory Networks of the Plant NLP Family.
Plants (Basel, Switzerland), 15(21):.
Nitrogen is a necessary macronutrient that limits plant growth and crop productivity, yet excessive fertilizer application has resulted in serious environmental consequences. The NIN-like protein (NLP) family consists of plant-specific transcription factors that serve as central regulators of nitrate signaling. In 2022, the discovery of NLP7 as an intracellular nitrate receptor represented a major conceptual shift from transcriptional regulation to signal perception. This review systematically summarizes the molecular architecture of NLP proteins, focusing on the conserved RWP-RK DNA-binding domain, the PB1 protein-protein interaction module, and the GAF-like domain associated with the integration of multiple signals. It also examines the species-specific expansion and evolutionary diversification of the NLP family, as well as the multilayered mechanisms that regulate NLP activity, including phosphorylation as a signal-dependent molecular switch, SUMOylation as a negative feedback mechanism, transcriptional regulation of downstream targets, and PB1-mediated protein interaction networks. In addition to nitrate signaling, NLPs serve as central hubs linking nitrogen and carbon metabolism and mediating responses to abiotic stresses including cold, heat, salinity, and iron deficiency. Notably, the NLP7-NIGT1.3 module coordinates a growth-stress trade-off during iron deficiency by modulating nitrate signaling intensity, revealing a previously unrecognized mechanism for balancing stress adaptation with growth maintenance. NLPs also participate in developmental processes, including lateral root formation and symbiotic nodulation. Finally, this review highlights the potential of NLP-based approaches for crop genetic improvement, such as overexpression of key NLP genes or CRISPR/Cas-mediated editing, to improve nitrogen use efficiency, stress tolerance, and yield. Collectively, these insights provide a theoretical foundation for developing crop varieties with improved nitrogen-use efficiency and context-dependent stress adaptation, while acknowledging the inherent trade-offs between productivity and resilience.
Additional Links: PMID-43028895
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43028895,
year = {2026},
author = {Ahmad, HI and Liu, Y and Chen, C and Jia, L and Zhu, H and Yang, J},
title = {From Nitrate Perception to Environmental Adaptation: Functional Elucidation and Regulatory Networks of the Plant NLP Family.},
journal = {Plants (Basel, Switzerland)},
volume = {15},
number = {21},
pages = {},
pmid = {43028895},
issn = {2223-7747},
support = {202502AE090025//Yunnan Province Science and Technology Department/ ; 202401BD070001-010//Joint Agricultural Project of Department of Science and Technology of Yunnan Province/ ; 202505AF350029//Yunnan Province Ye Zhibiao Expert Workstation/ ; },
abstract = {Nitrogen is a necessary macronutrient that limits plant growth and crop productivity, yet excessive fertilizer application has resulted in serious environmental consequences. The NIN-like protein (NLP) family consists of plant-specific transcription factors that serve as central regulators of nitrate signaling. In 2022, the discovery of NLP7 as an intracellular nitrate receptor represented a major conceptual shift from transcriptional regulation to signal perception. This review systematically summarizes the molecular architecture of NLP proteins, focusing on the conserved RWP-RK DNA-binding domain, the PB1 protein-protein interaction module, and the GAF-like domain associated with the integration of multiple signals. It also examines the species-specific expansion and evolutionary diversification of the NLP family, as well as the multilayered mechanisms that regulate NLP activity, including phosphorylation as a signal-dependent molecular switch, SUMOylation as a negative feedback mechanism, transcriptional regulation of downstream targets, and PB1-mediated protein interaction networks. In addition to nitrate signaling, NLPs serve as central hubs linking nitrogen and carbon metabolism and mediating responses to abiotic stresses including cold, heat, salinity, and iron deficiency. Notably, the NLP7-NIGT1.3 module coordinates a growth-stress trade-off during iron deficiency by modulating nitrate signaling intensity, revealing a previously unrecognized mechanism for balancing stress adaptation with growth maintenance. NLPs also participate in developmental processes, including lateral root formation and symbiotic nodulation. Finally, this review highlights the potential of NLP-based approaches for crop genetic improvement, such as overexpression of key NLP genes or CRISPR/Cas-mediated editing, to improve nitrogen use efficiency, stress tolerance, and yield. Collectively, these insights provide a theoretical foundation for developing crop varieties with improved nitrogen-use efficiency and context-dependent stress adaptation, while acknowledging the inherent trade-offs between productivity and resilience.},
}
RevDate: 2026-11-14
CmpDate: 2026-11-14
CRISPR/Cas9 Editing of Starch Branching Enzyme Genes Remodels Starch Structure and Improves Nutritional Quality in Sweet Potato.
Molecules (Basel, Switzerland), 31(21):.
Starch branching enzymes (SBEs) play a central role in determining amylopectin architecture and starch functionality, yet their contribution to starch nutritional quality and crop performance in sweet potato remains unclear. In this study, CRISPR/Cas9 was used to target SBEI and SBEII in sweet potato, generating lines with reduced SBE activity. Edited lines showed markedly increased amylose and resistant starch contents compared with the wild type. Amylopectin chain length analysis revealed a decrease in short chains and a relative increase in longer chains, indicating substantial remodeling of branch structure. Microscopic observations further showed reduced birefringence and structural irregularities in starch granules. These structural changes resulted in altered physicochemical properties, including decreased swelling power and solubility, elevated gelatinization temperature, and modified pasting behavior. In vitro digestion assays demonstrated significantly reduced starch digestibility and lower predicted glycemic index values. Whole-genome resequencing confirmed the stable integration of T-DNA and predicted limited insertion-associated effects, further supporting that the improved starch traits were primarily derived from targeted SBE editing. Importantly, storage root yield remained comparable to that of wild-type plants. Collectively, these results demonstrate that CRISPR/Cas9-mediated SBE editing effectively improves starch nutritional quality without compromising yield, providing a promising strategy for developing health-oriented sweet potato varieties.
Additional Links: PMID-43029178
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43029178,
year = {2026},
author = {Fan, W and Li, Y and Xu, Z and Nie, H and Gao, Y and Yang, J and Wang, H},
title = {CRISPR/Cas9 Editing of Starch Branching Enzyme Genes Remodels Starch Structure and Improves Nutritional Quality in Sweet Potato.},
journal = {Molecules (Basel, Switzerland)},
volume = {31},
number = {21},
pages = {},
pmid = {43029178},
issn = {1420-3049},
support = {G252407, G242407 and G232405//Shanghai Municipal Afforestation & City Appearance and Environmental Sanitation Administration/ ; 22JC1401300//the Science and Technology Commission of Shanghai Municipality/ ; 32472220 and 32300207//National Natural Science Foundation of China/ ; },
mesh = {*Ipomoea batatas/genetics/enzymology/metabolism ; *1,4-alpha-Glucan Branching Enzyme/genetics/metabolism ; *Starch/chemistry/metabolism/genetics ; *CRISPR-Cas Systems/genetics ; *Gene Editing ; *Nutritive Value ; Amylopectin/chemistry ; Plants, Genetically Modified ; Amylose ; },
abstract = {Starch branching enzymes (SBEs) play a central role in determining amylopectin architecture and starch functionality, yet their contribution to starch nutritional quality and crop performance in sweet potato remains unclear. In this study, CRISPR/Cas9 was used to target SBEI and SBEII in sweet potato, generating lines with reduced SBE activity. Edited lines showed markedly increased amylose and resistant starch contents compared with the wild type. Amylopectin chain length analysis revealed a decrease in short chains and a relative increase in longer chains, indicating substantial remodeling of branch structure. Microscopic observations further showed reduced birefringence and structural irregularities in starch granules. These structural changes resulted in altered physicochemical properties, including decreased swelling power and solubility, elevated gelatinization temperature, and modified pasting behavior. In vitro digestion assays demonstrated significantly reduced starch digestibility and lower predicted glycemic index values. Whole-genome resequencing confirmed the stable integration of T-DNA and predicted limited insertion-associated effects, further supporting that the improved starch traits were primarily derived from targeted SBE editing. Importantly, storage root yield remained comparable to that of wild-type plants. Collectively, these results demonstrate that CRISPR/Cas9-mediated SBE editing effectively improves starch nutritional quality without compromising yield, providing a promising strategy for developing health-oriented sweet potato varieties.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Ipomoea batatas/genetics/enzymology/metabolism
*1,4-alpha-Glucan Branching Enzyme/genetics/metabolism
*Starch/chemistry/metabolism/genetics
*CRISPR-Cas Systems/genetics
*Gene Editing
*Nutritive Value
Amylopectin/chemistry
Plants, Genetically Modified
Amylose
RevDate: 2026-11-14
CmpDate: 2026-11-14
CRISPR/Cas in food microbial biotechnology: from genome editing to precision microbiology.
Frontiers in microbiology, 17:1996037.
CRISPR/Cas technologies have opened new opportunities for the precise genetic engineering of microorganisms relevant to food biotechnology. Their programmability enables targeted genome modification, transcriptional regulation, sequence-specific antimicrobial activity, and nucleic acid detection, offering new strategies to improve fermentation processes, microbial safety, and the functional properties of food-associated strains. However, experimental evidence varies considerably across microorganisms and applications, and successful genome editing does not necessarily translate into improved technological performance. This review examines recent advances in CRISPR/Cas-based engineering of starter cultures, probiotic strains, and production microorganisms, alongside emerging strategies for bacteriophage resistance, pathogen and biofilm control, and food diagnostics. Particular emphasis is placed on distinguishing applications experimentally validated in food-related settings from proof-of-concept studies conducted in laboratory or biomedical contexts. The review also evaluates the major barriers to industrial implementation, including strain-specific editing efficiency, genetic stability, process robustness, and validation in food matrices. It also considers the distinct biosafety and regulatory implications of production microorganisms removed or inactivated during processing versus viable engineered cultures retained in final products. By integrating advances in molecular engineering with evidence of functional performance and practical implementation requirements, this review highlights both the opportunities and current limitations of CRISPR/Cas technologies in food microbial biotechnology.
Additional Links: PMID-43032083
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43032083,
year = {2026},
author = {Juszczuk-Kubiak, E and Piłka, N and Zielińska, E and Roszko, M},
title = {CRISPR/Cas in food microbial biotechnology: from genome editing to precision microbiology.},
journal = {Frontiers in microbiology},
volume = {17},
number = {},
pages = {1996037},
pmid = {43032083},
issn = {1664-302X},
abstract = {CRISPR/Cas technologies have opened new opportunities for the precise genetic engineering of microorganisms relevant to food biotechnology. Their programmability enables targeted genome modification, transcriptional regulation, sequence-specific antimicrobial activity, and nucleic acid detection, offering new strategies to improve fermentation processes, microbial safety, and the functional properties of food-associated strains. However, experimental evidence varies considerably across microorganisms and applications, and successful genome editing does not necessarily translate into improved technological performance. This review examines recent advances in CRISPR/Cas-based engineering of starter cultures, probiotic strains, and production microorganisms, alongside emerging strategies for bacteriophage resistance, pathogen and biofilm control, and food diagnostics. Particular emphasis is placed on distinguishing applications experimentally validated in food-related settings from proof-of-concept studies conducted in laboratory or biomedical contexts. The review also evaluates the major barriers to industrial implementation, including strain-specific editing efficiency, genetic stability, process robustness, and validation in food matrices. It also considers the distinct biosafety and regulatory implications of production microorganisms removed or inactivated during processing versus viable engineered cultures retained in final products. By integrating advances in molecular engineering with evidence of functional performance and practical implementation requirements, this review highlights both the opportunities and current limitations of CRISPR/Cas technologies in food microbial biotechnology.},
}
RevDate: 2026-11-15
CmpDate: 2026-11-15
HU promotes fidelity and leader-repeat integration during CRISPR adaptation in the type III-A system of Thermotoga profunda.
microLife, 7:uqag038.
CRISPR-Cas adaptive immunity relies on the acquisition of foreign DNA fragments as spacers within CRISPR arrays. Although spacer integration is generally catalysed by the conserved Cas1-Cas2 integrase complex, accurate integration frequently requires accessory factors. In the type I-E CRISPR-Cas system of Escherichia coli, the DNA-binding protein integration host factor (IHF) promotes leader-proximal spacer acquisition. The DNA bending properties of IHF exerted at the CRISPR locus are thought to form the mechanistic basis for the supportive function of IHF. However, many organisms lack IHF posing the questions how integration specificity is achieved in these organisms and whether analogous host factors contribute to adaptation in other CRISPR-Cas systems. Here, we investigated spacer integration in the type III-A CRISPR-Cas system of the hyperthermophilic bacterium Thermotoga profunda. Using reconstituted in vitro integration assays, we show that the TpCas1-TpCas2 complex alone exhibits limited integration fidelity and generates substantial off-target integration events. We identify the highly conserved histone-like protein HU (TpHU) as a critical cofactor for accurate spacer acquisition. Addition of TpHU strongly promotes integration at the leader-repeat junction while suppressing erroneous integration into noncanonical sites. TpHU therefore acts as a determinant of integration fidelity and target-site selection during adaptation.
Additional Links: PMID-43034631
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43034631,
year = {2026},
author = {Seimel, M and Willkomm, S and Grohmann, D},
title = {HU promotes fidelity and leader-repeat integration during CRISPR adaptation in the type III-A system of Thermotoga profunda.},
journal = {microLife},
volume = {7},
number = {},
pages = {uqag038},
pmid = {43034631},
issn = {2633-6693},
abstract = {CRISPR-Cas adaptive immunity relies on the acquisition of foreign DNA fragments as spacers within CRISPR arrays. Although spacer integration is generally catalysed by the conserved Cas1-Cas2 integrase complex, accurate integration frequently requires accessory factors. In the type I-E CRISPR-Cas system of Escherichia coli, the DNA-binding protein integration host factor (IHF) promotes leader-proximal spacer acquisition. The DNA bending properties of IHF exerted at the CRISPR locus are thought to form the mechanistic basis for the supportive function of IHF. However, many organisms lack IHF posing the questions how integration specificity is achieved in these organisms and whether analogous host factors contribute to adaptation in other CRISPR-Cas systems. Here, we investigated spacer integration in the type III-A CRISPR-Cas system of the hyperthermophilic bacterium Thermotoga profunda. Using reconstituted in vitro integration assays, we show that the TpCas1-TpCas2 complex alone exhibits limited integration fidelity and generates substantial off-target integration events. We identify the highly conserved histone-like protein HU (TpHU) as a critical cofactor for accurate spacer acquisition. Addition of TpHU strongly promotes integration at the leader-repeat junction while suppressing erroneous integration into noncanonical sites. TpHU therefore acts as a determinant of integration fidelity and target-site selection during adaptation.},
}
RevDate: 2026-11-18
CmpDate: 2026-11-16
Nanoparticle therapeutics for infectious diseases integrating AI-guided design, crispr delivery, phage synergy, and immune modulation.
Discover nano, 21(1):.
Infectious diseases continue to pose a global health challenge, intensified by antimicrobial resistance and limitations of pharmaceutical countermeasures. Nanotechnology offers a promising front against these barriers using intelligent, multifunctional systems. This review explores the convergence of Artificial Intelligence (AI), CRISPR gene editing, bacteriophage therapy, and immune modulation within the framework of second-generation nanoparticle therapeutics. AI-guided modelling enables predictive optimization of nanoparticle design on the basis of size, charge, and surface proteins, targeting specific pathogens and providing enhanced stability. Consequently, nanoparticles serve as precision nanocarriers and protective delivery vehicles for the CRISPR-Cas system, shielding nucleic acid cargo from enzymatic degradation and enabling targeted intracellular delivery via pH-responsive endosomal escape mechanisms. The nanoparticles not only provide protection but also enable tissue-targeting and infection-site-specific delivery of the CRISPR-Cas system, facilitating precise genome editing to reverse resistance in specific pathogens such as HIV and Mycobacterium tuberculosis. Phage nanoparticle hybrids further expand antimicrobial potency by enhancing phage stability, delivery, and host range. Moreover, engineered nanoparticles modulate the immune system via immunosuppressive and immunostimulant strategies for reducing hyperinflammation and enhancing pathogen clearance, respectively. Despite such encouraging laboratory outcomes, the clinical translation of AI-integrated nanoparticle platforms still faces a number of obstacles. Large-scale manufacturing, scalability, and reproducibility pose a significant challenge. Regulatory approvals for such multi-modal nano-drugs seem to get bogged down due to vague and scarce exemplary proofs. Furthermore, safety and efficacy apprehensions, unpredictable and complex host-phage interactions, cost-effectiveness, and equitable access remain a subject matter of concern. Conclusively, the convergence of advanced nanotechnology, artificial intelligence, and synthetic biology marks the dawn of a transformative era in infectious disease therapeutics where treatment is not only intelligent and adaptive but also ethically and globally inclusive.Clinical trial registrationNot applicable.
Additional Links: PMID-43037917
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43037917,
year = {2026},
author = {Mehmood, MS and Javaid, F and Afroz, E and Saleem, M and Ullah, H and Moh'd, AM and Shahid, I and Nazari, MJ},
title = {Nanoparticle therapeutics for infectious diseases integrating AI-guided design, crispr delivery, phage synergy, and immune modulation.},
journal = {Discover nano},
volume = {21},
number = {1},
pages = {},
pmid = {43037917},
issn = {2731-9229},
abstract = {Infectious diseases continue to pose a global health challenge, intensified by antimicrobial resistance and limitations of pharmaceutical countermeasures. Nanotechnology offers a promising front against these barriers using intelligent, multifunctional systems. This review explores the convergence of Artificial Intelligence (AI), CRISPR gene editing, bacteriophage therapy, and immune modulation within the framework of second-generation nanoparticle therapeutics. AI-guided modelling enables predictive optimization of nanoparticle design on the basis of size, charge, and surface proteins, targeting specific pathogens and providing enhanced stability. Consequently, nanoparticles serve as precision nanocarriers and protective delivery vehicles for the CRISPR-Cas system, shielding nucleic acid cargo from enzymatic degradation and enabling targeted intracellular delivery via pH-responsive endosomal escape mechanisms. The nanoparticles not only provide protection but also enable tissue-targeting and infection-site-specific delivery of the CRISPR-Cas system, facilitating precise genome editing to reverse resistance in specific pathogens such as HIV and Mycobacterium tuberculosis. Phage nanoparticle hybrids further expand antimicrobial potency by enhancing phage stability, delivery, and host range. Moreover, engineered nanoparticles modulate the immune system via immunosuppressive and immunostimulant strategies for reducing hyperinflammation and enhancing pathogen clearance, respectively. Despite such encouraging laboratory outcomes, the clinical translation of AI-integrated nanoparticle platforms still faces a number of obstacles. Large-scale manufacturing, scalability, and reproducibility pose a significant challenge. Regulatory approvals for such multi-modal nano-drugs seem to get bogged down due to vague and scarce exemplary proofs. Furthermore, safety and efficacy apprehensions, unpredictable and complex host-phage interactions, cost-effectiveness, and equitable access remain a subject matter of concern. Conclusively, the convergence of advanced nanotechnology, artificial intelligence, and synthetic biology marks the dawn of a transformative era in infectious disease therapeutics where treatment is not only intelligent and adaptive but also ethically and globally inclusive.Clinical trial registrationNot applicable.},
}
RevDate: 2026-11-16
CmpDate: 2026-11-16
The Traitor Virus approach: A virus-driven CRISPR platform for discovery of antiviral factors and mechanisms.
Advances in virus research, 126:87-123.
Innate defense mechanisms and cellular features determine the outcome of pathogen exposure. Successful viruses, such as HIV-1, have evolved to counteract antiviral defense mechanisms and to manipulate their host cells for effective virus production. Although many restriction factors have been identified, additional antiviral proteins and cellular pathways that restrict viral replication remain to be discovered. Many current approaches involve manipulation of the cells prior to virus exposure, are limited to single-round infection assays, and focus on early steps of the viral replication cycle. To overcome these limitations, we developed the "Traitor Virus" approach, a screening platform combining the CRISPR/Cas9 technology with the replicative fitness of HIV-1. In this system, libraries of replication-competent HIV-1 constructs deliver sgRNAs into Cas9-expressing cells. sgRNAs that inactivate antiviral genes or mechanisms and convert the cells into more effective virus producers enhance HIV-1 replication and become increasingly enriched thereby revealing their cellular opponents by deep sequencing. This chapter discusses the conceptual basis, applications, limitations, and future perspectives of this strategy for dissecting virus-host interactions.
Additional Links: PMID-43039616
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43039616,
year = {2026},
author = {Pastorio, C and Kirchhoff, F},
title = {The Traitor Virus approach: A virus-driven CRISPR platform for discovery of antiviral factors and mechanisms.},
journal = {Advances in virus research},
volume = {126},
number = {},
pages = {87-123},
doi = {10.1016/bs.aivir.2026.09.002},
pmid = {43039616},
issn = {1557-8399},
mesh = {*HIV-1/genetics/physiology/immunology ; Humans ; *Virus Replication ; *CRISPR-Cas Systems ; *Host-Pathogen Interactions ; *HIV Infections/virology/immunology ; *Antiviral Agents/pharmacology ; RNA, Guide, CRISPR-Cas Systems/genetics ; },
abstract = {Innate defense mechanisms and cellular features determine the outcome of pathogen exposure. Successful viruses, such as HIV-1, have evolved to counteract antiviral defense mechanisms and to manipulate their host cells for effective virus production. Although many restriction factors have been identified, additional antiviral proteins and cellular pathways that restrict viral replication remain to be discovered. Many current approaches involve manipulation of the cells prior to virus exposure, are limited to single-round infection assays, and focus on early steps of the viral replication cycle. To overcome these limitations, we developed the "Traitor Virus" approach, a screening platform combining the CRISPR/Cas9 technology with the replicative fitness of HIV-1. In this system, libraries of replication-competent HIV-1 constructs deliver sgRNAs into Cas9-expressing cells. sgRNAs that inactivate antiviral genes or mechanisms and convert the cells into more effective virus producers enhance HIV-1 replication and become increasingly enriched thereby revealing their cellular opponents by deep sequencing. This chapter discusses the conceptual basis, applications, limitations, and future perspectives of this strategy for dissecting virus-host interactions.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*HIV-1/genetics/physiology/immunology
Humans
*Virus Replication
*CRISPR-Cas Systems
*Host-Pathogen Interactions
*HIV Infections/virology/immunology
*Antiviral Agents/pharmacology
RNA, Guide, CRISPR-Cas Systems/genetics
RevDate: 2026-11-16
Genome architecture shapes clustered regularly interspaced short palindromic repeat-Cas off-target potential.
Trends in plant science pii:S1360-1385(26)00339-0 [Epub ahead of print].
Genome editing in plants is widely considered to be precise, yet genome architecture constrains its specificity. Across 47 plant species, genome size and ploidy shaped the predicted off-target landscapes of Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) systems, highlighting the importance of incorporating genome architecture into the molecular characterization and case-specific evaluation of edited crops.
Additional Links: PMID-43039771
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43039771,
year = {2026},
author = {Soulard, C and Mallet, J and Nogué, F},
title = {Genome architecture shapes clustered regularly interspaced short palindromic repeat-Cas off-target potential.},
journal = {Trends in plant science},
volume = {},
number = {},
pages = {},
doi = {10.1016/j.tplants.2026.10.014},
pmid = {43039771},
issn = {1878-4372},
abstract = {Genome editing in plants is widely considered to be precise, yet genome architecture constrains its specificity. Across 47 plant species, genome size and ploidy shaped the predicted off-target landscapes of Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) systems, highlighting the importance of incorporating genome architecture into the molecular characterization and case-specific evaluation of edited crops.},
}
RevDate: 2026-11-18
Retraction notice to "CRISPR-Cas and RNA sequencing reveal nutrient enhancement pathways in quinoa for plant-based athlete recovery diets and future food security" [Int. J. Biol. Macromol. 318 (2025) 144785].
International journal of biological macromolecules pii:S0141-8130(26)05126-3 [Epub ahead of print].
Additional Links: PMID-43039813
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43039813,
year = {2026},
author = {Bu, G and Ma, X and Jin, H and Wang, L},
title = {Retraction notice to "CRISPR-Cas and RNA sequencing reveal nutrient enhancement pathways in quinoa for plant-based athlete recovery diets and future food security" [Int. J. Biol. Macromol. 318 (2025) 144785].},
journal = {International journal of biological macromolecules},
volume = {},
number = {},
pages = {155173},
doi = {10.1016/j.ijbiomac.2026.155173},
pmid = {43039813},
issn = {1879-0003},
}
RevDate: 2026-11-18
CmpDate: 2026-11-18
CRISPR screens for the discovery of novel ferroptosis targets: progress and perspectives.
Biochemical pharmacology, 254(Pt 1):118410.
Ferroptosis is a distinct, iron-dependent form of regulated cell death characterized by lipid peroxidation. Despite its growing significance in physiology and disease, the molecular networks that govern ferroptosis are not yet fully understood. Genome-wide CRISPR screens have broadened the regulatory landscape of ferroptosis by revealing both conserved and context-dependent mechanisms. In this review, we summarize recent advances in CRISPR-based ferroptosis screens, highlighting a transition from in vitro CRISPR screens to in vivo platforms and single-cell CRISPR screens. We also discuss the potential translation of key targets, focusing on their structural druggability and therapeutic potential. By outlining objective-driven screening strategies, this review seeks to provide options for exploring the distinct mechanisms of ferroptosis and to accelerate its translation into therapeutic opportunities for various diseases.
Additional Links: PMID-42685872
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid42685872,
year = {2026},
author = {Yu, W and Cui, Y and Zhao, Q and Luo, L},
title = {CRISPR screens for the discovery of novel ferroptosis targets: progress and perspectives.},
journal = {Biochemical pharmacology},
volume = {254},
number = {Pt 1},
pages = {118410},
doi = {10.1016/j.bcp.2026.118410},
pmid = {42685872},
issn = {1873-2968},
mesh = {*Ferroptosis/drug effects/physiology/genetics ; Humans ; Animals ; *CRISPR-Cas Systems/physiology/genetics ; *Clustered Regularly Interspaced Short Palindromic Repeats/physiology/genetics ; *Drug Discovery/methods/trends ; },
abstract = {Ferroptosis is a distinct, iron-dependent form of regulated cell death characterized by lipid peroxidation. Despite its growing significance in physiology and disease, the molecular networks that govern ferroptosis are not yet fully understood. Genome-wide CRISPR screens have broadened the regulatory landscape of ferroptosis by revealing both conserved and context-dependent mechanisms. In this review, we summarize recent advances in CRISPR-based ferroptosis screens, highlighting a transition from in vitro CRISPR screens to in vivo platforms and single-cell CRISPR screens. We also discuss the potential translation of key targets, focusing on their structural druggability and therapeutic potential. By outlining objective-driven screening strategies, this review seeks to provide options for exploring the distinct mechanisms of ferroptosis and to accelerate its translation into therapeutic opportunities for various diseases.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Ferroptosis/drug effects/physiology/genetics
Humans
Animals
*CRISPR-Cas Systems/physiology/genetics
*Clustered Regularly Interspaced Short Palindromic Repeats/physiology/genetics
*Drug Discovery/methods/trends
RevDate: 2026-11-18
CmpDate: 2026-11-18
ePE-P3-SpRY enables efficient and PAM-flexible prime editing in rice.
The New phytologist, 252(6):2154-2162.
The ePE-P3-SpRY system enables PAM-flexible prime editing in rice.
Additional Links: PMID-42711672
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid42711672,
year = {2026},
author = {Chen, MY and Xu, YQ and Hong, FJ and Zhang, LJ and Jia, M and Wei, C and Wu, LQ and Jia, H and Sun, Y and Wang, C and Zhang, H},
title = {ePE-P3-SpRY enables efficient and PAM-flexible prime editing in rice.},
journal = {The New phytologist},
volume = {252},
number = {6},
pages = {2154-2162},
doi = {10.1111/nph.71568},
pmid = {42711672},
issn = {1469-8137},
support = {K2023002//Shanghai Agricultural Science and Technology Innovation Programs/ ; //the Agriculture Science and Technology Major Project/ ; },
mesh = {*Oryza/genetics ; Plants, Genetically Modified ; *CRISPR-Cas Systems/genetics ; Genome, Plant ; Base Sequence ; },
abstract = {The ePE-P3-SpRY system enables PAM-flexible prime editing in rice.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Oryza/genetics
Plants, Genetically Modified
*CRISPR-Cas Systems/genetics
Genome, Plant
Base Sequence
RevDate: 2026-11-18
CmpDate: 2026-11-18
CRISPR-associated enzymes are mislocalized to the cytoplasm in iPSC-derived neurons, resulting in KRAB(KOX1)-specific degradation.
Cell systems, 17(11):101737.
The use of CRISPR-associated enzymes in induced pluripotent stem cell (iPSC)-derived neurons presents unique challenges compared with dividing cell lines. For example, loss of dCas9-KRAB expression after differentiation has been observed and largely ascribed to transgene silencing. Here, we investigated the expression of CRISPR enzymes in iPSCs and Ngn2-derived neurons. We found that the commonly used dCas9-KRAB(KOX1) displayed a dramatic reduction in protein levels following differentiation, yet nCas9 constructs retained comparable levels. We further found that CRISPR constructs, primarily relying on the SV40 nuclear localization signal (NLS), fail to localize to the nuclei of neurons, despite having robust nuclear levels in iPSCs, leading to KRAB(KOX1)-specific cytoplasmic degradation. By testing other NLSs, we rescued neuronal nuclear localization and protein expression, confirming the contribution of mislocalization to the instability of dCas9-KRAB(KOX1) in neurons. As the lack of nuclear localization can have a profound impact on CRISPR activity, we suggest further investigation across cultured and in vivo postmitotic cell models. A record of this paper's transparent peer review process is included in the supplemental information.
Additional Links: PMID-42777717
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid42777717,
year = {2026},
author = {Cajka, G and Naseri, NN and Liu, MH and Shalem, O},
title = {CRISPR-associated enzymes are mislocalized to the cytoplasm in iPSC-derived neurons, resulting in KRAB(KOX1)-specific degradation.},
journal = {Cell systems},
volume = {17},
number = {11},
pages = {101737},
pmid = {42777717},
issn = {2405-4720},
support = {DP2 GM137416/GM/NIGMS NIH HHS/United States ; K99 AG084855/AG/NIA NIH HHS/United States ; R01 MH137578/MH/NIMH NIH HHS/United States ; R01 NS135829/NS/NINDS NIH HHS/United States ; },
mesh = {*Neurons/metabolism ; *Induced Pluripotent Stem Cells/metabolism ; Cytoplasm/metabolism ; Humans ; CRISPR-Cas Systems/genetics ; Cell Differentiation ; Cell Nucleus/metabolism ; },
abstract = {The use of CRISPR-associated enzymes in induced pluripotent stem cell (iPSC)-derived neurons presents unique challenges compared with dividing cell lines. For example, loss of dCas9-KRAB expression after differentiation has been observed and largely ascribed to transgene silencing. Here, we investigated the expression of CRISPR enzymes in iPSCs and Ngn2-derived neurons. We found that the commonly used dCas9-KRAB(KOX1) displayed a dramatic reduction in protein levels following differentiation, yet nCas9 constructs retained comparable levels. We further found that CRISPR constructs, primarily relying on the SV40 nuclear localization signal (NLS), fail to localize to the nuclei of neurons, despite having robust nuclear levels in iPSCs, leading to KRAB(KOX1)-specific cytoplasmic degradation. By testing other NLSs, we rescued neuronal nuclear localization and protein expression, confirming the contribution of mislocalization to the instability of dCas9-KRAB(KOX1) in neurons. As the lack of nuclear localization can have a profound impact on CRISPR activity, we suggest further investigation across cultured and in vivo postmitotic cell models. A record of this paper's transparent peer review process is included in the supplemental information.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Neurons/metabolism
*Induced Pluripotent Stem Cells/metabolism
Cytoplasm/metabolism
Humans
CRISPR-Cas Systems/genetics
Cell Differentiation
Cell Nucleus/metabolism
RevDate: 2026-11-18
CmpDate: 2026-11-18
Engineering uORFs in wheat improves abiotic stress tolerance without growth penalties.
The New phytologist, 252(6):2461-2477.
Developing climate-resilient crops is critical for ensuring global food security, yet agricultural productivity is frequently constrained by the trade-off between stress tolerance and growth. This challenge is particularly acute in allohexaploid wheat, a staple crop susceptible to abiotic stresses, underscoring the demand for precise gene regulation. Here, we established a simple, efficient, and transgene-free method for regulating gene expression in allohexaploid wheat by disrupting or creating de novo upstream open reading frames (uORFs) via genome editing. Using ribosome profiling, we identified 1199 actively translated uORFs across the wheat genome and developed a dual-luciferase screening pipeline to pinpoint potent translational repressors of positive regulators of abiotic stress. CRISPR/Cas9-mediated disruption of the uORFs in TaCIPK14 and TaGGP1 elevated downstream protein accumulation, thereby enhancing drought, cold, and salt tolerance of plants. Furthermore, base editing was employed to generate de novo uORFs in TaMADS26, effectively downregulating gene expression and improving drought resilience. Notably, both the transgene-free uorfTaGGP1-ACG and uORFTaMADS26 mutants conferred pronounced yield advantages under drought conditions without incurring growth penalties under well-watered conditions. This study provides a predictable and precise way for modulating gene expression, enabling the coordinated improvement of stress resilience and agronomic performance in wheat.
Additional Links: PMID-42892737
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid42892737,
year = {2026},
author = {Si, X and Yan, Y and Bai, S and Guo, G and Xiao, P and Hu, M and Xia, K and Ren, Y and Jiang, J and Fan, R and Ji, X and Wang, Y and Li, H and Dang, T and Gao, Q and Liu, L and Xiong, C and Liu, K and Zhou, Y and Song, CP},
title = {Engineering uORFs in wheat improves abiotic stress tolerance without growth penalties.},
journal = {The New phytologist},
volume = {252},
number = {6},
pages = {2461-2477},
doi = {10.1111/nph.71644},
pmid = {42892737},
issn = {1469-8137},
support = {252300421148//Natural Science Foundation of Henan Province/ ; 32670556//National Natural Science Foundation of China/ ; 32200333//National Natural Science Foundation of China/ ; },
mesh = {*Triticum/genetics/physiology/growth & development ; *Stress, Physiological/genetics ; Gene Expression Regulation, Plant ; Drought Resistance ; Plants, Genetically Modified ; *Open Reading Frames/genetics ; Plant Proteins/metabolism/genetics ; *Adaptation, Physiological/genetics/drug effects ; Droughts ; Mutation/genetics ; CRISPR-Cas Systems/genetics ; Salt Tolerance/genetics ; Gene Editing ; },
abstract = {Developing climate-resilient crops is critical for ensuring global food security, yet agricultural productivity is frequently constrained by the trade-off between stress tolerance and growth. This challenge is particularly acute in allohexaploid wheat, a staple crop susceptible to abiotic stresses, underscoring the demand for precise gene regulation. Here, we established a simple, efficient, and transgene-free method for regulating gene expression in allohexaploid wheat by disrupting or creating de novo upstream open reading frames (uORFs) via genome editing. Using ribosome profiling, we identified 1199 actively translated uORFs across the wheat genome and developed a dual-luciferase screening pipeline to pinpoint potent translational repressors of positive regulators of abiotic stress. CRISPR/Cas9-mediated disruption of the uORFs in TaCIPK14 and TaGGP1 elevated downstream protein accumulation, thereby enhancing drought, cold, and salt tolerance of plants. Furthermore, base editing was employed to generate de novo uORFs in TaMADS26, effectively downregulating gene expression and improving drought resilience. Notably, both the transgene-free uorfTaGGP1-ACG and uORFTaMADS26 mutants conferred pronounced yield advantages under drought conditions without incurring growth penalties under well-watered conditions. This study provides a predictable and precise way for modulating gene expression, enabling the coordinated improvement of stress resilience and agronomic performance in wheat.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Triticum/genetics/physiology/growth & development
*Stress, Physiological/genetics
Gene Expression Regulation, Plant
Drought Resistance
Plants, Genetically Modified
*Open Reading Frames/genetics
Plant Proteins/metabolism/genetics
*Adaptation, Physiological/genetics/drug effects
Droughts
Mutation/genetics
CRISPR-Cas Systems/genetics
Salt Tolerance/genetics
Gene Editing
RevDate: 2026-11-18
CmpDate: 2026-11-18
A targeting delivery platform for the mapping of responses to p53-independent intervention in heterogeneous patient cancer cells.
Journal of materials chemistry. B, 14(44):13783-13795.
Developing new cancer therapeutic strategies has become a central focus in precision oncology. However, a major challenge is the lack of robust models to accurately assess target vulnerability in patient-specific heterogeneous cancer cells, which limits the translation of research findings into effective clinical therapies. In this study, we developed an ex vivo blood-based model utilizing a versatile nano-delivery platform to evaluate the responsiveness of MDM2 knockout as a representative therapeutic approach in circulating malignant cells (CMCs) from patients stratified by their p53 status. In our genome editing plasmid delivery system (p@RPA), protamine sulfate was combined with a cell-penetrating peptide to condense the CRISPR-Cas9 plasmid into nano-cores. These nano-cores were then coated with chondroitin sulfate shells functionalized with the AS1411 aptamer, enabling the selective recognition of CD44 and/or nucleolin overexpressing malignant cells. Using the same vector, a molecular beacon delivery system (MBs@RPA) co-loaded with MBMDM2 for probing MDM2 mRNA, MBTP53 for probing TP53 mRNA and MBTP73 for probing TP73 mRNA was constructed for the in situ evaluation of biomarker changes induced by genome editing. p@RPA demonstrates satisfactory efficacy in mediating gene editing for MDM2 knockout in malignant cells. Notably, the knockout of MDM2 induces cell cycle arrest and leads to a marked upregulation of anti-tumor TAp73 irrespective of their p53 status. With efficient gene editing and mRNA probing achieved in patient-derived CMCs, we establish an ex vivo platform capable of in situ therapeutic efficacy assessment at single-cell resolution to explicitly reveal the underlying cellular heterogeneity across individual CMCs.
Additional Links: PMID-42949002
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid42949002,
year = {2026},
author = {Qi, LJ and Han, D and Huang, QY and Lei, JJ and Yang, CJ and Liao, XR and Gao, QY and Fu, FF and Cheng, SX},
title = {A targeting delivery platform for the mapping of responses to p53-independent intervention in heterogeneous patient cancer cells.},
journal = {Journal of materials chemistry. B},
volume = {14},
number = {44},
pages = {13783-13795},
doi = {10.1039/d6tb01990k},
pmid = {42949002},
issn = {2050-7518},
mesh = {Humans ; *Tumor Suppressor Protein p53/metabolism/genetics ; Proto-Oncogene Proteins c-mdm2/genetics/metabolism ; Cell Line, Tumor ; CRISPR-Cas Systems ; *Neoplasms/pathology ; },
abstract = {Developing new cancer therapeutic strategies has become a central focus in precision oncology. However, a major challenge is the lack of robust models to accurately assess target vulnerability in patient-specific heterogeneous cancer cells, which limits the translation of research findings into effective clinical therapies. In this study, we developed an ex vivo blood-based model utilizing a versatile nano-delivery platform to evaluate the responsiveness of MDM2 knockout as a representative therapeutic approach in circulating malignant cells (CMCs) from patients stratified by their p53 status. In our genome editing plasmid delivery system (p@RPA), protamine sulfate was combined with a cell-penetrating peptide to condense the CRISPR-Cas9 plasmid into nano-cores. These nano-cores were then coated with chondroitin sulfate shells functionalized with the AS1411 aptamer, enabling the selective recognition of CD44 and/or nucleolin overexpressing malignant cells. Using the same vector, a molecular beacon delivery system (MBs@RPA) co-loaded with MBMDM2 for probing MDM2 mRNA, MBTP53 for probing TP53 mRNA and MBTP73 for probing TP73 mRNA was constructed for the in situ evaluation of biomarker changes induced by genome editing. p@RPA demonstrates satisfactory efficacy in mediating gene editing for MDM2 knockout in malignant cells. Notably, the knockout of MDM2 induces cell cycle arrest and leads to a marked upregulation of anti-tumor TAp73 irrespective of their p53 status. With efficient gene editing and mRNA probing achieved in patient-derived CMCs, we establish an ex vivo platform capable of in situ therapeutic efficacy assessment at single-cell resolution to explicitly reveal the underlying cellular heterogeneity across individual CMCs.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Humans
*Tumor Suppressor Protein p53/metabolism/genetics
Proto-Oncogene Proteins c-mdm2/genetics/metabolism
Cell Line, Tumor
CRISPR-Cas Systems
*Neoplasms/pathology
RevDate: 2026-11-18
CmpDate: 2026-11-18
Transcription factor-regulated rolling circle transcription cascaded with Cas12a for sensitive determination of tetracycline.
Talanta, 314:130823.
The ability to perform convenient and user-friendly quantitative analysis of antibiotic residues in water is critical for mitigating ecological risks, yet current methods often suffer from limited sensitivity, fixed detection ranges, or complex procedures. Here, we present a hierarchical cascade signal amplification platform integrating rolling circle transcription (RCT) with CRISPR-Cas12a for one-pot tetracycline (Tc) detection. A rationally designed circular DNA template containing a T7 promoter, a TetR-binding motif, and a crRNA-encoding sequence serves as the molecular switch. In the absence of Tc, TetR binds to the template and blocks transcription. Upon Tc addition, TetR detaches, triggering RCT to produce numerous crRNA copies, which activate Cas12a-mediated trans-cleavage of fluorescent reporters, generating amplified signals. By adjusting the TetR-to-template ratio from 10:1 to 15:1, the detection range can be tuned from 6.0-100 nM to 20-600 nM, with detection limits of 1.35 nM and 16.4 nM, respectively. The system exhibits excellent selectivity against common interferents and achieves satisfactory recoveries (90%-110%) in spiked aquaculture tailwater, with results consistent with HPLC analysis. This platform offers hierarchical signal amplification, one-pot operation, tunable dynamic range, and modular template design, providing a versatile strategy for environmental pollutant monitoring.
Additional Links: PMID-42967393
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid42967393,
year = {2027},
author = {Chen, S and Wang, R and Su, Y and Zhang, J and Li, Z and Xie, S and Du, Z and Liu, J},
title = {Transcription factor-regulated rolling circle transcription cascaded with Cas12a for sensitive determination of tetracycline.},
journal = {Talanta},
volume = {314},
number = {},
pages = {130823},
doi = {10.1016/j.talanta.2026.130823},
pmid = {42967393},
issn = {1873-3573},
mesh = {*Tetracycline/analysis ; *CRISPR-Associated Proteins/genetics/metabolism ; *Transcription Factors/metabolism ; *Transcription, Genetic ; Limit of Detection ; *Anti-Bacterial Agents/analysis ; *CRISPR-Cas Systems ; *Endodeoxyribonucleases/genetics/metabolism ; *Bacterial Proteins/genetics ; },
abstract = {The ability to perform convenient and user-friendly quantitative analysis of antibiotic residues in water is critical for mitigating ecological risks, yet current methods often suffer from limited sensitivity, fixed detection ranges, or complex procedures. Here, we present a hierarchical cascade signal amplification platform integrating rolling circle transcription (RCT) with CRISPR-Cas12a for one-pot tetracycline (Tc) detection. A rationally designed circular DNA template containing a T7 promoter, a TetR-binding motif, and a crRNA-encoding sequence serves as the molecular switch. In the absence of Tc, TetR binds to the template and blocks transcription. Upon Tc addition, TetR detaches, triggering RCT to produce numerous crRNA copies, which activate Cas12a-mediated trans-cleavage of fluorescent reporters, generating amplified signals. By adjusting the TetR-to-template ratio from 10:1 to 15:1, the detection range can be tuned from 6.0-100 nM to 20-600 nM, with detection limits of 1.35 nM and 16.4 nM, respectively. The system exhibits excellent selectivity against common interferents and achieves satisfactory recoveries (90%-110%) in spiked aquaculture tailwater, with results consistent with HPLC analysis. This platform offers hierarchical signal amplification, one-pot operation, tunable dynamic range, and modular template design, providing a versatile strategy for environmental pollutant monitoring.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Tetracycline/analysis
*CRISPR-Associated Proteins/genetics/metabolism
*Transcription Factors/metabolism
*Transcription, Genetic
Limit of Detection
*Anti-Bacterial Agents/analysis
*CRISPR-Cas Systems
*Endodeoxyribonucleases/genetics/metabolism
*Bacterial Proteins/genetics
RevDate: 2026-11-18
CmpDate: 2026-11-18
A background-suppressed CRISPR/Cas13a-HRCA biosensor for ultrasensitive miR-137 detection toward differential screening of Alzheimer's disease.
Talanta, 314:130886.
Alzheimer's disease (AD) is associated with pathological changes that can occur years before the onset of clinical symptoms, highlighting the importance of sensitive biomarker detection for early diagnosis. Here, we developed a fluorescence biosensing platform based on CRISPR/Cas13a-assisted hyperbranched rolling circle amplification (CRISPR/Cas13a-HRCA) for the detection of the AD-related biomarker miR-137. A duplex composed of Linear-Bio and a Cas13a linker strand was first immobilized on streptavidin-coated magnetic beads to construct magnetic probes. In the presence of miR-137, the linker strand was displaced and released into solution through strand exchange and magnetic separation. The released linker activated the CRISPR/Cas13a system via complementary pairing with crRNA, leading to cleavage of the UUU site within the topological DNA reporter (TDR). The cleaved TDR subsequently initiated the HRCA reaction in the presence of Vent DNA polymerase and the P2 probe, generating abundant double-stranded DNA products for fluorescence readout using SYBR Green I. By combining CRISPR/Cas13a amplification, magnetic separation, and label-free fluorescence detection, the platform produced a fluorescence response to miR-137 over 10 fM-100 nM, with an LOD and LOQ of 1.77 and 11.11 fM, respectively. Recoveries ranged from 99% to 106%, with RSDs of 2.2-2.6% in aCSF. Furthermore, the method successfully distinguished cerebrospinal fluid samples from AD patients and healthy individuals, demonstrating its potential for AD-related miRNA analysis.
Additional Links: PMID-42971085
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid42971085,
year = {2027},
author = {Song, J and Yue, H and Zhang, C and Jiao, J and Jiao, J},
title = {A background-suppressed CRISPR/Cas13a-HRCA biosensor for ultrasensitive miR-137 detection toward differential screening of Alzheimer's disease.},
journal = {Talanta},
volume = {314},
number = {},
pages = {130886},
doi = {10.1016/j.talanta.2026.130886},
pmid = {42971085},
issn = {1873-3573},
mesh = {*MicroRNAs/genetics/cerebrospinal fluid ; Humans ; *Biosensing Techniques/methods ; *Alzheimer Disease/diagnosis/genetics/cerebrospinal fluid ; *CRISPR-Cas Systems ; Limit of Detection ; },
abstract = {Alzheimer's disease (AD) is associated with pathological changes that can occur years before the onset of clinical symptoms, highlighting the importance of sensitive biomarker detection for early diagnosis. Here, we developed a fluorescence biosensing platform based on CRISPR/Cas13a-assisted hyperbranched rolling circle amplification (CRISPR/Cas13a-HRCA) for the detection of the AD-related biomarker miR-137. A duplex composed of Linear-Bio and a Cas13a linker strand was first immobilized on streptavidin-coated magnetic beads to construct magnetic probes. In the presence of miR-137, the linker strand was displaced and released into solution through strand exchange and magnetic separation. The released linker activated the CRISPR/Cas13a system via complementary pairing with crRNA, leading to cleavage of the UUU site within the topological DNA reporter (TDR). The cleaved TDR subsequently initiated the HRCA reaction in the presence of Vent DNA polymerase and the P2 probe, generating abundant double-stranded DNA products for fluorescence readout using SYBR Green I. By combining CRISPR/Cas13a amplification, magnetic separation, and label-free fluorescence detection, the platform produced a fluorescence response to miR-137 over 10 fM-100 nM, with an LOD and LOQ of 1.77 and 11.11 fM, respectively. Recoveries ranged from 99% to 106%, with RSDs of 2.2-2.6% in aCSF. Furthermore, the method successfully distinguished cerebrospinal fluid samples from AD patients and healthy individuals, demonstrating its potential for AD-related miRNA analysis.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*MicroRNAs/genetics/cerebrospinal fluid
Humans
*Biosensing Techniques/methods
*Alzheimer Disease/diagnosis/genetics/cerebrospinal fluid
*CRISPR-Cas Systems
Limit of Detection
RevDate: 2026-11-18
CmpDate: 2026-11-18
Virus-like particles enable highly efficient gene editing across porcine and avian in vitro, ex vivo, and in ovo models.
PLoS biology, 24(11):e3004105.
Pigs and chickens are not only the most important livestock species for global food production but also serve as key model organisms in various research disciplines. The pig is widely used in translational research due to its anatomical and physiological similarity to humans, providing valuable insights into immunology, metabolism, and disease mechanisms. In contrast, the chicken has become an essential model for studies related to poultry health, animal welfare, and developmental biology. Its externally developing embryo offers exceptional accessibility for experimental manipulation. Recent advances in genome editing technologies, particularly CRISPR/Cas9, have further expanded the potential of these species for functional genomic studies, although the efficient delivery of such tools remains a major challenge. Here, we overcome this delivery limitation by using virus-like particles (VLPs). We evaluated VLPs as delivery vehicles for genome engineering tools in porcine and avian cultures, two key livestock species at the human-animal interface. VLP-mediated delivery enabled efficient Cre recombination and high CRISPR/Cas9 editing rates in porcine cells, organoids, and oocytes, particularly when multiplexed. In chickens, VLPs supported robust Cre recombination and Cas9-mediated editing in cell culture, tracheal organ cultures, and in ovo. Reporter VLPs and dCas9 VLPs further demonstrated the versatility of this platform across porcine and avian systems. Together, these findings establish VLPs as an efficient and time-saving strategy for gene editing in livestock cultures across in vitro, ex vivo and in ovo systems, with potential future applications for animal health, agricultural productivity, and translational One Health research.
Additional Links: PMID-43013686
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43013686,
year = {2026},
author = {Pauli, TM and von Heyl, T and Rieblinger, B and Schleibinger, ST and Liang, W and Schmauser, A and Arullmoli, M and Derrer, P and Eckstein, A and Jagana, S and Gatti Corrêa, C and Flisikowski, K and Flisikowska, T and Schusser, B},
title = {Virus-like particles enable highly efficient gene editing across porcine and avian in vitro, ex vivo, and in ovo models.},
journal = {PLoS biology},
volume = {24},
number = {11},
pages = {e3004105},
pmid = {43013686},
issn = {1545-7885},
mesh = {Animals ; *Gene Editing/methods ; CRISPR-Cas Systems/genetics ; Swine ; Chickens/genetics ; Chick Embryo ; Humans ; },
abstract = {Pigs and chickens are not only the most important livestock species for global food production but also serve as key model organisms in various research disciplines. The pig is widely used in translational research due to its anatomical and physiological similarity to humans, providing valuable insights into immunology, metabolism, and disease mechanisms. In contrast, the chicken has become an essential model for studies related to poultry health, animal welfare, and developmental biology. Its externally developing embryo offers exceptional accessibility for experimental manipulation. Recent advances in genome editing technologies, particularly CRISPR/Cas9, have further expanded the potential of these species for functional genomic studies, although the efficient delivery of such tools remains a major challenge. Here, we overcome this delivery limitation by using virus-like particles (VLPs). We evaluated VLPs as delivery vehicles for genome engineering tools in porcine and avian cultures, two key livestock species at the human-animal interface. VLP-mediated delivery enabled efficient Cre recombination and high CRISPR/Cas9 editing rates in porcine cells, organoids, and oocytes, particularly when multiplexed. In chickens, VLPs supported robust Cre recombination and Cas9-mediated editing in cell culture, tracheal organ cultures, and in ovo. Reporter VLPs and dCas9 VLPs further demonstrated the versatility of this platform across porcine and avian systems. Together, these findings establish VLPs as an efficient and time-saving strategy for gene editing in livestock cultures across in vitro, ex vivo and in ovo systems, with potential future applications for animal health, agricultural productivity, and translational One Health research.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Animals
*Gene Editing/methods
CRISPR-Cas Systems/genetics
Swine
Chickens/genetics
Chick Embryo
Humans
RevDate: 2026-11-13
CmpDate: 2026-11-13
CRISPR opens the door to targeted therapy against glioblastoma (Review).
International journal of oncology, 69(6):.
The progression in molecular understanding of glioblastoma (GBM) enables the identification of key therapeutic targets, allowing the advances of targeted therapy in GBM. However, to date, most clinical trial results have been disappointing. The clustered regularly interspaced short palindromic repeats (CRISPR) system is a revolutionary genome‑editing tool that has the potential to improve basic research and therapy for GBM. In the present review, the current status and challenges of targeted therapy in GBM are examined. As a potential approach to address the challenges, the development process and application scope of CRISPR are investigated. Furthermore, the application of CRISPR in the study of GBM is explored, mainly by conducting CRISPR screens and employing CRISPR to target genes associated with the malignant phenotype of GBM. Finally, delivery of CRISPR/CRISPR‑associated protein 9 (Cas9) for the treatment of GBM is briefly reviewed.
Additional Links: PMID-43023242
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43023242,
year = {2026},
author = {Zhang, C and Zhang, Y and Song, N and Zhang, L and Zhao, Y and Yao, C},
title = {CRISPR opens the door to targeted therapy against glioblastoma (Review).},
journal = {International journal of oncology},
volume = {69},
number = {6},
pages = {},
doi = {10.3892/ijo.2026.5957},
pmid = {43023242},
issn = {1791-2423},
mesh = {Humans ; *Glioblastoma/genetics/therapy ; *CRISPR-Cas Systems ; *Brain Neoplasms/genetics/therapy ; *Molecular Targeted Therapy/methods ; *Gene Editing/methods ; Animals ; *Genetic Therapy/methods ; },
abstract = {The progression in molecular understanding of glioblastoma (GBM) enables the identification of key therapeutic targets, allowing the advances of targeted therapy in GBM. However, to date, most clinical trial results have been disappointing. The clustered regularly interspaced short palindromic repeats (CRISPR) system is a revolutionary genome‑editing tool that has the potential to improve basic research and therapy for GBM. In the present review, the current status and challenges of targeted therapy in GBM are examined. As a potential approach to address the challenges, the development process and application scope of CRISPR are investigated. Furthermore, the application of CRISPR in the study of GBM is explored, mainly by conducting CRISPR screens and employing CRISPR to target genes associated with the malignant phenotype of GBM. Finally, delivery of CRISPR/CRISPR‑associated protein 9 (Cas9) for the treatment of GBM is briefly reviewed.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Humans
*Glioblastoma/genetics/therapy
*CRISPR-Cas Systems
*Brain Neoplasms/genetics/therapy
*Molecular Targeted Therapy/methods
*Gene Editing/methods
Animals
*Genetic Therapy/methods
RevDate: 2026-11-14
CmpDate: 2026-11-13
Recent approaches to modulate citrinin biosynthesis in Monascus species: a review.
World journal of microbiology & biotechnology, 42(12):.
The filamentous fungi Monascus spp. are rich sources of secondary metabolites that include Monascus azaphilone pigments, monacolin K, and γ-aminobutyric acid, making them significant in the food, nutraceutical, cosmetic and pharmaceutical industries. Despite the industrial importance of this fungus, its production of citrinin, a nephrotoxic polyketide mycotoxin, remains a major drawback and limits its commercial application. Recent research studies have shown that the mechanism that governs citrinin biosynthesis highlights the interactions between Biosynthetic Gene Clusters (BGCs), epigenetic modifications, global regulatory networks, and environmental factors. The current understanding of the molecular and epigenetic mechanisms used to mitigate citrinin production in Monascus spp. is discussed in this review. Emphasis is given on histone acetylation and deacetylation, methylation, chromatin remodeling, the velvet complex, and the modulation of toxin biosynthesis through RNA-level gene expression control. The recent advances are critically evaluated for engineering citrinin-free strains, including transcriptomics, proteomics, multi-omics, RNA interference, CRISPR/Cas genome editing, and synthetic biology. The comparative analysis of these approaches shows that integrating epigenetic engineering with advanced genome and metabolic engineering can regulate citrinin while maintaining other important metabolite yields. Combining multi-omics and artificial intelligence-guided strain design with epigenetic interventions will accelerate the development of safe, sustainable, and high-yielding Monascus-assisted bioprocesses.
Additional Links: PMID-43024006
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43024006,
year = {2026},
author = {Mahesh, T and Subburamu, K and Sundaram, S and Rajendran, P and Subramanian, M and Vishwas, PA},
title = {Recent approaches to modulate citrinin biosynthesis in Monascus species: a review.},
journal = {World journal of microbiology & biotechnology},
volume = {42},
number = {12},
pages = {},
pmid = {43024006},
issn = {1573-0972},
mesh = {*Citrinin/biosynthesis ; *Monascus/genetics/metabolism ; Epigenesis, Genetic ; Gene Expression Regulation, Fungal ; Multigene Family ; Metabolic Engineering/methods ; Secondary Metabolism ; Biosynthetic Pathways/genetics ; Multiomics ; },
abstract = {The filamentous fungi Monascus spp. are rich sources of secondary metabolites that include Monascus azaphilone pigments, monacolin K, and γ-aminobutyric acid, making them significant in the food, nutraceutical, cosmetic and pharmaceutical industries. Despite the industrial importance of this fungus, its production of citrinin, a nephrotoxic polyketide mycotoxin, remains a major drawback and limits its commercial application. Recent research studies have shown that the mechanism that governs citrinin biosynthesis highlights the interactions between Biosynthetic Gene Clusters (BGCs), epigenetic modifications, global regulatory networks, and environmental factors. The current understanding of the molecular and epigenetic mechanisms used to mitigate citrinin production in Monascus spp. is discussed in this review. Emphasis is given on histone acetylation and deacetylation, methylation, chromatin remodeling, the velvet complex, and the modulation of toxin biosynthesis through RNA-level gene expression control. The recent advances are critically evaluated for engineering citrinin-free strains, including transcriptomics, proteomics, multi-omics, RNA interference, CRISPR/Cas genome editing, and synthetic biology. The comparative analysis of these approaches shows that integrating epigenetic engineering with advanced genome and metabolic engineering can regulate citrinin while maintaining other important metabolite yields. Combining multi-omics and artificial intelligence-guided strain design with epigenetic interventions will accelerate the development of safe, sustainable, and high-yielding Monascus-assisted bioprocesses.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Citrinin/biosynthesis
*Monascus/genetics/metabolism
Epigenesis, Genetic
Gene Expression Regulation, Fungal
Multigene Family
Metabolic Engineering/methods
Secondary Metabolism
Biosynthetic Pathways/genetics
Multiomics
RevDate: 2026-11-14
CmpDate: 2026-11-13
Integrative CRISPR-Cas9 dependency analysis identifies CDC45 as a candidate prognostic biomarker with preliminary functional validation in prostate adenocarcinoma.
Journal of molecular histology, 57(6):.
Prostate adenocarcinoma (PRAD) has become one of the most prevalent malignancies in men worldwide. Although advances in diagnostic techniques and targeted therapies have improved clinical outcomes, a significant subset of patients still develops aggressive, metastatic disease with limited treatment options. At present, identifying reliable biomarkers for early risk stratification remains a critical unmet need in prostate cancer research. This study presents a dependency-informed prognostic prioritization approach by integrating multi-omics data to enhance clinical risk stratification in prostate adenocarcinoma (PRAD). Integrated analysis of CRISPR-Cas9 dependency screens and bulk RNA sequencing data prioritized tumor-dependent genes associated with PRAD cell viability. Pathway enrichment analysis indicated the involvement of these candidate genes in cell cycle regulation and tumor progression. Subsequently, an 11-gene prognostic signature was constructed via LASSO regression, effectively stratifying patients, with the high-risk cohort demonstrating significantly reduced Progression-Free Interval (PFI; log-rank p < 0.001). Among the prioritized hub genes, CDC45 exhibited marked upregulation in tumor tissues, which was confirmed by Western blotting and qRT-PCR. Collectively, this study provides a dependency-informed prognostic framework for PRAD and nominates CDC45 as a candidate prognostic biomarker, laying the groundwork for future mechanistically resolved investigations.
Additional Links: PMID-43024108
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43024108,
year = {2026},
author = {Xie, Y and Wang, S and Gao, Y},
title = {Integrative CRISPR-Cas9 dependency analysis identifies CDC45 as a candidate prognostic biomarker with preliminary functional validation in prostate adenocarcinoma.},
journal = {Journal of molecular histology},
volume = {57},
number = {6},
pages = {},
pmid = {43024108},
issn = {1567-2387},
support = {KY28880624//The First Affiliated Hospital of Wannan Medical College Special Fund for Talent Introduction/ ; 202204295107020011//Anhui Provincial Special Fund for Translational Research in Clinical Medicine/ ; },
mesh = {Humans ; Male ; *Prostatic Neoplasms/genetics/pathology/metabolism ; *Adenocarcinoma/genetics/pathology/metabolism ; *Biomarkers, Tumor/genetics/metabolism ; Prognosis ; *CRISPR-Cas Systems/genetics ; *Cell Cycle Proteins/genetics/metabolism ; Gene Expression Regulation, Neoplastic ; Cell Line, Tumor ; Gene Expression Profiling ; },
abstract = {Prostate adenocarcinoma (PRAD) has become one of the most prevalent malignancies in men worldwide. Although advances in diagnostic techniques and targeted therapies have improved clinical outcomes, a significant subset of patients still develops aggressive, metastatic disease with limited treatment options. At present, identifying reliable biomarkers for early risk stratification remains a critical unmet need in prostate cancer research. This study presents a dependency-informed prognostic prioritization approach by integrating multi-omics data to enhance clinical risk stratification in prostate adenocarcinoma (PRAD). Integrated analysis of CRISPR-Cas9 dependency screens and bulk RNA sequencing data prioritized tumor-dependent genes associated with PRAD cell viability. Pathway enrichment analysis indicated the involvement of these candidate genes in cell cycle regulation and tumor progression. Subsequently, an 11-gene prognostic signature was constructed via LASSO regression, effectively stratifying patients, with the high-risk cohort demonstrating significantly reduced Progression-Free Interval (PFI; log-rank p < 0.001). Among the prioritized hub genes, CDC45 exhibited marked upregulation in tumor tissues, which was confirmed by Western blotting and qRT-PCR. Collectively, this study provides a dependency-informed prognostic framework for PRAD and nominates CDC45 as a candidate prognostic biomarker, laying the groundwork for future mechanistically resolved investigations.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Humans
Male
*Prostatic Neoplasms/genetics/pathology/metabolism
*Adenocarcinoma/genetics/pathology/metabolism
*Biomarkers, Tumor/genetics/metabolism
Prognosis
*CRISPR-Cas Systems/genetics
*Cell Cycle Proteins/genetics/metabolism
Gene Expression Regulation, Neoplastic
Cell Line, Tumor
Gene Expression Profiling
RevDate: 2026-11-14
CmpDate: 2026-11-13
Base editing-mediated precision genome engineering in Toxoplasma gondii.
PLoS neglected tropical diseases, 20(11):e0014864.
Functional genomics in Toxoplasma gondii (T. gondii), an obligate intracellular parasite of global medical importance, primarily relies on CRISPR-Cas9-mediated gene disruption. However, conventional CRISPR-Cas9 editing relies on generating double-strand breaks (DSBs), which are repaired either by error-prone non-homologous end joining or by homology-directed repair requiring donor templates and time-consuming clone isolation. Here, we established the first two base editor platforms in T. gondii: adenine base editors (ABEs) and cytosine base editors (CBEs), which enable precise point mutations via direct base conversion without DSBs or donor templates. We successfully employed ABE and CBE to introduce high-efficiency A > G and C > T conversions at defined genomic loci, respectively. By targeting the critical virulence gene ROP18, we demonstrate that ABE-mediated i-Silence (start codon disruption) and CBE-mediated i-STOP (premature stop codon introduction) strategies can efficiently generate functional T. gondii null mutants. The resulting base-edited parasite strains exhibited a complete loss of ROP18 protein expression and showed attenuated virulence and proliferation phenotypes equivalent to those of a conventional ROP18 knockout strain, as validated in both cellular and mouse models. We then conducted a genome-wide analysis predicting that the i-Silence and i-STOP strategies enable targeted inactivation of nearly all genes in the T. gondii genome (>99.6% coverage). Since our approach does not require DSBs, it enables researchers to achieve efficient, precise nucleotide substitutions without the risk of chromosomal rearrangements. We propose base editing as a powerful genetic tool in T. gondii, paving the way for high-resolution functional pathogenesis studies and the further development of genetically stable attenuated vaccines.
Additional Links: PMID-43024681
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43024681,
year = {2026},
author = {Liu, F and Wu, Y and Chen, Z and Liu, X and Yu, L and Shen, J and Xu, Y and Yuan, J and Li, J and Cheng, W},
title = {Base editing-mediated precision genome engineering in Toxoplasma gondii.},
journal = {PLoS neglected tropical diseases},
volume = {20},
number = {11},
pages = {e0014864},
pmid = {43024681},
issn = {1935-2735},
mesh = {*Toxoplasma/genetics/pathogenicity ; Animals ; Mice ; *Genetic Engineering/methods ; Virulence ; *Genome, Protozoan ; Protozoan Proteins/genetics/metabolism ; Female ; CRISPR-Cas Systems ; Protein Serine-Threonine Kinases ; },
abstract = {Functional genomics in Toxoplasma gondii (T. gondii), an obligate intracellular parasite of global medical importance, primarily relies on CRISPR-Cas9-mediated gene disruption. However, conventional CRISPR-Cas9 editing relies on generating double-strand breaks (DSBs), which are repaired either by error-prone non-homologous end joining or by homology-directed repair requiring donor templates and time-consuming clone isolation. Here, we established the first two base editor platforms in T. gondii: adenine base editors (ABEs) and cytosine base editors (CBEs), which enable precise point mutations via direct base conversion without DSBs or donor templates. We successfully employed ABE and CBE to introduce high-efficiency A > G and C > T conversions at defined genomic loci, respectively. By targeting the critical virulence gene ROP18, we demonstrate that ABE-mediated i-Silence (start codon disruption) and CBE-mediated i-STOP (premature stop codon introduction) strategies can efficiently generate functional T. gondii null mutants. The resulting base-edited parasite strains exhibited a complete loss of ROP18 protein expression and showed attenuated virulence and proliferation phenotypes equivalent to those of a conventional ROP18 knockout strain, as validated in both cellular and mouse models. We then conducted a genome-wide analysis predicting that the i-Silence and i-STOP strategies enable targeted inactivation of nearly all genes in the T. gondii genome (>99.6% coverage). Since our approach does not require DSBs, it enables researchers to achieve efficient, precise nucleotide substitutions without the risk of chromosomal rearrangements. We propose base editing as a powerful genetic tool in T. gondii, paving the way for high-resolution functional pathogenesis studies and the further development of genetically stable attenuated vaccines.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Toxoplasma/genetics/pathogenicity
Animals
Mice
*Genetic Engineering/methods
Virulence
*Genome, Protozoan
Protozoan Proteins/genetics/metabolism
Female
CRISPR-Cas Systems
Protein Serine-Threonine Kinases
RevDate: 2026-11-14
CmpDate: 2026-11-13
GEX1-mediated semigamy induces both maternal and paternal haploids in cotton.
Science advances, 12(46):eaei1433.
How semigamy generates haploids during double fertilization has remained elusive for more than six decades. Here, we identify Gamete Expressed 1 (GEX1) as the gene underlying semigamy and show that it mediates dual-origin haploid induction in cotton. A naturally occurring mutation in GEX1 disrupts normal nuclear membrane fusion during fertilization, resulting in delayed or incomplete karyogamy. Cytological analyses reveal that delayed karyogamy allows the closely apposed but unfused gametic nuclei to undergo independent mitotic divisions, giving rise to maternal haploids, paternal haploids, and chimeric progeny. CRISPR-Cas9-mediated disruption of GEX1 reproduced the characteristic defects in nuclear fusion and enabled both maternal and paternal haploid induction within a single generation. Together, our findings uncover a genetically tractable mechanism underlying semigamy that links nuclear membrane fusion dynamics to haploid formation and establish a versatile strategy for rapidly generating doubled haploids from both parental genomes to accelerate crop breeding.
Additional Links: PMID-43024697
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43024697,
year = {2026},
author = {Li, T and Pan, J and Li, Y and Yao, J and Fang, S and Cao, Z and Zhu, S and Zhang, Y and Chen, W},
title = {GEX1-mediated semigamy induces both maternal and paternal haploids in cotton.},
journal = {Science advances},
volume = {12},
number = {46},
pages = {eaei1433},
pmid = {43024697},
issn = {2375-2548},
mesh = {*Haploidy ; *Gossypium/genetics ; *Plant Proteins/genetics/metabolism ; CRISPR-Cas Systems ; Mutation ; Fertilization/genetics ; },
abstract = {How semigamy generates haploids during double fertilization has remained elusive for more than six decades. Here, we identify Gamete Expressed 1 (GEX1) as the gene underlying semigamy and show that it mediates dual-origin haploid induction in cotton. A naturally occurring mutation in GEX1 disrupts normal nuclear membrane fusion during fertilization, resulting in delayed or incomplete karyogamy. Cytological analyses reveal that delayed karyogamy allows the closely apposed but unfused gametic nuclei to undergo independent mitotic divisions, giving rise to maternal haploids, paternal haploids, and chimeric progeny. CRISPR-Cas9-mediated disruption of GEX1 reproduced the characteristic defects in nuclear fusion and enabled both maternal and paternal haploid induction within a single generation. Together, our findings uncover a genetically tractable mechanism underlying semigamy that links nuclear membrane fusion dynamics to haploid formation and establish a versatile strategy for rapidly generating doubled haploids from both parental genomes to accelerate crop breeding.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Haploidy
*Gossypium/genetics
*Plant Proteins/genetics/metabolism
CRISPR-Cas Systems
Mutation
Fertilization/genetics
RevDate: 2026-11-13
Recent advances in design strategies for rapid mycoplasma detection: Towards point-of-care testing.
Talanta, 315:130913 pii:S0039-9140(26)01569-9 [Epub ahead of print].
Mycoplasma pathogens present significant challenges for clinical point-of-care testing (POCT) due to their pathogenicity, public health implications, and the limitations of conventional detection methods. This review systematically summarizes recent advances in rapid mycoplasma detection technologies, with emphasis on sensing design principles, technical bottlenecks, innovative solutions, and clinical performance. Three major technology systems are comprehensively discussed: (1) Molecular diagnostic platforms, focusing on optimization strategies for non-CRISPR isothermal amplification and CRISPR/Cas-based systems that leverage collateral cleavage for ultra-sensitive detection; (2) Emerging biosensing technologies, encompassing colorimetric, fluorescence, and electrochemical modalities, with detailed analysis of transducer functionalization and signal transduction mechanisms; and (3) Lateral flow assays (LFAs), highlighting innovative signal amplification strategies for rapid nucleic acid and antigen/antibody testing. Furthermore, the integration of mass spectrometry (MS) with metabolomics for high-throughput metabolic profiling is examined. Finally, we discuss the core challenges of mycoplasma POCT, including sample preparation, matching detection technologies to the unique biological traits of Mycoplasma, and use cases such as at-home testing. Building on these challenges, we also outline future prospects: discrimination between viable and non-viable organisms, resistance-informed testing, and device-level integration. These insights collectively define a roadmap for next-generation 'sample-to-answer' POCT devices. This review aims to bridge the gap between laboratory innovation and clinical diagnostics for mycoplasma management.
Additional Links: PMID-43025037
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43025037,
year = {2026},
author = {Xu, Z and Yuan, Y and Ye, T and Gong, X and Li, D and Ding, Y and Li, Z and Chen, R and Deng, X and Li, Y and He, K and Liu, X and Cui, R and Li, D and Xu, L},
title = {Recent advances in design strategies for rapid mycoplasma detection: Towards point-of-care testing.},
journal = {Talanta},
volume = {315},
number = {},
pages = {130913},
doi = {10.1016/j.talanta.2026.130913},
pmid = {43025037},
issn = {1873-3573},
abstract = {Mycoplasma pathogens present significant challenges for clinical point-of-care testing (POCT) due to their pathogenicity, public health implications, and the limitations of conventional detection methods. This review systematically summarizes recent advances in rapid mycoplasma detection technologies, with emphasis on sensing design principles, technical bottlenecks, innovative solutions, and clinical performance. Three major technology systems are comprehensively discussed: (1) Molecular diagnostic platforms, focusing on optimization strategies for non-CRISPR isothermal amplification and CRISPR/Cas-based systems that leverage collateral cleavage for ultra-sensitive detection; (2) Emerging biosensing technologies, encompassing colorimetric, fluorescence, and electrochemical modalities, with detailed analysis of transducer functionalization and signal transduction mechanisms; and (3) Lateral flow assays (LFAs), highlighting innovative signal amplification strategies for rapid nucleic acid and antigen/antibody testing. Furthermore, the integration of mass spectrometry (MS) with metabolomics for high-throughput metabolic profiling is examined. Finally, we discuss the core challenges of mycoplasma POCT, including sample preparation, matching detection technologies to the unique biological traits of Mycoplasma, and use cases such as at-home testing. Building on these challenges, we also outline future prospects: discrimination between viable and non-viable organisms, resistance-informed testing, and device-level integration. These insights collectively define a roadmap for next-generation 'sample-to-answer' POCT devices. This review aims to bridge the gap between laboratory innovation and clinical diagnostics for mycoplasma management.},
}
RevDate: 2026-11-14
CmpDate: 2026-11-14
Point-of-Care Testing for Aquatic Animal Disease Diagnosis: A Socio-Technical Review of Technologies Enabling Sustainable Aquaculture and Blue Food Security.
Animals : an open access journal from MDPI, 16(21):.
Disease outbreaks are among the principal constraints on the sustainability of global aquaculture, yet diagnostic capacity remains concentrated in centralized laboratories far from the point of production. Point-of-care testing (POCT)-immunochromatographic strips, isothermal amplification (LAMP, RPA/RAA), CRISPR-Cas assays, microfluidics and biosensors-can compress the diagnosis-to-intervention window from days to about an hour. This structured narrative review draws on a documented search of the Web of Science Core Collection, Scopus, PubMed and the China National Knowledge Infrastructure (2000-2026), with explicit inclusion criteria and a three-tier evidence-grading scheme (Section Review Methodology and Evidence Grading). We synthesize the evidence in the following three tiers: the technical landscape, comparing eight representative platform classes on sensitivity, turnaround, instrument dependence and deployment maturity; the application geography, tracing how POCT has entered pond-side screening, hatchery biosecurity, border inspection of live aquatic trade and IoT-based surveillance networks across East Asian freshwater, Indo-Pacific shrimp and North Atlantic salmonid systems, with markedly uneven evidence of routine adoption; and the bottlenecks that determine whether analytical performance becomes a sustainability outcome-sample-matrix interference, cold-chain dependence, the absence of unified field-performance standards (with WOAH diagnostic-kit registration suspended from May 2024 to May 2027), ambiguous legal status of POCT results, and smallholder affordability. Adopting a sustainability-transition perspective, we argue that the binding constraint is no longer assay chemistry but socio-technical governance, and that POCT should be positioned as enabling infrastructure for antimicrobial stewardship (SDG 3), loss avoidance and trade resilience (SDG 2/12), and aquatic ecosystem protection (SDG 14). We close with coordinated action imperatives for researchers, standard setters, policymakers and industry, including field-validation-first study designs and use of the 2024-2027 standards window to establish graded performance claims for on-site aquatic diagnostics.
Additional Links: PMID-43027249
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43027249,
year = {2026},
author = {Jiang, N and Zhang, Y and Yu, H and Zhang, X},
title = {Point-of-Care Testing for Aquatic Animal Disease Diagnosis: A Socio-Technical Review of Technologies Enabling Sustainable Aquaculture and Blue Food Security.},
journal = {Animals : an open access journal from MDPI},
volume = {16},
number = {21},
pages = {},
pmid = {43027249},
issn = {2076-2615},
support = {KJCX20261207//Beijing Academy of Agriculture and Forestry Sciences/ ; GHPT2026-16//Chinese Academy of Agricultural Sciences/ ; PT2026-19//National Engineering Research Center for Freshwaters/ ; },
abstract = {Disease outbreaks are among the principal constraints on the sustainability of global aquaculture, yet diagnostic capacity remains concentrated in centralized laboratories far from the point of production. Point-of-care testing (POCT)-immunochromatographic strips, isothermal amplification (LAMP, RPA/RAA), CRISPR-Cas assays, microfluidics and biosensors-can compress the diagnosis-to-intervention window from days to about an hour. This structured narrative review draws on a documented search of the Web of Science Core Collection, Scopus, PubMed and the China National Knowledge Infrastructure (2000-2026), with explicit inclusion criteria and a three-tier evidence-grading scheme (Section Review Methodology and Evidence Grading). We synthesize the evidence in the following three tiers: the technical landscape, comparing eight representative platform classes on sensitivity, turnaround, instrument dependence and deployment maturity; the application geography, tracing how POCT has entered pond-side screening, hatchery biosecurity, border inspection of live aquatic trade and IoT-based surveillance networks across East Asian freshwater, Indo-Pacific shrimp and North Atlantic salmonid systems, with markedly uneven evidence of routine adoption; and the bottlenecks that determine whether analytical performance becomes a sustainability outcome-sample-matrix interference, cold-chain dependence, the absence of unified field-performance standards (with WOAH diagnostic-kit registration suspended from May 2024 to May 2027), ambiguous legal status of POCT results, and smallholder affordability. Adopting a sustainability-transition perspective, we argue that the binding constraint is no longer assay chemistry but socio-technical governance, and that POCT should be positioned as enabling infrastructure for antimicrobial stewardship (SDG 3), loss avoidance and trade resilience (SDG 2/12), and aquatic ecosystem protection (SDG 14). We close with coordinated action imperatives for researchers, standard setters, policymakers and industry, including field-validation-first study designs and use of the 2024-2027 standards window to establish graded performance claims for on-site aquatic diagnostics.},
}
RevDate: 2026-11-14
CmpDate: 2026-11-14
CRISPR-Based Engineering of Mesenchymal Stem Cells: Functional Enhancement, Translational Challenges, and Clinical Perspectives.
Cells, 15(21):.
Mesenchymal stem cells (MSCs) are promising platforms for regenerative and immunomodulatory therapies, but their clinical performance is limited by donor heterogeneity, variable potency, and limited persistence. CRISPR-based engineering provides programmable approaches to modify MSC function through genome editing and transcriptional regulation. This review examines CRISPR/Cas9-mediated knockout and knock-in, dCas9-based transcriptional regulation, and emerging base-, prime-, and epigenome-editing technologies for MSC engineering. These approaches can enhance survival and stress resistance, homing and tissue retention, paracrine and extracellular vesicle activity, immunomodulation, immune compatibility, and lineage-associated functions. Key translational challenges include efficient delivery, engineered-population heterogeneity, genomic safety, immunogenicity, phenotypic stability, scalable manufacturing, and mechanism-linked potency assessment. The appropriate engineering strategy should therefore be selected according to the intended therapeutic mechanism and product development requirements. Clinical translation will ultimately depend on demonstrating reproducible functional enhancement, manufacturing consistency, genomic and phenotypic stability, and validated therapeutic potency.
Additional Links: PMID-43027384
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43027384,
year = {2026},
author = {Facicilia, G and Sartika, CR and Hadisaputri, YE and Rostinawati, T},
title = {CRISPR-Based Engineering of Mesenchymal Stem Cells: Functional Enhancement, Translational Challenges, and Clinical Perspectives.},
journal = {Cells},
volume = {15},
number = {21},
pages = {},
pmid = {43027384},
issn = {2073-4409},
mesh = {*Mesenchymal Stem Cells/metabolism/cytology ; Humans ; *CRISPR-Cas Systems/genetics ; Animals ; *Gene Editing/methods ; *Translational Research, Biomedical ; Epigenome Editing ; },
abstract = {Mesenchymal stem cells (MSCs) are promising platforms for regenerative and immunomodulatory therapies, but their clinical performance is limited by donor heterogeneity, variable potency, and limited persistence. CRISPR-based engineering provides programmable approaches to modify MSC function through genome editing and transcriptional regulation. This review examines CRISPR/Cas9-mediated knockout and knock-in, dCas9-based transcriptional regulation, and emerging base-, prime-, and epigenome-editing technologies for MSC engineering. These approaches can enhance survival and stress resistance, homing and tissue retention, paracrine and extracellular vesicle activity, immunomodulation, immune compatibility, and lineage-associated functions. Key translational challenges include efficient delivery, engineered-population heterogeneity, genomic safety, immunogenicity, phenotypic stability, scalable manufacturing, and mechanism-linked potency assessment. The appropriate engineering strategy should therefore be selected according to the intended therapeutic mechanism and product development requirements. Clinical translation will ultimately depend on demonstrating reproducible functional enhancement, manufacturing consistency, genomic and phenotypic stability, and validated therapeutic potency.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Mesenchymal Stem Cells/metabolism/cytology
Humans
*CRISPR-Cas Systems/genetics
Animals
*Gene Editing/methods
*Translational Research, Biomedical
Epigenome Editing
RevDate: 2026-11-14
CmpDate: 2026-11-14
Integrated Multi-Omics Analysis of the Response of Lycium barbarum 'Ningqi-1' to Powdery Mildew Infection and Functional Characterization of LbMLO6.
International journal of molecular sciences, 27(21):.
Powdery mildew severely constrains the production of Lycium barbarum L., yet the molecular mechanisms underlying its response to infection remain poorly understood. Here, 'Ningqi-1' plants were inoculated with the powdery mildew pathogen and sampled at 0, 12, 24, and 48 hpi for integrated transcriptomic, proteomic, and metabolomic analyses. Quantitative PCR and CRISPR/Cas9-mediated gene editing were further used to evaluate the candidate susceptibility gene LbMLO6. Infection induced extensive molecular reprogramming, yielding 1299 differentially expressed genes with sustained changes, 75 DAPs shared across all three time points, and 127 shared differentially accumulated metabolites. These molecules were mainly enriched in plant-pathogen interaction, plant hormone signal transduction, MAPK signaling, phenylpropanoid biosynthesis, and α-linolenic acid metabolism pathways, suggesting coordinated roles for Ca[2+] signaling, reactive oxygen species, defense-related proteins, and secondary metabolism in the host response. Integrated multi-omics analysis identified LbMLO6 as a candidate gene associated with powdery mildew susceptibility, its expression was markedly induced from 24 hpi onward. CRISPR/Cas9-edited LbMLO6 lines showed reduced fungal development compared with the control, particularly during the early stages of infection. These findings provide preliminary evidence that LbMLO6 may be associated with powdery mildew susceptibility in L. barbarum.
Additional Links: PMID-43027668
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43027668,
year = {2026},
author = {Xu, W and Luo, L and Wang, J and Ren, R and Zhou, J and Wang, C and Qin, K and Li, Y and Li, Y and Zhang, X and Wang, J and Si, B and Duan, L and Dai, G},
title = {Integrated Multi-Omics Analysis of the Response of Lycium barbarum 'Ningqi-1' to Powdery Mildew Infection and Functional Characterization of LbMLO6.},
journal = {International journal of molecular sciences},
volume = {27},
number = {21},
pages = {},
pmid = {43027668},
issn = {1422-0067},
support = {2021BEF02005//Education Department of Ningxia Hui Autonomous Region/ ; 2022AAC03290//Science and Technology Department of Ningxia/ ; (2025BG319)//North Minzu University/ ; 1700009002//Ningxia·Hui·Autonomous·Region·Youth·Science·and·Technology·Talent· Support·Program/ ; },
mesh = {*Plant Diseases/microbiology/genetics ; Multiomics ; *Ascomycota/pathogenicity ; *Lycium/microbiology/genetics/metabolism ; *Plant Proteins/genetics/metabolism ; Disease Resistance/genetics ; Host-Pathogen Interactions/genetics ; Gene Expression Regulation, Plant ; Metabolomics/methods ; Proteomics/methods ; CRISPR-Cas Systems ; Gene Expression Profiling ; Gene Editing ; Transcriptome ; },
abstract = {Powdery mildew severely constrains the production of Lycium barbarum L., yet the molecular mechanisms underlying its response to infection remain poorly understood. Here, 'Ningqi-1' plants were inoculated with the powdery mildew pathogen and sampled at 0, 12, 24, and 48 hpi for integrated transcriptomic, proteomic, and metabolomic analyses. Quantitative PCR and CRISPR/Cas9-mediated gene editing were further used to evaluate the candidate susceptibility gene LbMLO6. Infection induced extensive molecular reprogramming, yielding 1299 differentially expressed genes with sustained changes, 75 DAPs shared across all three time points, and 127 shared differentially accumulated metabolites. These molecules were mainly enriched in plant-pathogen interaction, plant hormone signal transduction, MAPK signaling, phenylpropanoid biosynthesis, and α-linolenic acid metabolism pathways, suggesting coordinated roles for Ca[2+] signaling, reactive oxygen species, defense-related proteins, and secondary metabolism in the host response. Integrated multi-omics analysis identified LbMLO6 as a candidate gene associated with powdery mildew susceptibility, its expression was markedly induced from 24 hpi onward. CRISPR/Cas9-edited LbMLO6 lines showed reduced fungal development compared with the control, particularly during the early stages of infection. These findings provide preliminary evidence that LbMLO6 may be associated with powdery mildew susceptibility in L. barbarum.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Plant Diseases/microbiology/genetics
Multiomics
*Ascomycota/pathogenicity
*Lycium/microbiology/genetics/metabolism
*Plant Proteins/genetics/metabolism
Disease Resistance/genetics
Host-Pathogen Interactions/genetics
Gene Expression Regulation, Plant
Metabolomics/methods
Proteomics/methods
CRISPR-Cas Systems
Gene Expression Profiling
Gene Editing
Transcriptome
RevDate: 2026-11-14
CmpDate: 2026-11-14
Raffinose in Brassica Crops: Integrating Plant Stress Physiology, Food Quality, Nutrition and Precision Breeding.
International journal of molecular sciences, 27(21):.
Raffinose-family oligosaccharides (RFOs) have nutritional and physiological significance that cannot be inferred from concentration alone. In Brassica, interpretation of their food value and definition of breeding targets require consideration of edible organ, environmental history, analytical resolution, and intended use. This critical review integrates evidence on RFO composition, plant physiology, food quality, and nutrition with an evidence-weighted assessment of conventional breeding, genetic transformation, and new genomic techniques. Direct Brassica experiments are distinguished from evidence derived from soybean and Arabidopsis and from prospective applications. Direct studies demonstrate that RFO metabolism in Brassica is manipulable, but they do not support a universal strategy for improving vegetable or meal quality. Genome-editing studies in soybean further show that reductions in total RFOs may coexist with increased raffinose and that lower RFO concentrations do not themselves demonstrate nutritional benefit. Tissue-specific regulation may offer a route to balance seed composition with stress responses, although genotype-dependent regeneration remains an important constraint. A three-tier framework is therefore proposed in which raffinose is interpreted as a stress-responsive metabolite, a potential food-quality indicator, and a context-dependent nutritional component. Compound-specific phenotyping, functional validation, and product-relevant physiological testing should precede deployment of low-RFO or stress-responsive Brassica material.
Additional Links: PMID-43027908
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43027908,
year = {2026},
author = {Czernicka, M and Czernicka, M},
title = {Raffinose in Brassica Crops: Integrating Plant Stress Physiology, Food Quality, Nutrition and Precision Breeding.},
journal = {International journal of molecular sciences},
volume = {27},
number = {21},
pages = {},
pmid = {43027908},
issn = {1422-0067},
mesh = {*Raffinose/metabolism ; *Brassica/metabolism/genetics/physiology ; *Plant Breeding ; *Stress, Physiological ; *Crops, Agricultural/metabolism/genetics ; Food Quality ; Nutritive Value ; },
abstract = {Raffinose-family oligosaccharides (RFOs) have nutritional and physiological significance that cannot be inferred from concentration alone. In Brassica, interpretation of their food value and definition of breeding targets require consideration of edible organ, environmental history, analytical resolution, and intended use. This critical review integrates evidence on RFO composition, plant physiology, food quality, and nutrition with an evidence-weighted assessment of conventional breeding, genetic transformation, and new genomic techniques. Direct Brassica experiments are distinguished from evidence derived from soybean and Arabidopsis and from prospective applications. Direct studies demonstrate that RFO metabolism in Brassica is manipulable, but they do not support a universal strategy for improving vegetable or meal quality. Genome-editing studies in soybean further show that reductions in total RFOs may coexist with increased raffinose and that lower RFO concentrations do not themselves demonstrate nutritional benefit. Tissue-specific regulation may offer a route to balance seed composition with stress responses, although genotype-dependent regeneration remains an important constraint. A three-tier framework is therefore proposed in which raffinose is interpreted as a stress-responsive metabolite, a potential food-quality indicator, and a context-dependent nutritional component. Compound-specific phenotyping, functional validation, and product-relevant physiological testing should precede deployment of low-RFO or stress-responsive Brassica material.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Raffinose/metabolism
*Brassica/metabolism/genetics/physiology
*Plant Breeding
*Stress, Physiological
*Crops, Agricultural/metabolism/genetics
Food Quality
Nutritive Value
RevDate: 2026-11-17
CmpDate: 2026-11-17
Gene-edited live-attenuated vaccines against Toxoplasma gondii: recent advances and future frontiers.
Parasites & vectors, 19(1):.
Toxoplasma gondii is a protozoan parasite that infects nearly one third of the world's population and endangers the health of immunocompromised people, pregnant women, and livestock. There are no existing drugs able to treat the infection and prevent tissue cysts from developing. Therefore, the creation of a safe vaccine should be considered as a matter of great importance. While many of the vaccines have not proven successful in the past, recently created live-attenuated vaccines (LAVs) using CRISPR-Cas9 gene editing technology were able to outperform the previous ones. The current review aims to highlight the recent progress in genetically engineered LAVs against T. gondii. In particular, the knockout strains affecting metabolic genes (ompdc, uprt, and adsl), virulence genes (rop18), and host-parasite interactions (gra5, gra72, had2a, and cdpk3) will be mentioned. LAVs described above demonstrate high attenuating effects and ability to protect mice by inducing immunity on the basis of specific IgG (IgG2a), IFN-γ, IL-12, and CD4[+], CD8[+] T cells. Furthermore, vaccination provides protection from a lethal infection caused by types I, II, and Chinese 1 strains of T. gondii as well as preventing development of tissue cysts in chronic infection. RHΔompdcΔuprt is an example of an LAV that can be used to reduce oocyst shedding in cats and promote the One Health concept. In general terms, genetically engineered LAVs can effectively deal with toxoplasmosis infection with better attenuation immunogenicity balance than other vaccines. Nonetheless, several problems need consideration.
Additional Links: PMID-42252477
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid42252477,
year = {2026},
author = {Sang, X and Zhang, H and Zhang, Y and Jin, Y and Sun, F and Feng, Y and Al-Olayan, E and Yang, N and El-Ashram, S},
title = {Gene-edited live-attenuated vaccines against Toxoplasma gondii: recent advances and future frontiers.},
journal = {Parasites & vectors},
volume = {19},
number = {1},
pages = {},
pmid = {42252477},
issn = {1756-3305},
support = {31902297//National Natural Science Foundation of China/ ; 32072891//National Natural Science Foundation of China/ ; 32373039//National Natural Science Foundation of China/ ; 31672546//National Natural Science Foundation of China/ ; 2025-MSLH-610//Liaoning Provincial Science and Technology Joint Program/ ; ORF-RC-2026-4500//Ongoing Research Funding Program-Research chairs/ ; },
mesh = {*Toxoplasma/immunology/genetics ; *Protozoan Vaccines/immunology/genetics ; Vaccines, Attenuated/immunology/genetics ; Animals ; *Gene Editing ; Humans ; *Toxoplasmosis/prevention & control/immunology ; Protozoan Proteins/genetics/immunology ; CRISPR-Cas Systems ; Mice ; Antibodies, Protozoan ; Toxoplasmosis, Animal/prevention & control ; },
abstract = {Toxoplasma gondii is a protozoan parasite that infects nearly one third of the world's population and endangers the health of immunocompromised people, pregnant women, and livestock. There are no existing drugs able to treat the infection and prevent tissue cysts from developing. Therefore, the creation of a safe vaccine should be considered as a matter of great importance. While many of the vaccines have not proven successful in the past, recently created live-attenuated vaccines (LAVs) using CRISPR-Cas9 gene editing technology were able to outperform the previous ones. The current review aims to highlight the recent progress in genetically engineered LAVs against T. gondii. In particular, the knockout strains affecting metabolic genes (ompdc, uprt, and adsl), virulence genes (rop18), and host-parasite interactions (gra5, gra72, had2a, and cdpk3) will be mentioned. LAVs described above demonstrate high attenuating effects and ability to protect mice by inducing immunity on the basis of specific IgG (IgG2a), IFN-γ, IL-12, and CD4[+], CD8[+] T cells. Furthermore, vaccination provides protection from a lethal infection caused by types I, II, and Chinese 1 strains of T. gondii as well as preventing development of tissue cysts in chronic infection. RHΔompdcΔuprt is an example of an LAV that can be used to reduce oocyst shedding in cats and promote the One Health concept. In general terms, genetically engineered LAVs can effectively deal with toxoplasmosis infection with better attenuation immunogenicity balance than other vaccines. Nonetheless, several problems need consideration.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Toxoplasma/immunology/genetics
*Protozoan Vaccines/immunology/genetics
Vaccines, Attenuated/immunology/genetics
Animals
*Gene Editing
Humans
*Toxoplasmosis/prevention & control/immunology
Protozoan Proteins/genetics/immunology
CRISPR-Cas Systems
Mice
Antibodies, Protozoan
Toxoplasmosis, Animal/prevention & control
RevDate: 2026-11-17
CmpDate: 2026-11-17
Genome-wide CRISPR-Cas9-based screening revealed the role of ubiquitin ligase TRIM25 in ribosome degradation via ribophagy.
Autophagy, 22(12):3599-3614.
Ribophagy is a crucial mechanism that maintains ribosome homeostasis in the cell by directing nonfunctional ribosomes to degradation via macroautophagy/autophagy. Impaired ribophagy may lead to ribosome quality control disorders and may consequently be associated with various diseases known as ribosomopathies. This topic has been actively studied over the past decade, but the complete mechanism of ribophagy is not fully understood. To study the mechanism of ribophagy, we performed a genome-wide CRISPR-Cas9-based screening using a fluorescent ribophagy reporter, which is a cell line with ribosomes carrying RPL29 fused with mCherry and GFP fluorescent proteins. Using the genome-wide Brunello library of guide RNAs, we identified the most promising targets for further study, including the ubiquitin ligase TRIM25, for which we have shown specific binding to the ribosome during ribophagy induction, leading to ubiquitination of the ribosome on the nascent peptide chain and degradation of the whole ribosome. Our findings also demonstrated that poly(I:C) treatment, which mimics viral infection, activates ribophagy in a TRIM25-dependent manner, suggesting the ribophagy pathway could be an antiviral defense mechanism. Taken together, we discovered a novel regulator of ribophagy, TRIM25, which provides new insights into the regulation of selective autophagy in the context of ribosomopathies.Abbreviations: CHX: cycloheximide; FACS: fluorescence-activated cell sorting; GFP: green fluorescent protein; MAGeCK: model-based Analysis of Genome-wide CRISPR-Cas9 Knockout; MOI: multiplicity of infection; poly(I:C): polyinosinic:polycytidylic acid; RFP: red fluorescent protein.
Additional Links: PMID-42438948
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid42438948,
year = {2026},
author = {Golubeva, J and Mikhailov, A and Shepelev, N and Pleshko, E and Guseva, E and Sidorova, V and Shagimardanova, E and Andrianova, N and Plotnikov, E and Karpov, D and Novikova, S and Zgoda, V and Rubtsova, M and Dontsova, O and Sergiev, P},
title = {Genome-wide CRISPR-Cas9-based screening revealed the role of ubiquitin ligase TRIM25 in ribosome degradation via ribophagy.},
journal = {Autophagy},
volume = {22},
number = {12},
pages = {3599-3614},
doi = {10.1080/15548627.2026.2702255},
pmid = {42438948},
issn = {1554-8635},
mesh = {*CRISPR-Cas Systems/genetics ; Humans ; *Ubiquitin-Protein Ligases/metabolism/genetics ; *Ribosomes/metabolism ; *Tripartite Motif Proteins/metabolism/genetics ; *Transcription Factors/metabolism/genetics ; *Autophagy/genetics/drug effects ; Ubiquitination ; },
abstract = {Ribophagy is a crucial mechanism that maintains ribosome homeostasis in the cell by directing nonfunctional ribosomes to degradation via macroautophagy/autophagy. Impaired ribophagy may lead to ribosome quality control disorders and may consequently be associated with various diseases known as ribosomopathies. This topic has been actively studied over the past decade, but the complete mechanism of ribophagy is not fully understood. To study the mechanism of ribophagy, we performed a genome-wide CRISPR-Cas9-based screening using a fluorescent ribophagy reporter, which is a cell line with ribosomes carrying RPL29 fused with mCherry and GFP fluorescent proteins. Using the genome-wide Brunello library of guide RNAs, we identified the most promising targets for further study, including the ubiquitin ligase TRIM25, for which we have shown specific binding to the ribosome during ribophagy induction, leading to ubiquitination of the ribosome on the nascent peptide chain and degradation of the whole ribosome. Our findings also demonstrated that poly(I:C) treatment, which mimics viral infection, activates ribophagy in a TRIM25-dependent manner, suggesting the ribophagy pathway could be an antiviral defense mechanism. Taken together, we discovered a novel regulator of ribophagy, TRIM25, which provides new insights into the regulation of selective autophagy in the context of ribosomopathies.Abbreviations: CHX: cycloheximide; FACS: fluorescence-activated cell sorting; GFP: green fluorescent protein; MAGeCK: model-based Analysis of Genome-wide CRISPR-Cas9 Knockout; MOI: multiplicity of infection; poly(I:C): polyinosinic:polycytidylic acid; RFP: red fluorescent protein.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*CRISPR-Cas Systems/genetics
Humans
*Ubiquitin-Protein Ligases/metabolism/genetics
*Ribosomes/metabolism
*Tripartite Motif Proteins/metabolism/genetics
*Transcription Factors/metabolism/genetics
*Autophagy/genetics/drug effects
Ubiquitination
RevDate: 2026-11-16
CmpDate: 2026-11-16
Programmable enzymes for targeted gene insertion.
Nature reviews. Genetics, 27(12):920-934.
Genome editing technologies have advanced from nuclease-based reagents that generate programmed DNA double-strand breaks, which can cause deleterious effects, to next-generation reagents that perform controlled DNA modification through double-strand break-independent mechanisms, such as base editing and prime editing. Although these approaches enable precise small-scale sequence changes, methods for programmable insertion of large DNA cargos have been limited. The ability to write entire genes or large regions into the genome could transform the treatment of genetically heterogeneous disorders, for which numerous pathogenic variants underlie a common disease and mutation-specific editing strategies are impractical. Recent advances in computational genome mining have accelerated the discovery of naturally occurring enzymes with novel biochemical and functional properties, including recombinases and transposases capable of large-scale modifications. Moreover, directed evolution, rational engineering and expanded homologue discovery are enabling the repurposing and optimization of these systems for genome engineering. Here we review recent technology development efforts that harness diverse enzymes for kilobase-scale genome engineering, with a particular focus on CRISPR-associated transposase systems.
Additional Links: PMID-42706407
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid42706407,
year = {2026},
author = {Lampe, GD and King, RT and Sternberg, SH},
title = {Programmable enzymes for targeted gene insertion.},
journal = {Nature reviews. Genetics},
volume = {27},
number = {12},
pages = {920-934},
pmid = {42706407},
issn = {1471-0064},
mesh = {Humans ; Transposases/genetics/metabolism ; *CRISPR-Cas Systems ; *Gene Editing/methods ; *Genetic Engineering/methods ; Animals ; Recombinases/genetics/metabolism ; *Mutagenesis, Insertional/methods ; },
abstract = {Genome editing technologies have advanced from nuclease-based reagents that generate programmed DNA double-strand breaks, which can cause deleterious effects, to next-generation reagents that perform controlled DNA modification through double-strand break-independent mechanisms, such as base editing and prime editing. Although these approaches enable precise small-scale sequence changes, methods for programmable insertion of large DNA cargos have been limited. The ability to write entire genes or large regions into the genome could transform the treatment of genetically heterogeneous disorders, for which numerous pathogenic variants underlie a common disease and mutation-specific editing strategies are impractical. Recent advances in computational genome mining have accelerated the discovery of naturally occurring enzymes with novel biochemical and functional properties, including recombinases and transposases capable of large-scale modifications. Moreover, directed evolution, rational engineering and expanded homologue discovery are enabling the repurposing and optimization of these systems for genome engineering. Here we review recent technology development efforts that harness diverse enzymes for kilobase-scale genome engineering, with a particular focus on CRISPR-associated transposase systems.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Humans
Transposases/genetics/metabolism
*CRISPR-Cas Systems
*Gene Editing/methods
*Genetic Engineering/methods
Animals
Recombinases/genetics/metabolism
*Mutagenesis, Insertional/methods
RevDate: 2026-11-17
CmpDate: 2026-11-17
LwaCas13a protein- and crRNA-enabled RPA-CRISPR/Cas13a platform for rapid visual differentiation of goose parvovirus and novel goose parvovirus.
International journal of biological macromolecules, 383(Pt 2):154658.
Waterfowl parvoviruses, including goose parvovirus and novel goose parvovirus, are highly transmissible pathogens that pose serious threats to flock health and the poultry industry. In this paper, we report a macromolecule-enabled recombinase polymerase amplification (RPA)-CRISPR/Cas13a platform for the rapid, sensitive, and field-deployable visual detection of these viruses by, targeting VP3. Guided by crRNA, LwaCas13a specifically recognizes complementary target RNA and is activated to exert non-specific collateral cleavage activity, efficiently degrading nearby single-stranded RNAs. Species-conserved VP3 fragments with stable interspecies differences were used to design RPA primers and crRNAs, and reaction conditions were systematically optimized. This dual-mode system integrates real-time fluorescence with lateral flow test strips detection, achieving fluorescence detection limits of 1 × 10[0] copies/μL and lateral flow test strips detection limits of 1 × 10[1] copies/μL for goose parvovirus and 1 × 10[2]copies/μL for novel goose parvovirus, with no cross-reactivity with common avian pathogens. Clinical validation demonstrated high concordance with qPCR and superior sensitivity to conventional PCR. Overall, this macromolecule-driven RPA-CRISPR/Cas13a assay offers a robust, rapid, and accurate tool for the on-site differential diagnosis of waterfowl parvoviruses, enabling timely surveillance and disease control.
Additional Links: PMID-42805520
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid42805520,
year = {2026},
author = {Yu, S and Chen, Z and Zhang, J and Liu, G and Zhao, S and Zhang, Q and Diao, Y and Tang, Y and He, D and Hu, J},
title = {LwaCas13a protein- and crRNA-enabled RPA-CRISPR/Cas13a platform for rapid visual differentiation of goose parvovirus and novel goose parvovirus.},
journal = {International journal of biological macromolecules},
volume = {383},
number = {Pt 2},
pages = {154658},
doi = {10.1016/j.ijbiomac.2026.154658},
pmid = {42805520},
issn = {1879-0003},
mesh = {Animals ; *CRISPR-Cas Systems/genetics ; *Parvovirus/genetics/isolation & purification ; *Parvovirinae/genetics ; *Nucleic Acid Amplification Techniques/methods ; *Geese/virology ; Rapid Diagnostic Tests ; *Parvoviridae Infections/diagnosis/virology/veterinary ; *Recombinases/metabolism/genetics ; },
abstract = {Waterfowl parvoviruses, including goose parvovirus and novel goose parvovirus, are highly transmissible pathogens that pose serious threats to flock health and the poultry industry. In this paper, we report a macromolecule-enabled recombinase polymerase amplification (RPA)-CRISPR/Cas13a platform for the rapid, sensitive, and field-deployable visual detection of these viruses by, targeting VP3. Guided by crRNA, LwaCas13a specifically recognizes complementary target RNA and is activated to exert non-specific collateral cleavage activity, efficiently degrading nearby single-stranded RNAs. Species-conserved VP3 fragments with stable interspecies differences were used to design RPA primers and crRNAs, and reaction conditions were systematically optimized. This dual-mode system integrates real-time fluorescence with lateral flow test strips detection, achieving fluorescence detection limits of 1 × 10[0] copies/μL and lateral flow test strips detection limits of 1 × 10[1] copies/μL for goose parvovirus and 1 × 10[2]copies/μL for novel goose parvovirus, with no cross-reactivity with common avian pathogens. Clinical validation demonstrated high concordance with qPCR and superior sensitivity to conventional PCR. Overall, this macromolecule-driven RPA-CRISPR/Cas13a assay offers a robust, rapid, and accurate tool for the on-site differential diagnosis of waterfowl parvoviruses, enabling timely surveillance and disease control.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Animals
*CRISPR-Cas Systems/genetics
*Parvovirus/genetics/isolation & purification
*Parvovirinae/genetics
*Nucleic Acid Amplification Techniques/methods
*Geese/virology
Rapid Diagnostic Tests
*Parvoviridae Infections/diagnosis/virology/veterinary
*Recombinases/metabolism/genetics
RevDate: 2026-11-17
CmpDate: 2026-11-17
CRISPR Nanomachinery-Sensitized Nanocatalytic Tumor Ferroptosis in Triple-Negative Breast Cancer.
Advanced materials (Deerfield Beach, Fla.), 38(64):.
The luminal androgen receptor (LAR) subtype of triple-negative breast cancer (TNBC) represents a formidable therapeutic challenge, necessitating sophisticated strategies that exploit unique tumor vulnerabilities. In the present work, we introduce a biomimetic nanotherapeutic that integrates single-atom iron nanocatalysts (FeSA) co-loaded with a CRISPR-Cas9 plasmid targeting Glutathione Peroxidase 4 (Gpx4), the key regulator of ferroptosis, and is camouflaged with a homologous cancer cell membrane to ensure precise tumor tropism and excellent biocompatibility. In an orthotopic LAR-TNBC model, the nanotherapeutic achieved ∼98% tumor regression and markedly extended survival. Comprehensive mechanistic analyses confirmed efficient on-target Gpx4 disruption, which synergistically amplified the FeSA-catalyzed ferroptotic cascade. Unbiased transcriptomic profiling further revealed extensive reprogramming of the tumor molecular landscape, resulting in significant cancer cell ferroptosis by DNA damage response and p53 signaling pathway activation. This work establishes a highly synergistic and targeted approach, presenting a potent therapeutic modality for aggressive and chemoresistant malignancies.
Additional Links: PMID-42839688
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid42839688,
year = {2026},
author = {Wang, Y and Liang, L and Huo, D and Ge, D and Yu, J and Qiu, S and Duan, QY and Yin, P and Shi, J and Huo, M},
title = {CRISPR Nanomachinery-Sensitized Nanocatalytic Tumor Ferroptosis in Triple-Negative Breast Cancer.},
journal = {Advanced materials (Deerfield Beach, Fla.)},
volume = {38},
number = {64},
pages = {},
doi = {10.1002/adma.75199},
pmid = {42839688},
issn = {1521-4095},
support = {2022YFB3804500//National Key R&D Program of China/ ; 82402459//National Natural Science Foundation of China/ ; 82372121//National Natural Science Foundation of China/ ; 22335006//National Natural Science Foundation of China/ ; 2025-0717-YB-02//Tongji University Medicine-X Interdisciplinary Research Initiative/ ; ZDBS-LY-SLH029//Key Research Program of Frontier Sciences, Chinese Academy of Sciences/ ; 23DX1900200//Basic Research Program of Shanghai Municipal Government/ ; 2024ZDXK0044//2024 Shanghai Municipal Health and Wellness System Key Discipline Construction Project/ ; 23QA1409500//Shanghai Rising-Star Program/ ; //Research Unit of Nanocatalytic Medicine in Specific Therapy for Serious Disease/ ; 2021RU012//Chinese Academy of Medical Sciences/ ; },
mesh = {*Ferroptosis/genetics ; *Triple Negative Breast Neoplasms/pathology/therapy/genetics/metabolism ; Cell Line, Tumor ; Animals ; Humans ; *CRISPR-Cas Systems/genetics ; Phospholipid Hydroperoxide Glutathione Peroxidase/genetics/metabolism ; Catalysis ; Female ; Mice ; Iron/chemistry ; },
abstract = {The luminal androgen receptor (LAR) subtype of triple-negative breast cancer (TNBC) represents a formidable therapeutic challenge, necessitating sophisticated strategies that exploit unique tumor vulnerabilities. In the present work, we introduce a biomimetic nanotherapeutic that integrates single-atom iron nanocatalysts (FeSA) co-loaded with a CRISPR-Cas9 plasmid targeting Glutathione Peroxidase 4 (Gpx4), the key regulator of ferroptosis, and is camouflaged with a homologous cancer cell membrane to ensure precise tumor tropism and excellent biocompatibility. In an orthotopic LAR-TNBC model, the nanotherapeutic achieved ∼98% tumor regression and markedly extended survival. Comprehensive mechanistic analyses confirmed efficient on-target Gpx4 disruption, which synergistically amplified the FeSA-catalyzed ferroptotic cascade. Unbiased transcriptomic profiling further revealed extensive reprogramming of the tumor molecular landscape, resulting in significant cancer cell ferroptosis by DNA damage response and p53 signaling pathway activation. This work establishes a highly synergistic and targeted approach, presenting a potent therapeutic modality for aggressive and chemoresistant malignancies.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Ferroptosis/genetics
*Triple Negative Breast Neoplasms/pathology/therapy/genetics/metabolism
Cell Line, Tumor
Animals
Humans
*CRISPR-Cas Systems/genetics
Phospholipid Hydroperoxide Glutathione Peroxidase/genetics/metabolism
Catalysis
Female
Mice
Iron/chemistry
RevDate: 2026-11-17
CmpDate: 2026-11-17
Chemically composed Cas9 (ChemComCas9) for spatio-temporal regulation and precision genome engineering applications.
Chemical communications (Cambridge, England), 62(90):23212-23228.
Chemically composed Cas9 (ChemComCas9) has emerged as a highly versatile CRISPR enzyme, offering tunable, on-demand, and targeted control over genome engineering functions. Despite its programmable, sequence-specific activity, uncontrolled or prolonged exposure to Cas9 can lead to severe genotoxicity, restricting its enormous clinical potential. To circumvent its non-specific and uncontrolled activities, Cas9 has been chemically modified for spatio-temporal and precision control. For developing such ChemComCas9, the WT Cas9 has been chemically modified using either its surface-exposed natural cysteine or by the installation of additional cysteine residues, or an unnatural amino acid has been incorporated for chemical modification. Such strategies include the incorporation of peptides, polymers, antibodies, stimuli-responsive moieties, and biorthogonal conjugation techniques that allow external control over Cas9 activation, localization, and activity. In addition, various short peptides have been either genetically fused or chemically conjugated for spatiotemporal regulation and probing. These approaches enable conditional activation of Cas9 in response to light, small molecules, or intracellular triggers, thereby minimizing off-target effects and increasing editing efficiency. In this review, we discuss a systematic evolution of chemically composed Cas9 (ChemComCas9) for precision genome engineering and gene therapy applications.
Additional Links: PMID-42872603
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid42872603,
year = {2026},
author = {Das, P and Samoi, TB and Maji, B},
title = {Chemically composed Cas9 (ChemComCas9) for spatio-temporal regulation and precision genome engineering applications.},
journal = {Chemical communications (Cambridge, England)},
volume = {62},
number = {90},
pages = {23212-23228},
doi = {10.1039/d6cc01929c},
pmid = {42872603},
issn = {1364-548X},
mesh = {*Genetic Engineering/methods ; *CRISPR-Cas Systems ; Humans ; },
abstract = {Chemically composed Cas9 (ChemComCas9) has emerged as a highly versatile CRISPR enzyme, offering tunable, on-demand, and targeted control over genome engineering functions. Despite its programmable, sequence-specific activity, uncontrolled or prolonged exposure to Cas9 can lead to severe genotoxicity, restricting its enormous clinical potential. To circumvent its non-specific and uncontrolled activities, Cas9 has been chemically modified for spatio-temporal and precision control. For developing such ChemComCas9, the WT Cas9 has been chemically modified using either its surface-exposed natural cysteine or by the installation of additional cysteine residues, or an unnatural amino acid has been incorporated for chemical modification. Such strategies include the incorporation of peptides, polymers, antibodies, stimuli-responsive moieties, and biorthogonal conjugation techniques that allow external control over Cas9 activation, localization, and activity. In addition, various short peptides have been either genetically fused or chemically conjugated for spatiotemporal regulation and probing. These approaches enable conditional activation of Cas9 in response to light, small molecules, or intracellular triggers, thereby minimizing off-target effects and increasing editing efficiency. In this review, we discuss a systematic evolution of chemically composed Cas9 (ChemComCas9) for precision genome engineering and gene therapy applications.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Genetic Engineering/methods
*CRISPR-Cas Systems
Humans
RevDate: 2026-11-16
CmpDate: 2026-11-16
Rewriting wheat karyotypes through centromere-targeted chromosome engineering.
Nature plants, 12(11):2219-2233.
Engineering karyotypes could expand the genetic and breeding potential of crops, but restructuring gigabase-scale polyploid genomes remains challenging. Here we develop centromere editing-mediated chromosomal variation, a strategy using CRISPR-Cas9 to target abundant centromeric retrotransposons in hexaploid wheat. Centromere editing-mediated chromosomal variation efficiently induces simultaneous chromosome cleavage across the genome, generating diverse karyotypic variants and reconfiguring up to 11 chromosomes in one generation. Notably, it produces widespread reciprocal translocations, with one line carrying six events involving seven chromosomes. Newly formed translocation chromosomes undergo centromere remodelling, enabling their relatively stable maintenance and heritable transmission. Moreover, balanced translocations impose minimal transcriptional perturbation and maintaining normal growth. These results establish centromeres as effective sites for chromosome engineering breeding and provide a scalable framework for karyotype redesign in polyploid crops.
Additional Links: PMID-42919901
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid42919901,
year = {2026},
author = {Zhou, X and Chen, Y and Li, C and Teng, W and Cui, Y and Tan, X and Hu, M and Zhou, Y and Xie, X and Guo, W and Yan, W and Sun, Q and Ni, Z and Wang, Y and Su, H and Zong, Y},
title = {Rewriting wheat karyotypes through centromere-targeted chromosome engineering.},
journal = {Nature plants},
volume = {12},
number = {11},
pages = {2219-2233},
pmid = {42919901},
issn = {2055-0278},
mesh = {*Triticum/genetics ; *Centromere/genetics ; *Chromosomes, Plant/genetics ; *Genetic Engineering/methods ; *Karyotype ; CRISPR-Cas Systems ; Polyploidy ; Retroelements ; Gene Editing ; },
abstract = {Engineering karyotypes could expand the genetic and breeding potential of crops, but restructuring gigabase-scale polyploid genomes remains challenging. Here we develop centromere editing-mediated chromosomal variation, a strategy using CRISPR-Cas9 to target abundant centromeric retrotransposons in hexaploid wheat. Centromere editing-mediated chromosomal variation efficiently induces simultaneous chromosome cleavage across the genome, generating diverse karyotypic variants and reconfiguring up to 11 chromosomes in one generation. Notably, it produces widespread reciprocal translocations, with one line carrying six events involving seven chromosomes. Newly formed translocation chromosomes undergo centromere remodelling, enabling their relatively stable maintenance and heritable transmission. Moreover, balanced translocations impose minimal transcriptional perturbation and maintaining normal growth. These results establish centromeres as effective sites for chromosome engineering breeding and provide a scalable framework for karyotype redesign in polyploid crops.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Triticum/genetics
*Centromere/genetics
*Chromosomes, Plant/genetics
*Genetic Engineering/methods
*Karyotype
CRISPR-Cas Systems
Polyploidy
Retroelements
Gene Editing
RevDate: 2026-11-17
CmpDate: 2026-11-17
Antigen scaffolds drive preferential expansion of functional genetically engineered CAR and TCR T cells.
Cell reports. Medicine, 7(11):103128.
T cells engineered to express recombinant T cell receptors (TCRs) or chimeric antigen receptors (CARs) can induce durable clinical responses in solid and hematological malignancies. However, manufacturing is resource intensive and often yields highly differentiated, exhausted T cell products. To address this, we developed an antigen-scaffold (Ag-scaffold) technology that presents cognate antigen alongside stimulatory cytokines to preferentially expand genetically engineered T cells. We expanded CRISPR-Cas9- and lentivirally engineered TCR T cells with peptide MHC (pMHC)-presenting Ag-scaffolds and anti-CD19 CAR T cells with CD19-presenting Ag-scaffolds. By applying cognate pMHC Ag-scaffolds, we achieved on average 69% (±22%) antigen-specific T cells after 14 days of culture with a cytotoxic, proliferative profile. Ag-scaffold expansion enhanced initial TCR and CAR cytotoxicity; repeated rechallenges showed sustained control. In vivo, Ag-scaffold-expanded CRISPR-Cas9-engineered NY-ESO-1-specific TCR T cells and anti-CD19 CAR T cells also showed improved tumor control in lymphoma and solid tumor xenograft models compared to cells expanded with IL2/7/15.
Additional Links: PMID-42987830
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid42987830,
year = {2026},
author = {Johansen, KH and Ramanathan, K and Rodriguez-Pardo, C and Gjelstrup, AK and Halldórsdóttir, HR and Voss, LF and Tvingsholm, S and Grand, LS and Dionisio, E and Skriver, AH and Frederiksen, LP and Bjørnson, M and Svensson-Frej, M and Ormhøj, M and Hadrup, SR},
title = {Antigen scaffolds drive preferential expansion of functional genetically engineered CAR and TCR T cells.},
journal = {Cell reports. Medicine},
volume = {7},
number = {11},
pages = {103128},
doi = {10.1016/j.xcrm.2026.103128},
pmid = {42987830},
issn = {2666-3791},
mesh = {Humans ; Animals ; *Receptors, Antigen, T-Cell/metabolism/immunology/genetics ; *Receptors, Chimeric Antigen/immunology/metabolism/genetics ; *T-Lymphocytes/immunology/metabolism ; Mice ; *Genetic Engineering ; CRISPR-Cas Systems/genetics ; Immunotherapy, Adoptive/methods ; Antigens, CD19/immunology ; Cell Proliferation ; *Antigens/immunology ; },
abstract = {T cells engineered to express recombinant T cell receptors (TCRs) or chimeric antigen receptors (CARs) can induce durable clinical responses in solid and hematological malignancies. However, manufacturing is resource intensive and often yields highly differentiated, exhausted T cell products. To address this, we developed an antigen-scaffold (Ag-scaffold) technology that presents cognate antigen alongside stimulatory cytokines to preferentially expand genetically engineered T cells. We expanded CRISPR-Cas9- and lentivirally engineered TCR T cells with peptide MHC (pMHC)-presenting Ag-scaffolds and anti-CD19 CAR T cells with CD19-presenting Ag-scaffolds. By applying cognate pMHC Ag-scaffolds, we achieved on average 69% (±22%) antigen-specific T cells after 14 days of culture with a cytotoxic, proliferative profile. Ag-scaffold expansion enhanced initial TCR and CAR cytotoxicity; repeated rechallenges showed sustained control. In vivo, Ag-scaffold-expanded CRISPR-Cas9-engineered NY-ESO-1-specific TCR T cells and anti-CD19 CAR T cells also showed improved tumor control in lymphoma and solid tumor xenograft models compared to cells expanded with IL2/7/15.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Humans
Animals
*Receptors, Antigen, T-Cell/metabolism/immunology/genetics
*Receptors, Chimeric Antigen/immunology/metabolism/genetics
*T-Lymphocytes/immunology/metabolism
Mice
*Genetic Engineering
CRISPR-Cas Systems/genetics
Immunotherapy, Adoptive/methods
Antigens, CD19/immunology
Cell Proliferation
*Antigens/immunology
RevDate: 2026-11-11
CmpDate: 2026-11-12
Prime Editing-Mediated Genome Modification in Saccharomyces cerevisiae.
Methods in molecular biology (Clifton, N.J.), 3099:253-272.
Prime editing is a highly versatile genome editing technology that enables precise genetic modifications in eukaryotes. Here, we present a detailed step-by-step protocol for conducting prime editing in Saccharomyces cerevisiae. In particular, we describe the design of prime editing guide RNAs (pegRNAs), yeast transformation with prime editor and pegRNA plasmids, and controlled expression through galactose induction. We demonstrate the protocol by targeting the CAN1 gene and achieving editing efficiencies of 22% and 55% with two different pegRNAs. We provide protocols for genomic DNA extraction, PCR amplification, and editing quantification using both Sanger and next-generation sequencing. Given the important role of yeast in both basic research and biotechnology applications, this protocol provides valuable tools for studying gene function and precise engineering of yeast strains.
Additional Links: PMID-43015555
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43015555,
year = {2027},
author = {Kaur, N and Langley, J and Billon, P},
title = {Prime Editing-Mediated Genome Modification in Saccharomyces cerevisiae.},
journal = {Methods in molecular biology (Clifton, N.J.)},
volume = {3099},
number = {},
pages = {253-272},
pmid = {43015555},
issn = {1940-6029},
mesh = {*Saccharomyces cerevisiae/genetics ; *Gene Editing/methods ; *Genome, Fungal ; Transformation, Genetic ; RNA, Guide, CRISPR-Cas Systems/genetics ; CRISPR-Cas Systems ; Saccharomyces cerevisiae Proteins/genetics ; Plasmids/genetics ; Amino Acid Transport Systems, Basic ; },
abstract = {Prime editing is a highly versatile genome editing technology that enables precise genetic modifications in eukaryotes. Here, we present a detailed step-by-step protocol for conducting prime editing in Saccharomyces cerevisiae. In particular, we describe the design of prime editing guide RNAs (pegRNAs), yeast transformation with prime editor and pegRNA plasmids, and controlled expression through galactose induction. We demonstrate the protocol by targeting the CAN1 gene and achieving editing efficiencies of 22% and 55% with two different pegRNAs. We provide protocols for genomic DNA extraction, PCR amplification, and editing quantification using both Sanger and next-generation sequencing. Given the important role of yeast in both basic research and biotechnology applications, this protocol provides valuable tools for studying gene function and precise engineering of yeast strains.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Saccharomyces cerevisiae/genetics
*Gene Editing/methods
*Genome, Fungal
Transformation, Genetic
RNA, Guide, CRISPR-Cas Systems/genetics
CRISPR-Cas Systems
Saccharomyces cerevisiae Proteins/genetics
Plasmids/genetics
Amino Acid Transport Systems, Basic
RevDate: 2026-11-12
CmpDate: 2026-11-12
CRISPR screening-informed liver cancer stratification identifies ciclesonide as a novel adjuvant drug to alleviate sorafenib resistance.
BMC cancer, 26(1):.
Sorafenib remains a standard therapy for hepatocellular carcinoma (HCC), but intratumor heterogeneity and drug resistance limit its efficacy. To identify resistance-associated genes, we performed a CRISPR activation screen and integrated results with TCGA and GTEx data. Using univariate Cox and LASSO regression, we constructed a five-gene (AKR1B15, BMF, GBA, GINS2, SMC2) sorafenib sensitivity-related prognostic signature. In the TCGA-LIHC training cohort (n = 371), patients with high-risk scores showed significantly worse overall survival and reduced sorafenib sensitivity, which was validated in the ICGC-US cohort. High risk scores also correlated with adverse clinicopathological features. Drug perturbation Gene Set Enrichment Analysis (dpGSEA) identified ciclesonide as a potential sensitizer to sorafenib. Cell viability assays and a subcutaneous xenograft model confirmed that ciclesonide enhanced the antitumor efficacy of sorafenib. RNA sequencing further suggested that this effect may be mediated through regulation of the cell cycle pathway. Collectively, the sorafenib DS-related prognostic signature may serve as an independent prognostic biomarker and predictor of sorafenib sensitivity in HCC, while the combination of sorafenib and ciclesonide represents a promising strategy to improve targeted therapy.
Additional Links: PMID-43015682
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43015682,
year = {2026},
author = {Liu, T and Liu, K and Hou, Y and Chu, Z and Li, J and Sun, M and Wu, L and Liu, Q and Zhou, Z and Zhang, Q and Wang, B and Wen, Q and Wang, X and Min, J},
title = {CRISPR screening-informed liver cancer stratification identifies ciclesonide as a novel adjuvant drug to alleviate sorafenib resistance.},
journal = {BMC cancer},
volume = {26},
number = {1},
pages = {},
pmid = {43015682},
issn = {1471-2407},
support = {CSTB2024NSCQ-MSX1057//Natural Science Foundation of Chongqing/ ; CSTB2024NSCQ-KJFZMSX0019//Natural Science Foundation of Chongqing/ ; 32500508//the National Natural Science Foundation of China/ ; CSTB2024TIAD-KPX0028//Science and Technology Innovation Key R&D Program of Chongqing/ ; CX2024008//Innovation Support Program for Overseas Returned Scholars of Chongqing/ ; },
mesh = {Humans ; *Sorafenib/pharmacology/therapeutic use ; *Liver Neoplasms/drug therapy/genetics/pathology/mortality ; *Drug Resistance, Neoplasm/genetics/drug effects ; *Carcinoma, Hepatocellular/drug therapy/genetics/pathology/mortality ; Animals ; Female ; Mice ; Prognosis ; Xenograft Model Antitumor Assays ; Male ; CRISPR-Cas Systems ; Cell Line, Tumor ; Biomarkers, Tumor/genetics ; Gene Expression Regulation, Neoplastic/drug effects ; Antineoplastic Agents/pharmacology ; Middle Aged ; },
abstract = {Sorafenib remains a standard therapy for hepatocellular carcinoma (HCC), but intratumor heterogeneity and drug resistance limit its efficacy. To identify resistance-associated genes, we performed a CRISPR activation screen and integrated results with TCGA and GTEx data. Using univariate Cox and LASSO regression, we constructed a five-gene (AKR1B15, BMF, GBA, GINS2, SMC2) sorafenib sensitivity-related prognostic signature. In the TCGA-LIHC training cohort (n = 371), patients with high-risk scores showed significantly worse overall survival and reduced sorafenib sensitivity, which was validated in the ICGC-US cohort. High risk scores also correlated with adverse clinicopathological features. Drug perturbation Gene Set Enrichment Analysis (dpGSEA) identified ciclesonide as a potential sensitizer to sorafenib. Cell viability assays and a subcutaneous xenograft model confirmed that ciclesonide enhanced the antitumor efficacy of sorafenib. RNA sequencing further suggested that this effect may be mediated through regulation of the cell cycle pathway. Collectively, the sorafenib DS-related prognostic signature may serve as an independent prognostic biomarker and predictor of sorafenib sensitivity in HCC, while the combination of sorafenib and ciclesonide represents a promising strategy to improve targeted therapy.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Humans
*Sorafenib/pharmacology/therapeutic use
*Liver Neoplasms/drug therapy/genetics/pathology/mortality
*Drug Resistance, Neoplasm/genetics/drug effects
*Carcinoma, Hepatocellular/drug therapy/genetics/pathology/mortality
Animals
Female
Mice
Prognosis
Xenograft Model Antitumor Assays
Male
CRISPR-Cas Systems
Cell Line, Tumor
Biomarkers, Tumor/genetics
Gene Expression Regulation, Neoplastic/drug effects
Antineoplastic Agents/pharmacology
Middle Aged
RevDate: 2026-11-13
CmpDate: 2026-11-12
Tetrahedral DNA nanostructure-gated solution-phase CRISPR/Cas12a system for probe immobilization-free, reagent-efficient, and dual-phase electrochemical detection of circulating microRNAs in liquid biopsy.
Journal of nanobiotechnology, 24(1):.
Liquid-biopsy nucleic acid biomarkers hold strong promise for non-invasive cancer diagnostics, yet their ultralow abundance presents substantial analytical challenges. Conventional electrochemical biosensors rely on complex probe immobilization, whereas emerging homogeneous strategies remain susceptible to matrix interference and require large reaction volumes. Here, we report a probe immobilization-free, reagent-efficient, dual-phase electrochemical platform that integrates solution-phase CRISPR/Cas12a reactions with a tetrahedral DNA nanostructure (TDN)-based interfacial gating mechanism for detecting circulating microRNAs. We found that TDNs extended with a thiolated blocking fragment (BF) impose a pronounced steric gating effect at the electrode-solution interface: the large, rigid TDN architecture prevents intact BF-linked structures from approaching the gold electrode, whereas smaller Cas12a-generated thiolated fragments readily assemble via Au-S interactions. This size-dependent gating transition switches the electrode from an HRP-accessible to an HRP-blocking state, producing a sharply resolved signal decrease that faithfully maps solution-phase cleavage onto an electrochemical readout. Using a target-competitive binding strategy to generate the activator DNA, this interfacial gating mechanism was developed into a robust dual-phase sensing platform driven by CRISPR/Cas12a. Because target recognition and Cas12a-mediated cleavage occur entirely in solution and only the final reaction products contact the electrode, the architecture retains high homogeneous reaction efficiency while avoiding diffusion-governed limitations and eliminating probe immobilization. The 10 µL reaction volume enables substantial reagent savings and strong compatibility with complex matrices. The assay achieves a detection limit of 4.1 aM and accurately quantifies renal cancer-associated circulating miRNA-21 in peripheral blood, yielding results fully consistent with RT-qPCR.
Additional Links: PMID-43015759
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43015759,
year = {2026},
author = {Chen, S and Ye, H and Lin, B and Huang, D and Chen, Y and Li, N and Zhuang, J and Wei, Y and Xu, N},
title = {Tetrahedral DNA nanostructure-gated solution-phase CRISPR/Cas12a system for probe immobilization-free, reagent-efficient, and dual-phase electrochemical detection of circulating microRNAs in liquid biopsy.},
journal = {Journal of nanobiotechnology},
volume = {24},
number = {1},
pages = {},
pmid = {43015759},
issn = {1477-3155},
support = {21705092//National Natural Science Foundation of China/ ; 2025J01697//Natural Science Foundation of Fujian Province/ ; },
mesh = {Humans ; *DNA Nanostructures/chemistry ; *Biosensing Techniques/methods ; *Electrochemical Techniques/methods ; *CRISPR-Cas Systems/genetics ; Liquid Biopsy/methods ; *Circulating MicroRNA/blood/analysis ; Electrodes ; *MicroRNAs/blood ; Gold/chemistry ; DNA/chemistry ; },
abstract = {Liquid-biopsy nucleic acid biomarkers hold strong promise for non-invasive cancer diagnostics, yet their ultralow abundance presents substantial analytical challenges. Conventional electrochemical biosensors rely on complex probe immobilization, whereas emerging homogeneous strategies remain susceptible to matrix interference and require large reaction volumes. Here, we report a probe immobilization-free, reagent-efficient, dual-phase electrochemical platform that integrates solution-phase CRISPR/Cas12a reactions with a tetrahedral DNA nanostructure (TDN)-based interfacial gating mechanism for detecting circulating microRNAs. We found that TDNs extended with a thiolated blocking fragment (BF) impose a pronounced steric gating effect at the electrode-solution interface: the large, rigid TDN architecture prevents intact BF-linked structures from approaching the gold electrode, whereas smaller Cas12a-generated thiolated fragments readily assemble via Au-S interactions. This size-dependent gating transition switches the electrode from an HRP-accessible to an HRP-blocking state, producing a sharply resolved signal decrease that faithfully maps solution-phase cleavage onto an electrochemical readout. Using a target-competitive binding strategy to generate the activator DNA, this interfacial gating mechanism was developed into a robust dual-phase sensing platform driven by CRISPR/Cas12a. Because target recognition and Cas12a-mediated cleavage occur entirely in solution and only the final reaction products contact the electrode, the architecture retains high homogeneous reaction efficiency while avoiding diffusion-governed limitations and eliminating probe immobilization. The 10 µL reaction volume enables substantial reagent savings and strong compatibility with complex matrices. The assay achieves a detection limit of 4.1 aM and accurately quantifies renal cancer-associated circulating miRNA-21 in peripheral blood, yielding results fully consistent with RT-qPCR.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Humans
*DNA Nanostructures/chemistry
*Biosensing Techniques/methods
*Electrochemical Techniques/methods
*CRISPR-Cas Systems/genetics
Liquid Biopsy/methods
*Circulating MicroRNA/blood/analysis
Electrodes
*MicroRNAs/blood
Gold/chemistry
DNA/chemistry
RevDate: 2026-11-13
CmpDate: 2026-11-12
Mitochondrial base editing for disease modeling and therapeutic correction.
Genome biology, 27(1):.
Recent development of mitochondrial DNA (mtDNA) editors has made it possible to generate experimental models carrying patient-relevant mtDNA mutations, characterize disease-associated phenotypes in cells and animals, and directly correct pathogenic variants in vivo. Here, we summarize the current landscape of mtDNA base editors and discuss key considerations for their application to mitochondrial disease model generation, including target selection, cross-species conservation, editing window constraints, strand bias, sequence-context dependence, and the balance between editing efficiency and safety. We further review strategies for validating mtDNA-edited models at functional, molecular, and organismal levels, and highlight recent studies demonstrating therapeutic rescue in animal models.
Additional Links: PMID-43015858
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43015858,
year = {2026},
author = {Hong, S and Kim, S and Seong, JK and Kim, Y and Lee, H},
title = {Mitochondrial base editing for disease modeling and therapeutic correction.},
journal = {Genome biology},
volume = {27},
number = {1},
pages = {},
pmid = {43015858},
issn = {1474-760X},
mesh = {Animals ; Humans ; *DNA, Mitochondrial/genetics ; *Mitochondrial Diseases/genetics/therapy ; *Mitochondria/genetics ; Disease Models, Animal ; Mutation ; CRISPR-Cas Systems ; },
abstract = {Recent development of mitochondrial DNA (mtDNA) editors has made it possible to generate experimental models carrying patient-relevant mtDNA mutations, characterize disease-associated phenotypes in cells and animals, and directly correct pathogenic variants in vivo. Here, we summarize the current landscape of mtDNA base editors and discuss key considerations for their application to mitochondrial disease model generation, including target selection, cross-species conservation, editing window constraints, strand bias, sequence-context dependence, and the balance between editing efficiency and safety. We further review strategies for validating mtDNA-edited models at functional, molecular, and organismal levels, and highlight recent studies demonstrating therapeutic rescue in animal models.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Animals
Humans
*DNA, Mitochondrial/genetics
*Mitochondrial Diseases/genetics/therapy
*Mitochondria/genetics
Disease Models, Animal
Mutation
CRISPR-Cas Systems
RevDate: 2026-11-12
CmpDate: 2026-11-12
RPA-primed droplet-partitioned CRISPR/Cas12a assay for low-copy detection of Candida albicans in vaginal specimens.
Frontiers in cellular and infection microbiology, 16:1960866.
Candida albicans is a major cause of vulvovaginal candidiasis, and sensitive detection of low-abundance fungal DNA remains challenging in clinical specimens. In this study, we developed a two-stage assay combining rapid recombinase polymerase amplification (RPA) with droplet-partitioned CRISPR/Cas12a fluorescence detection. Target DNA was first amplified by RPA for 10 min and subsequently analyzed in vortex-generated polydisperse droplets without microfluidic chip fabrication. Using predefined NTC-based analytical criteria, the operational LoDs were 10 copies/μL for the bulk RPA-Cas12a assay and 1 copy/μL for the droplet-partitioned format under the tested conditions. No cross-reactivity was observed with the tested non-target organisms, including additional clinically relevant non-albicans Candida species. In a preliminary evaluation of 28 residual vaginal swab specimens, the assay showed complete concordance with a routine composite clinical reference using an exploratory cohort-derived droplet-count cutoff. Because the comparator was not species-specific for C. albicans, these findings represent preliminary concordance rather than definitive diagnostic accuracy. The complete workflow was performed within approximately 1 h using basic laboratory equipment. These findings demonstrate that droplet partitioning can improve the low-copy analytical readout of RPA-Cas12a detection and provide a practical approach for qualitative identification of C. albicans DNA in vaginal specimens.
Additional Links: PMID-43016415
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43016415,
year = {2026},
author = {Long, J and Xie, J and Liu, F and Peng, J and Xu, WF and Li, XH},
title = {RPA-primed droplet-partitioned CRISPR/Cas12a assay for low-copy detection of Candida albicans in vaginal specimens.},
journal = {Frontiers in cellular and infection microbiology},
volume = {16},
number = {},
pages = {1960866},
pmid = {43016415},
issn = {2235-2988},
mesh = {*Candida albicans/genetics/isolation & purification ; Female ; *Candidiasis, Vulvovaginal/diagnosis/microbiology ; Humans ; *CRISPR-Cas Systems ; *Vagina/microbiology ; Sensitivity and Specificity ; *Nucleic Acid Amplification Techniques/methods ; DNA, Fungal/genetics ; Rapid Diagnostic Tests ; Recombinases/metabolism ; },
abstract = {Candida albicans is a major cause of vulvovaginal candidiasis, and sensitive detection of low-abundance fungal DNA remains challenging in clinical specimens. In this study, we developed a two-stage assay combining rapid recombinase polymerase amplification (RPA) with droplet-partitioned CRISPR/Cas12a fluorescence detection. Target DNA was first amplified by RPA for 10 min and subsequently analyzed in vortex-generated polydisperse droplets without microfluidic chip fabrication. Using predefined NTC-based analytical criteria, the operational LoDs were 10 copies/μL for the bulk RPA-Cas12a assay and 1 copy/μL for the droplet-partitioned format under the tested conditions. No cross-reactivity was observed with the tested non-target organisms, including additional clinically relevant non-albicans Candida species. In a preliminary evaluation of 28 residual vaginal swab specimens, the assay showed complete concordance with a routine composite clinical reference using an exploratory cohort-derived droplet-count cutoff. Because the comparator was not species-specific for C. albicans, these findings represent preliminary concordance rather than definitive diagnostic accuracy. The complete workflow was performed within approximately 1 h using basic laboratory equipment. These findings demonstrate that droplet partitioning can improve the low-copy analytical readout of RPA-Cas12a detection and provide a practical approach for qualitative identification of C. albicans DNA in vaginal specimens.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Candida albicans/genetics/isolation & purification
Female
*Candidiasis, Vulvovaginal/diagnosis/microbiology
Humans
*CRISPR-Cas Systems
*Vagina/microbiology
Sensitivity and Specificity
*Nucleic Acid Amplification Techniques/methods
DNA, Fungal/genetics
Rapid Diagnostic Tests
Recombinases/metabolism
RevDate: 2026-11-12
CmpDate: 2026-11-12
Highly sensitive and specific detection of aminoglycoside resistance methylase gene armA by multiple cross displacement amplification-CRISPR/Cas12a technique.
Frontiers in cellular and infection microbiology, 16:1947114.
INTRODUCTION: The 16S rRNA methylase armA serves as a key molecular determinant conferring high-level resistance to aminoglycoside antibiotics in bacterial pathogens. Development of a rapid and reliable armA gene detection assay will improve surveillance of enzyme-producing strains and support drug resistance control in diverse ecological settings.
METHODS: A multiple cross displacement amplification (MCDA) combined with CRISPR/Cas12a system assay was established to identify armA gene with rapidity, specificity, and sensitivity.
RESULTS: The entire experimental process, including genomic DNA extraction (15 minutes), MCDA reaction (40 minutes), CRISPR/Cas12a-mediated cleavage (5 minutes), and fluorescence detection (10 minutes), can be completed within 70 minutes. In terms of analytical specificity, the assay yielded positive results for all armA-positive isolates and negative results for all non-armA samples. The sensitivity of the MCDA-CRISPR/Cas12a assay reached a detection limit as low as 10 copies/mL of armA-positive plasmid DNA. In 129 cultured clinical isolates validated by whole-genome sequencing, the assay achieved 100% concordance for armA detection.
DISCUSSION: The technique established in this study provides a rapid and accurate diagnostic approach for laboratory-based surveillance of armA in clinical and livestock settings, with future potential for point-of-care adaptation following further simplification and validation.
Additional Links: PMID-43016540
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43016540,
year = {2026},
author = {Gong, L and Wang, J and Zhang, Y and Xu, H and Liu, X and Chen, X and Li, M and Li, Y and Wu, L and Wang, Y and Shen, X},
title = {Highly sensitive and specific detection of aminoglycoside resistance methylase gene armA by multiple cross displacement amplification-CRISPR/Cas12a technique.},
journal = {Frontiers in cellular and infection microbiology},
volume = {16},
number = {},
pages = {1947114},
pmid = {43016540},
issn = {2235-2988},
mesh = {*Aminoglycosides/pharmacology ; *Drug Resistance, Bacterial/genetics ; Sensitivity and Specificity ; *CRISPR-Cas Systems ; Anti-Bacterial Agents/pharmacology ; *Methyltransferases/genetics ; *Nucleic Acid Amplification Techniques/methods ; *Bacteria/genetics/drug effects/enzymology ; *Bacterial Proteins/genetics ; DNA, Bacterial/genetics ; Rapid Diagnostic Tests ; Humans ; },
abstract = {INTRODUCTION: The 16S rRNA methylase armA serves as a key molecular determinant conferring high-level resistance to aminoglycoside antibiotics in bacterial pathogens. Development of a rapid and reliable armA gene detection assay will improve surveillance of enzyme-producing strains and support drug resistance control in diverse ecological settings.
METHODS: A multiple cross displacement amplification (MCDA) combined with CRISPR/Cas12a system assay was established to identify armA gene with rapidity, specificity, and sensitivity.
RESULTS: The entire experimental process, including genomic DNA extraction (15 minutes), MCDA reaction (40 minutes), CRISPR/Cas12a-mediated cleavage (5 minutes), and fluorescence detection (10 minutes), can be completed within 70 minutes. In terms of analytical specificity, the assay yielded positive results for all armA-positive isolates and negative results for all non-armA samples. The sensitivity of the MCDA-CRISPR/Cas12a assay reached a detection limit as low as 10 copies/mL of armA-positive plasmid DNA. In 129 cultured clinical isolates validated by whole-genome sequencing, the assay achieved 100% concordance for armA detection.
DISCUSSION: The technique established in this study provides a rapid and accurate diagnostic approach for laboratory-based surveillance of armA in clinical and livestock settings, with future potential for point-of-care adaptation following further simplification and validation.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Aminoglycosides/pharmacology
*Drug Resistance, Bacterial/genetics
Sensitivity and Specificity
*CRISPR-Cas Systems
Anti-Bacterial Agents/pharmacology
*Methyltransferases/genetics
*Nucleic Acid Amplification Techniques/methods
*Bacteria/genetics/drug effects/enzymology
*Bacterial Proteins/genetics
DNA, Bacterial/genetics
Rapid Diagnostic Tests
Humans
RevDate: 2026-11-14
CmpDate: 2026-11-12
Application of AI-designed OpenCRISPR-1 for highly efficient gene editing in soybean (Glycine max L.) and Nicotiana benthamiana.
Transgenic research, 35(1):.
The widespread application of CRISPR/Cas genome editing for commercial crop improvement is currently hindered by a complex and restrictive intellectual property (IP) landscape. The recent development of OpenCRISPR-1, a fully AI-designed Cas9-like nuclease, provides a promising alternative with an accessible licensing framework; however, its efficacy in dicotyledonous plants remains largely uncharacterized. Here, we report the successful adaptation of the OpenCRISPR-1 system for targeted mutagenesis in soybean (Glycine max L.) and Nicotiana benthamiana. We constructed a plant-optimized binary vector (pBSE-OpenCRISPR-1) and validated its editing capability. In soybean (Glycine max), an Agrobacterium rhizogenes-mediated hairy root transformation assay targeting the GmFAD2-1B gene demonstrated that OpenCRISPR-1 actively induces site-specific mutations. In Nicotiana benthamiana, stable Agrobacterium-mediated transformation targeting the phytoene desaturase homologs (NbPDSa/b) achieved overall editing in 75% of T0 transgenic lines (27/36). Analysis of individual homologs revealed editing rates of 66.7% (24/36) at both the NbPDSa and NbPDSb loci. Complete editing of the target locus occurred in 13.9% of events for NbPDSb and 2.8% for NbPDSa, including one event (2.8%) displaying simultaneous complete editing across all alleles resulting in a visible albino phenotype. Deep amplicon and Sanger sequencing revealed a characteristic mutation profile dominated by small insertions and deletions occurring two to three nucleotides upstream of the PAM. These results demonstrate that the AI-designed OpenCRISPR-1 system is a highly active and versatile nuclease for dicot genome engineering. By providing expanded freedom-to-operate, this tool broadens access to crop trait improvement worldwide.
Additional Links: PMID-43018681
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43018681,
year = {2026},
author = {Nguyen, CX and Do, PT and Tran, TM},
title = {Application of AI-designed OpenCRISPR-1 for highly efficient gene editing in soybean (Glycine max L.) and Nicotiana benthamiana.},
journal = {Transgenic research},
volume = {35},
number = {1},
pages = {},
pmid = {43018681},
issn = {1573-9368},
mesh = {*Nicotiana/genetics/growth & development ; *Glycine max/genetics/growth & development ; *Gene Editing/methods ; *Plants, Genetically Modified/genetics/growth & development ; *CRISPR-Cas Systems/genetics ; Agrobacterium/genetics ; },
abstract = {The widespread application of CRISPR/Cas genome editing for commercial crop improvement is currently hindered by a complex and restrictive intellectual property (IP) landscape. The recent development of OpenCRISPR-1, a fully AI-designed Cas9-like nuclease, provides a promising alternative with an accessible licensing framework; however, its efficacy in dicotyledonous plants remains largely uncharacterized. Here, we report the successful adaptation of the OpenCRISPR-1 system for targeted mutagenesis in soybean (Glycine max L.) and Nicotiana benthamiana. We constructed a plant-optimized binary vector (pBSE-OpenCRISPR-1) and validated its editing capability. In soybean (Glycine max), an Agrobacterium rhizogenes-mediated hairy root transformation assay targeting the GmFAD2-1B gene demonstrated that OpenCRISPR-1 actively induces site-specific mutations. In Nicotiana benthamiana, stable Agrobacterium-mediated transformation targeting the phytoene desaturase homologs (NbPDSa/b) achieved overall editing in 75% of T0 transgenic lines (27/36). Analysis of individual homologs revealed editing rates of 66.7% (24/36) at both the NbPDSa and NbPDSb loci. Complete editing of the target locus occurred in 13.9% of events for NbPDSb and 2.8% for NbPDSa, including one event (2.8%) displaying simultaneous complete editing across all alleles resulting in a visible albino phenotype. Deep amplicon and Sanger sequencing revealed a characteristic mutation profile dominated by small insertions and deletions occurring two to three nucleotides upstream of the PAM. These results demonstrate that the AI-designed OpenCRISPR-1 system is a highly active and versatile nuclease for dicot genome engineering. By providing expanded freedom-to-operate, this tool broadens access to crop trait improvement worldwide.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Nicotiana/genetics/growth & development
*Glycine max/genetics/growth & development
*Gene Editing/methods
*Plants, Genetically Modified/genetics/growth & development
*CRISPR-Cas Systems/genetics
Agrobacterium/genetics
RevDate: 2026-11-14
CmpDate: 2026-11-12
A new CRISPR/Cas9 GALC Knockout Cellular Model Reveals Lactosylceramide Accumulation Similar to Twitcher Mice.
Molecular neurobiology, 63(1):.
Krabbe disease (KD) is a lysosomal sphingolipidosis caused by the deficiency of galactocerebrosidase (GALC), leading to profound alterations in sphingolipid metabolism and severe neurodegeneration. While psychosine (Psy) accumulation is a well-established hallmark of KD, emerging evidence suggests that lactosylceramide (LacCer) may also contribute to disease pathogenesis. Here, we generated a novel human oligodendrocytic model of GALC deficiency by CRISPR/Cas9-mediated GALC knockout in MO3.13 cells and used it to investigate sphingolipid alterations associated with impaired GALC activity. GALC[-/-] MO3.13 cells showed a marked reduction in GALC transcript levels and enzymatic activity, confirming the successful establishment of a disease-relevant cellular model. Our results demonstrated that a) GALC knockout MO3.13 cells accumulated Psy and LacCer, and b) LacCer content was increased in the brain and heart isolated from twitcher (TWI) mice, the most widely used spontaneous animal model of KD. In parallel, AKT signalling was evaluated in both systems, supporting a link between LacCer dysregulation and altered cellular signalling pathways. Overall, these findings identify LacCer accumulation as a conserved feature of GALC deficiency across cellular and animal models and support the use of GALC[-/-] MO3.13 cells as a novel in vitro platform to investigate KD pathogenesis and candidate therapeutic strategies.
Additional Links: PMID-43018866
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43018866,
year = {2026},
author = {Del Grosso, A and Papini, N and De Sarlo, M and Carpi, S and Scaccini, L and Colagiorgio, L and Suman, AF and Mancini, DF and Fazzi, D and Pellegrino, RM and Signore, G and Rocchiccioli, S and Cecchini, M and Tringali, C},
title = {A new CRISPR/Cas9 GALC Knockout Cellular Model Reveals Lactosylceramide Accumulation Similar to Twitcher Mice.},
journal = {Molecular neurobiology},
volume = {63},
number = {1},
pages = {},
pmid = {43018866},
issn = {1559-1182},
support = {grant agreement no. 2018-008F2//Association Européenne contre les Leucodystrophies/ ; Grant No. 2023-064C//Association Européenne contre les Leucodystrophies/ ; CUP B53C24000900001//Ministero dell'Università e della Ricerca/ ; },
mesh = {Animals ; *Lactosylceramides/metabolism ; *CRISPR-Cas Systems/genetics ; Humans ; *Galactosylceramidase/metabolism/deficiency/genetics ; Mice, Knockout ; Proto-Oncogene Proteins c-akt/metabolism ; *Gene Knockout Techniques ; Signal Transduction ; Brain/metabolism ; Disease Models, Animal ; Mice ; Leukodystrophy, Globoid Cell/metabolism/genetics/pathology ; Oligodendroglia/metabolism ; Psychosine/metabolism ; Cell Line ; },
abstract = {Krabbe disease (KD) is a lysosomal sphingolipidosis caused by the deficiency of galactocerebrosidase (GALC), leading to profound alterations in sphingolipid metabolism and severe neurodegeneration. While psychosine (Psy) accumulation is a well-established hallmark of KD, emerging evidence suggests that lactosylceramide (LacCer) may also contribute to disease pathogenesis. Here, we generated a novel human oligodendrocytic model of GALC deficiency by CRISPR/Cas9-mediated GALC knockout in MO3.13 cells and used it to investigate sphingolipid alterations associated with impaired GALC activity. GALC[-/-] MO3.13 cells showed a marked reduction in GALC transcript levels and enzymatic activity, confirming the successful establishment of a disease-relevant cellular model. Our results demonstrated that a) GALC knockout MO3.13 cells accumulated Psy and LacCer, and b) LacCer content was increased in the brain and heart isolated from twitcher (TWI) mice, the most widely used spontaneous animal model of KD. In parallel, AKT signalling was evaluated in both systems, supporting a link between LacCer dysregulation and altered cellular signalling pathways. Overall, these findings identify LacCer accumulation as a conserved feature of GALC deficiency across cellular and animal models and support the use of GALC[-/-] MO3.13 cells as a novel in vitro platform to investigate KD pathogenesis and candidate therapeutic strategies.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Animals
*Lactosylceramides/metabolism
*CRISPR-Cas Systems/genetics
Humans
*Galactosylceramidase/metabolism/deficiency/genetics
Mice, Knockout
Proto-Oncogene Proteins c-akt/metabolism
*Gene Knockout Techniques
Signal Transduction
Brain/metabolism
Disease Models, Animal
Mice
Leukodystrophy, Globoid Cell/metabolism/genetics/pathology
Oligodendroglia/metabolism
Psychosine/metabolism
Cell Line
RevDate: 2026-11-14
CmpDate: 2026-11-12
Structural basis for loop-dependent inhibition by AcrIIC1 anti-CRISPR proteins.
Nature communications, 17(1):.
Most characterized anti-CRISPR proteins act via well-defined core inhibitory mechanisms, yet how auxiliary structural elements modulate and potentiate these canonical processes remains poorly understood. Here, we show that AcrIIC1Boe represses Nme1Cas9 activity through an integrated, loop-coupled regulatory mode. Based on canonical occlusion of the HNH catalytic site, the extended loop of AcrIIC1Boe provides an additional coupled regulatory layer to remodel sgRNA spacer arrangement and R-loop progression, thereby enhancing Cas9 inhibition. Loop deletion largely abrogates robust inhibition, indicating that this loop module is indispensable for full AcrIIC1 inhibitory potency. Consistently, transplantation of this functional loop into the weakly active AcrIIC1Nme1 efficiently elevates its inhibitory performance. Our findings identify a loop-mediated regulatory strategy that potentiates the canonical HNH occlusion mechanism, clarify the structural basis for functional divergence across AcrIIC1 homologs, and offer a modular engineering principle for the rational design and optimization of anti-CRISPR proteins with enhanced potency.
Additional Links: PMID-43020790
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43020790,
year = {2026},
author = {Wang, S and Zhang, Z and Luan, C and Zhu, C and Liu, C and Li, W and Wang, Q and Liu, X and Yang, H and Xiao, Y and Wang, Z},
title = {Structural basis for loop-dependent inhibition by AcrIIC1 anti-CRISPR proteins.},
journal = {Nature communications},
volume = {17},
number = {1},
pages = {},
pmid = {43020790},
issn = {2041-1723},
support = {25ZXDFQY00120//Tianjin Science and Technology Committee (Tianjin Municipal Science and Technology Commission)/ ; 31970048//National Natural Science Foundation of China (National Science Foundation of China)/ ; },
mesh = {*CRISPR-Cas Systems ; RNA, Guide, CRISPR-Cas Systems/genetics/metabolism ; *CRISPR-Associated Protein 9/metabolism/genetics/chemistry ; Humans ; Catalytic Domain ; *Bacterial Proteins/metabolism/genetics/chemistry ; Models, Molecular ; },
abstract = {Most characterized anti-CRISPR proteins act via well-defined core inhibitory mechanisms, yet how auxiliary structural elements modulate and potentiate these canonical processes remains poorly understood. Here, we show that AcrIIC1Boe represses Nme1Cas9 activity through an integrated, loop-coupled regulatory mode. Based on canonical occlusion of the HNH catalytic site, the extended loop of AcrIIC1Boe provides an additional coupled regulatory layer to remodel sgRNA spacer arrangement and R-loop progression, thereby enhancing Cas9 inhibition. Loop deletion largely abrogates robust inhibition, indicating that this loop module is indispensable for full AcrIIC1 inhibitory potency. Consistently, transplantation of this functional loop into the weakly active AcrIIC1Nme1 efficiently elevates its inhibitory performance. Our findings identify a loop-mediated regulatory strategy that potentiates the canonical HNH occlusion mechanism, clarify the structural basis for functional divergence across AcrIIC1 homologs, and offer a modular engineering principle for the rational design and optimization of anti-CRISPR proteins with enhanced potency.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*CRISPR-Cas Systems
RNA, Guide, CRISPR-Cas Systems/genetics/metabolism
*CRISPR-Associated Protein 9/metabolism/genetics/chemistry
Humans
Catalytic Domain
*Bacterial Proteins/metabolism/genetics/chemistry
Models, Molecular
RevDate: 2026-11-14
CmpDate: 2026-11-12
Coupling hfCas13d with Circular gRNA Array Precursors Extends RNA Knockdown and Improves Biocatalysis in Yeast.
Nature communications, 17(1):.
CRISPR-based RNA cleavage holds promise for gene knockdown but its applications in metabolic engineering remain largely unexplored. Here we reconstitute three mammalian CRISPR-based RNA cleavage systems to arrest the intermediate metabolic reactions in the yeast Candida viswanathii to produce hydroxydecanoic acid (HDA), an important nylon precursor. We identify hfCas13d as the optimal effector and next develop a circular guide RNA (CgRNA) precursor architecture to enhance and extend the knockdown of genes involved in HDA production. This hfCas13d/CgRNA precursor platform also represses genes in other yeasts and E. coli, demonstrating broad microbial applicability. Single and dual CgRNA precursor arrays enable multiplexed pathway repression, with dual arrays reducing byproduct formation and increasing HDA titer to 17.8 g/L in shake flasks. Bioreactor fermentation further boosts HDA production to 37.2 g/L. Together, this work establishes hfCas13d/CgRNA as a programmable RNA regulatory platform for engineering microbial cell factories.
Additional Links: PMID-43020793
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43020793,
year = {2026},
author = {Thi Le, XM and Truong, VA and Dang, QT and Huang, SC and Nguyen, MTT and Hu, YC},
title = {Coupling hfCas13d with Circular gRNA Array Precursors Extends RNA Knockdown and Improves Biocatalysis in Yeast.},
journal = {Nature communications},
volume = {17},
number = {1},
pages = {},
pmid = {43020793},
issn = {2041-1723},
mesh = {*Candida/genetics/metabolism ; *RNA, Guide, CRISPR-Cas Systems/genetics/metabolism ; *Gene Knockdown Techniques/methods ; Biocatalysis ; CRISPR-Cas Systems ; Metabolic Engineering/methods ; Escherichia coli/genetics/metabolism ; *RNA, Circular/genetics/metabolism ; Fermentation ; Bioreactors ; Fungal Proteins/genetics/metabolism ; },
abstract = {CRISPR-based RNA cleavage holds promise for gene knockdown but its applications in metabolic engineering remain largely unexplored. Here we reconstitute three mammalian CRISPR-based RNA cleavage systems to arrest the intermediate metabolic reactions in the yeast Candida viswanathii to produce hydroxydecanoic acid (HDA), an important nylon precursor. We identify hfCas13d as the optimal effector and next develop a circular guide RNA (CgRNA) precursor architecture to enhance and extend the knockdown of genes involved in HDA production. This hfCas13d/CgRNA precursor platform also represses genes in other yeasts and E. coli, demonstrating broad microbial applicability. Single and dual CgRNA precursor arrays enable multiplexed pathway repression, with dual arrays reducing byproduct formation and increasing HDA titer to 17.8 g/L in shake flasks. Bioreactor fermentation further boosts HDA production to 37.2 g/L. Together, this work establishes hfCas13d/CgRNA as a programmable RNA regulatory platform for engineering microbial cell factories.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Candida/genetics/metabolism
*RNA, Guide, CRISPR-Cas Systems/genetics/metabolism
*Gene Knockdown Techniques/methods
Biocatalysis
CRISPR-Cas Systems
Metabolic Engineering/methods
Escherichia coli/genetics/metabolism
*RNA, Circular/genetics/metabolism
Fermentation
Bioreactors
Fungal Proteins/genetics/metabolism
RevDate: 2026-11-14
CmpDate: 2026-11-12
Translating pathogen biology into diagnostic and management strategies for gummy stem blight in cucumber production.
Crop health, 4(1):.
Gummy stem blight (GSB) is a major disease of cucurbits caused by Stagonosporopsis spp. and is increasingly problematic in intensive cucumber production systems, particularly where warm, humid environments favour infection, sporulation and rapid disease spread. GSB can infect vegetative and reproductive tissues and remain latent in fruit for several days before visible symptoms develop, creating a distinctive commercial challenge: disease may be difficult to detect before harvest yet cause significant post-harvest losses, reducing grower and retailer confidence. Compounding these problems, current diagnostic tools for detecting pre-symptomatic infection are often insufficiently validated for species specificity, sensitivity, turnaround time, cost, crude-sample compatibility and practical use by production staff. Many of these limitations reflect the relative lack of genomic resources for Stagonosporopsis. Therefore, this review integrates evidence from other pathosystems with current knowledge of Stagonosporopsis taxonomy, infection biology, epidemiology, diagnostics, fungicide resistance, effector biology and host resistance to identify pathways towards grower-ready tools. Specifically, we focus on how recent advances in genomics, paired with previously designed detection systems such as loop-mediated isothermal amplification (LAMP) and clustered regularly interspaced short palindromic repeats/CRISPR-associated proteins (CRISPR/Cas), could be adapted for species-specific detection of the causal pathogen and, simultaneously, provide a regional profile of fungicide resistance. In parallel, we explore how a deeper functional genomic understanding of the disease, particularly of effector proteins expressed during the early stages of infection, could provide valuable insights into the dynamics of this host-pathogen interaction and support strategies to disrupt these interactions through novel fungistatic compounds and the development of disease-resistant cultivars. Together, these approaches could support a staged technology-development and adoption roadmap for more precise, rapid and sustainable GSB management in cucumber production.
Additional Links: PMID-43020961
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43020961,
year = {2026},
author = {Ranjan, A and Lu, A and Hutton, C and Bricknell, O and Redman, A and Tissue, DT and Plett, JM},
title = {Translating pathogen biology into diagnostic and management strategies for gummy stem blight in cucumber production.},
journal = {Crop health},
volume = {4},
number = {1},
pages = {},
pmid = {43020961},
issn = {2948-1945},
support = {P2-028//Hawkesbury Institute for the Environment, Western Sydney University/ ; P2-028//Perfection Fresh Pty Ltd/ ; P2-028//CRC/ ; },
abstract = {Gummy stem blight (GSB) is a major disease of cucurbits caused by Stagonosporopsis spp. and is increasingly problematic in intensive cucumber production systems, particularly where warm, humid environments favour infection, sporulation and rapid disease spread. GSB can infect vegetative and reproductive tissues and remain latent in fruit for several days before visible symptoms develop, creating a distinctive commercial challenge: disease may be difficult to detect before harvest yet cause significant post-harvest losses, reducing grower and retailer confidence. Compounding these problems, current diagnostic tools for detecting pre-symptomatic infection are often insufficiently validated for species specificity, sensitivity, turnaround time, cost, crude-sample compatibility and practical use by production staff. Many of these limitations reflect the relative lack of genomic resources for Stagonosporopsis. Therefore, this review integrates evidence from other pathosystems with current knowledge of Stagonosporopsis taxonomy, infection biology, epidemiology, diagnostics, fungicide resistance, effector biology and host resistance to identify pathways towards grower-ready tools. Specifically, we focus on how recent advances in genomics, paired with previously designed detection systems such as loop-mediated isothermal amplification (LAMP) and clustered regularly interspaced short palindromic repeats/CRISPR-associated proteins (CRISPR/Cas), could be adapted for species-specific detection of the causal pathogen and, simultaneously, provide a regional profile of fungicide resistance. In parallel, we explore how a deeper functional genomic understanding of the disease, particularly of effector proteins expressed during the early stages of infection, could provide valuable insights into the dynamics of this host-pathogen interaction and support strategies to disrupt these interactions through novel fungistatic compounds and the development of disease-resistant cultivars. Together, these approaches could support a staged technology-development and adoption roadmap for more precise, rapid and sustainable GSB management in cucumber production.},
}
RevDate: 2026-11-14
CmpDate: 2026-11-12
Deciphering the landscape of human pathogenome in non-typhoidal Salmonella through multidimensional genomics.
BMC microbiology, 26(1):.
BACKGROUND: Non-typhoidal Salmonella (NTS) is a leading foodborne pathogen causing severe gastrointestinal and systemic infections, posing a significant global health burden. This study employed a genomic approach to investigate the functional and distribution characteristics of human pathogenome in NTS, aiming to provide molecular targets and a theoretical foundation for novel anti-salmonellosis strategies.
RESULTS: Analysis of eight NTS strains revealed 2,000 virulence genes encoding 263 factors, predominantly effector delivery systems (41%), of which type III secretion system (T3SS) genes constituted the majority (66.3%). A total of 217 partial sequences from 13 salmonella pathogenicity islands (SPIs) were identified, with SPI-2 (26.7%), SPI-1 (24%), and SPI-13 (10.6%) being most prevalent. Key virulence genes in SPI-1 (35 T3SS1-related genes), SPI-2 (30 T3SS2-related genes), and SPI-5 (sopB/sigD, pipB) were conserved across all strains. We identified 7,868 human pathogenicity-related genes, functionally enriched in metabolic/cellular processes, catalytic activity, and binding. Human pathogenicity-related virulence genes were mainly classified as delivery systems, adhesion factors, and nutrient metabolism factors. Enzymatic analysis showed human pathogenicity-related protease genes were primarily serine, cysteine, and metallopeptidases, while human pathogenicity-related carbohydrase-active genes were associated with glycoside hydrolases, glycosyltransferases, and carbohydrate esterases. Functional annotation with the Kyoto Encyclopedia of Genes and Genomes indicated human pathogenicity-related protease genes enrichment in signaling, cellular, metabolic, and genetic information processing pathways, particularly in antibiotic resistance and infectious diseases, while human pathogenicity-related carbohydrase-active genes were enriched in carbohydrate metabolism and glycan biosynthesis. A structurally conserved, metal-chelating non-ribosomal peptide metallophore (NRP-metallophore) gene cluster was present in all strains, containing biosynthetic virulence genes (entA, entC, entF, entB, entE, fes) and transport-related virulence genes (fep family, entS). Functional type I-E clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated (Cas) systems with variable numbers of CRISPR arrays but conserved direct repeats were identified in most strains.
CONCLUSIONS: NTS strains carried conserved T3SS effectors, human pathogenicity-related factors enriched in metabolism, catalysis, antibiotic resistance, and infection pathways, a conserved NRP-metallophore gene cluster for iron acquisition, and a functional type I-E CRISPR-Cas system, collectively defining key genetic determinants for pathogenesis.
Additional Links: PMID-43021084
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43021084,
year = {2026},
author = {Liu, H and Rui, K and Wang, T and Zheng, L},
title = {Deciphering the landscape of human pathogenome in non-typhoidal Salmonella through multidimensional genomics.},
journal = {BMC microbiology},
volume = {26},
number = {1},
pages = {},
pmid = {43021084},
issn = {1471-2180},
support = {2022-JSYZ-13//The Second Phase of Jinshan Medical Personnel Training Program/ ; },
mesh = {Humans ; *Virulence Factors/genetics ; Genomic Islands ; *Genomics/methods ; *Salmonella/genetics/pathogenicity/classification ; *Genome, Bacterial ; *Salmonella Infections/microbiology ; Type III Secretion Systems/genetics ; Bacterial Proteins/genetics ; Virulence/genetics ; },
abstract = {BACKGROUND: Non-typhoidal Salmonella (NTS) is a leading foodborne pathogen causing severe gastrointestinal and systemic infections, posing a significant global health burden. This study employed a genomic approach to investigate the functional and distribution characteristics of human pathogenome in NTS, aiming to provide molecular targets and a theoretical foundation for novel anti-salmonellosis strategies.
RESULTS: Analysis of eight NTS strains revealed 2,000 virulence genes encoding 263 factors, predominantly effector delivery systems (41%), of which type III secretion system (T3SS) genes constituted the majority (66.3%). A total of 217 partial sequences from 13 salmonella pathogenicity islands (SPIs) were identified, with SPI-2 (26.7%), SPI-1 (24%), and SPI-13 (10.6%) being most prevalent. Key virulence genes in SPI-1 (35 T3SS1-related genes), SPI-2 (30 T3SS2-related genes), and SPI-5 (sopB/sigD, pipB) were conserved across all strains. We identified 7,868 human pathogenicity-related genes, functionally enriched in metabolic/cellular processes, catalytic activity, and binding. Human pathogenicity-related virulence genes were mainly classified as delivery systems, adhesion factors, and nutrient metabolism factors. Enzymatic analysis showed human pathogenicity-related protease genes were primarily serine, cysteine, and metallopeptidases, while human pathogenicity-related carbohydrase-active genes were associated with glycoside hydrolases, glycosyltransferases, and carbohydrate esterases. Functional annotation with the Kyoto Encyclopedia of Genes and Genomes indicated human pathogenicity-related protease genes enrichment in signaling, cellular, metabolic, and genetic information processing pathways, particularly in antibiotic resistance and infectious diseases, while human pathogenicity-related carbohydrase-active genes were enriched in carbohydrate metabolism and glycan biosynthesis. A structurally conserved, metal-chelating non-ribosomal peptide metallophore (NRP-metallophore) gene cluster was present in all strains, containing biosynthetic virulence genes (entA, entC, entF, entB, entE, fes) and transport-related virulence genes (fep family, entS). Functional type I-E clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated (Cas) systems with variable numbers of CRISPR arrays but conserved direct repeats were identified in most strains.
CONCLUSIONS: NTS strains carried conserved T3SS effectors, human pathogenicity-related factors enriched in metabolism, catalysis, antibiotic resistance, and infection pathways, a conserved NRP-metallophore gene cluster for iron acquisition, and a functional type I-E CRISPR-Cas system, collectively defining key genetic determinants for pathogenesis.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Humans
*Virulence Factors/genetics
Genomic Islands
*Genomics/methods
*Salmonella/genetics/pathogenicity/classification
*Genome, Bacterial
*Salmonella Infections/microbiology
Type III Secretion Systems/genetics
Bacterial Proteins/genetics
Virulence/genetics
RevDate: 2026-11-13
CmpDate: 2026-11-13
A self-driven probiotic nanosystem reshapes extracellular matrix by knockdown of DDR1 for enhanced tumor immunotherapy.
Journal of nanobiotechnology, 24(1):.
Immunotherapy represents a promising therapeutic approach for tumor suppression, yet its efficacy is significantly limited by the immunosuppressive extracellular matrix (ECM) characteristic of solid tumors. To achieve simultaneous ECM remodeling and immune activation within a single system, we have developed a self-driven probiotic nanosystem (PL@LDH-CB) based on the probiotic Clostridium butyricum (CB), which incorporates a plasmid-loaded layered double hydroxide (PL@LDH) gene-editing module. Following intravenous administration, the PL@LDH-CB system actively targets tumor sites by leveraging CB's natural tropism toward hypoxic conditions, thereby efficiently delivering the PL@LDH gene-editing module for ECM reshaping. Within tumors, CB and its metabolites significantly enhance anti-cancer immune responses. Concurrently, the released PL@LDH enables stable nuclear expression of CRISPR-Cas9, precisely knocking down Ddr1-a gene encoding discoidin domain receptor 1 (DDR1) that mediates immune exclusion through promoting collagen fibrillogenesis and fiber alignment. The depletion of DDR1 ultimately reduces intratumoral solid stress (a compressive force exerted by collagen fibers), leading to comprehensive ECM remodeling. This process markedly improves the infiltration of activated T cells within tumors, thereby significantly enhancing immunotherapeutic outcomes.
Additional Links: PMID-43021263
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43021263,
year = {2026},
author = {Cao, L and He, Y and Li, W and He, Y and Li, G and Duan, Y and Chen, M and Liu, C and Yang, K and Wu, W and Pu, Y},
title = {A self-driven probiotic nanosystem reshapes extracellular matrix by knockdown of DDR1 for enhanced tumor immunotherapy.},
journal = {Journal of nanobiotechnology},
volume = {24},
number = {1},
pages = {},
pmid = {43021263},
issn = {1477-3155},
support = {82472107, 82402302, 82304558, 52402353//National Natural Science Foundation of China/ ; 2025ZNSFSC0237//Sichuan Science and Technology Program/ ; },
mesh = {*Extracellular Matrix/metabolism ; *Immunotherapy/methods ; Animals ; *Probiotics/pharmacology/chemistry ; Mice ; Humans ; CRISPR-Cas Systems ; Cell Line, Tumor ; Gene Editing ; Gene Knockdown Techniques ; *Neoplasms/therapy ; },
abstract = {Immunotherapy represents a promising therapeutic approach for tumor suppression, yet its efficacy is significantly limited by the immunosuppressive extracellular matrix (ECM) characteristic of solid tumors. To achieve simultaneous ECM remodeling and immune activation within a single system, we have developed a self-driven probiotic nanosystem (PL@LDH-CB) based on the probiotic Clostridium butyricum (CB), which incorporates a plasmid-loaded layered double hydroxide (PL@LDH) gene-editing module. Following intravenous administration, the PL@LDH-CB system actively targets tumor sites by leveraging CB's natural tropism toward hypoxic conditions, thereby efficiently delivering the PL@LDH gene-editing module for ECM reshaping. Within tumors, CB and its metabolites significantly enhance anti-cancer immune responses. Concurrently, the released PL@LDH enables stable nuclear expression of CRISPR-Cas9, precisely knocking down Ddr1-a gene encoding discoidin domain receptor 1 (DDR1) that mediates immune exclusion through promoting collagen fibrillogenesis and fiber alignment. The depletion of DDR1 ultimately reduces intratumoral solid stress (a compressive force exerted by collagen fibers), leading to comprehensive ECM remodeling. This process markedly improves the infiltration of activated T cells within tumors, thereby significantly enhancing immunotherapeutic outcomes.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Extracellular Matrix/metabolism
*Immunotherapy/methods
Animals
*Probiotics/pharmacology/chemistry
Mice
Humans
CRISPR-Cas Systems
Cell Line, Tumor
Gene Editing
Gene Knockdown Techniques
*Neoplasms/therapy
RevDate: 2026-11-16
CmpDate: 2026-11-16
Optimized Cas9-Enriched Nanopore Sequencing and Analysis Workflow for Clinical Diagnosis of Repeat Expansion Disorders.
Advanced science (Weinheim, Baden-Wurttemberg, Germany), 13(64):.
Short tandem repeat (STR) expansion is a major genetic mechanism underlying numerous neurogenetic disorders. However, traditional PCR amplification and short-read next-generation sequencing-based methods often fail to detect large-scale, complex expansions and to capture methylation information. Thus, this study aimed to modify an amplification-free nanopore Cas9-targeted sequencing (nCATS) platform to achieve uniform coverage across 56 currently defined STR loci using a single test with genomic DNA from patient-derived blood cells and to develop a dedicated analysis algorithm, STRiker, capable of identifying internal motif contexts and de novo repeat structures. Ultimately, this study identified pathogenic repeat expansions in 12 of 37 patients (32.4%) with cerebellar ataxia who remained genetically undiagnosed despite extensive prior genetic testing, in FGF14 (n = 4), ATXN8OS, NOP56, RFC1 (n = 2 each), and PRNP and NOTCH2NLC (n = 1 each). Additionally, family-based cascade screening revealed six relatives with repeat expansions in five families. These results demonstrate a broader diversity of pathogenic repeat structures, particularly in FGF14, and illustrate that CpG methylation can mitigate the pathogenic effects of repeat expansions. This nCATS-STRiker workflow offers a powerful strategy for improving the diagnosis of STR-related neurogenetic diseases, such as cerebellar ataxia and other diseases.
Additional Links: PMID-42667167
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid42667167,
year = {2026},
author = {Lee, S and Jung, C and Kim, M and Kim, N and Hwang, GH and Lee, ST and Chu, K and Lee, SK and Kim, HJ and Chae, JH and Bae, S and Moon, J},
title = {Optimized Cas9-Enriched Nanopore Sequencing and Analysis Workflow for Clinical Diagnosis of Repeat Expansion Disorders.},
journal = {Advanced science (Weinheim, Baden-Wurttemberg, Germany)},
volume = {13},
number = {64},
pages = {},
pmid = {42667167},
issn = {2198-3844},
support = {RS-2024-00344068//National Research Foundation of Korea/ ; RS-2026-25618734//Korea Health Industry Development Institute/ ; 25202MFDS003//Ministry of Food and Drug Safety/ ; 25B-001-0700//SNUH Lee Kun-hee Child Cancer & Rare Disease Project/ ; },
mesh = {Humans ; *Nanopore Sequencing/methods ; *Microsatellite Repeats/genetics ; Workflow ; *Genetic Testing/methods ; *CRISPR-Cas Systems/genetics ; *Cerebellar Ataxia/genetics/diagnosis ; High-Throughput Nucleotide Sequencing/methods ; *DNA Repeat Expansion/genetics ; Female ; },
abstract = {Short tandem repeat (STR) expansion is a major genetic mechanism underlying numerous neurogenetic disorders. However, traditional PCR amplification and short-read next-generation sequencing-based methods often fail to detect large-scale, complex expansions and to capture methylation information. Thus, this study aimed to modify an amplification-free nanopore Cas9-targeted sequencing (nCATS) platform to achieve uniform coverage across 56 currently defined STR loci using a single test with genomic DNA from patient-derived blood cells and to develop a dedicated analysis algorithm, STRiker, capable of identifying internal motif contexts and de novo repeat structures. Ultimately, this study identified pathogenic repeat expansions in 12 of 37 patients (32.4%) with cerebellar ataxia who remained genetically undiagnosed despite extensive prior genetic testing, in FGF14 (n = 4), ATXN8OS, NOP56, RFC1 (n = 2 each), and PRNP and NOTCH2NLC (n = 1 each). Additionally, family-based cascade screening revealed six relatives with repeat expansions in five families. These results demonstrate a broader diversity of pathogenic repeat structures, particularly in FGF14, and illustrate that CpG methylation can mitigate the pathogenic effects of repeat expansions. This nCATS-STRiker workflow offers a powerful strategy for improving the diagnosis of STR-related neurogenetic diseases, such as cerebellar ataxia and other diseases.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Humans
*Nanopore Sequencing/methods
*Microsatellite Repeats/genetics
Workflow
*Genetic Testing/methods
*CRISPR-Cas Systems/genetics
*Cerebellar Ataxia/genetics/diagnosis
High-Throughput Nucleotide Sequencing/methods
*DNA Repeat Expansion/genetics
Female
RevDate: 2026-11-16
CmpDate: 2026-11-16
Single-Molecule Imaging of Endogenous RNA Using a Miniaturized and Circularly Permuted CRISPR-Cas13 Degron-Masking System CDegSR.
Advanced science (Weinheim, Baden-Wurttemberg, Germany), 13(64):.
Visualizing the spatiotemporal dynamics of endogenous, unmodified RNA within living cells is crucial for understanding gene regulation. Yet, existing techniques are often hindered by high background fluorescence and the steric hindrance posed by CRISPR effectors. To address this, we developed CDegSR (CRISPR-mediated Degron-based Signal Restoration), a compact, fluorogenic system for high-contrast RNA imaging at single-molecule resolution. By miniaturizing dPspCas13b to its essential recognition lobe and employing circular permutation, we repositioned the protein termini to enable target-dependent masking of a potent degron. This approach promotes rapid proteasomal degradation of effectors not bound to targets while selectively stabilizing those attached to target RNA. Using CDegSR, we achieved single-molecule tracking of endogenous POLR2A transcripts, revealing that nuclear crowding and the translation machinery are the main physical constraints on mRNA mobility. CDegSR provides a versatile, low-perturbation toolkit for dissecting the transcriptomic lifecycle at single-molecule resolution.
Additional Links: PMID-42671029
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid42671029,
year = {2026},
author = {Shao, S and Zhang, H},
title = {Single-Molecule Imaging of Endogenous RNA Using a Miniaturized and Circularly Permuted CRISPR-Cas13 Degron-Masking System CDegSR.},
journal = {Advanced science (Weinheim, Baden-Wurttemberg, Germany)},
volume = {13},
number = {64},
pages = {},
pmid = {42671029},
issn = {2198-3844},
support = {32570818//National Natural Science Foundation of China/ ; 32270737//National Natural Science Foundation of China/ ; 32570674//National Natural Science Foundation of China/ ; 32300571//National Natural Science Foundation of China/ ; cstc2024ycjh-bgzxm0072//Chongqing Talent Program for Exceptional Young Talents/ ; CSTB2023NSCQ-MSX0167//Natural Science Foundation of Chongqing/ ; CSTB2023NSCQ-MSX0798//Natural Science Foundation of Chongqing/ ; },
mesh = {*Single Molecule Imaging/methods ; *CRISPR-Cas Systems/genetics ; Degrons ; *RNA/genetics ; Humans ; },
abstract = {Visualizing the spatiotemporal dynamics of endogenous, unmodified RNA within living cells is crucial for understanding gene regulation. Yet, existing techniques are often hindered by high background fluorescence and the steric hindrance posed by CRISPR effectors. To address this, we developed CDegSR (CRISPR-mediated Degron-based Signal Restoration), a compact, fluorogenic system for high-contrast RNA imaging at single-molecule resolution. By miniaturizing dPspCas13b to its essential recognition lobe and employing circular permutation, we repositioned the protein termini to enable target-dependent masking of a potent degron. This approach promotes rapid proteasomal degradation of effectors not bound to targets while selectively stabilizing those attached to target RNA. Using CDegSR, we achieved single-molecule tracking of endogenous POLR2A transcripts, revealing that nuclear crowding and the translation machinery are the main physical constraints on mRNA mobility. CDegSR provides a versatile, low-perturbation toolkit for dissecting the transcriptomic lifecycle at single-molecule resolution.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Single Molecule Imaging/methods
*CRISPR-Cas Systems/genetics
Degrons
*RNA/genetics
Humans
RevDate: 2026-11-16
CmpDate: 2026-11-16
A multiplex genome editing pipeline for rapid combinatorial trait engineering.
Cell reports methods, 6(11):101572.
Current de-extinction efforts center on editing the genomes of extant species to express key traits that evolved in closely related extinct species. These complex projects require advances in genetic engineering pipelines coupled with animal model production as an approach to test hypotheses about genotype and phenotype associations. Here, we establish a multiplex genome engineering pipeline capable of introducing up to eleven genomic modifications across seven different genes simultaneously in viable founder mice. Our workflows achieved high editing efficiencies spanning three genome-editing modalities: Cas9 knockout, Cas9-mediated homology-dependent repair (HDR), and cytosine base editing and included editing of zygotes and embryonic stem cells. As a proof of concept, we produced six mouse models with modifications in genes involved in hair development and lipid metabolism, and the resulting mice displayed predicted hair phenotypes including curly, textured coats, and gold hair. This study advances methods of rapid establishment of complex genetic models, with a wide array of applications.
Additional Links: PMID-42673961
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid42673961,
year = {2026},
author = {Chen, R and Coquelin, ML and Srirattana, K and Sampaio, RV and Weston, J and Ganji, R and Wilson, RA and Beebe, J and Ledesma, A and Sullivan, J and Qin, Y and Chao, JC and Papizan, JB and Mastracci, A and Bhide, K and Mathews, JA and Knox, G and Oglesby, R and Menon, M and van der Valk, T and Bow, A and Cantarel, BL and James, MW and Kehler, J and Dalén, L and Lamm, B and Church, GM and Shapiro, B and Abrams, ME},
title = {A multiplex genome editing pipeline for rapid combinatorial trait engineering.},
journal = {Cell reports methods},
volume = {6},
number = {11},
pages = {101572},
doi = {10.1016/j.crmeth.2026.101572},
pmid = {42673961},
issn = {2667-2375},
mesh = {Animals ; *Gene Editing/methods ; Mice ; CRISPR-Cas Systems/genetics ; *Genetic Engineering/methods ; Phenotype ; Genome ; Mice, Transgenic ; Embryonic Stem Cells/metabolism ; },
abstract = {Current de-extinction efforts center on editing the genomes of extant species to express key traits that evolved in closely related extinct species. These complex projects require advances in genetic engineering pipelines coupled with animal model production as an approach to test hypotheses about genotype and phenotype associations. Here, we establish a multiplex genome engineering pipeline capable of introducing up to eleven genomic modifications across seven different genes simultaneously in viable founder mice. Our workflows achieved high editing efficiencies spanning three genome-editing modalities: Cas9 knockout, Cas9-mediated homology-dependent repair (HDR), and cytosine base editing and included editing of zygotes and embryonic stem cells. As a proof of concept, we produced six mouse models with modifications in genes involved in hair development and lipid metabolism, and the resulting mice displayed predicted hair phenotypes including curly, textured coats, and gold hair. This study advances methods of rapid establishment of complex genetic models, with a wide array of applications.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Animals
*Gene Editing/methods
Mice
CRISPR-Cas Systems/genetics
*Genetic Engineering/methods
Phenotype
Genome
Mice, Transgenic
Embryonic Stem Cells/metabolism
RevDate: 2026-11-16
CmpDate: 2026-11-16
Integrated Organoid CRISPR Screening Reveals NF1 as a Gatekeeper of Cervical Squamous Malignant Transformation.
Cancer research, 86(22):5641-5666.
UNLABELLED: Cervical cancer can progress from high-grade squamous intraepithelial lesions driven by persistent human papillomavirus (HPV) infection. Identifying the gatekeepers restraining malignant transformation could reveal strategies to prevent and treat cervical cancer. In this study, we integrated single-cell transcriptomics, CRISPR-Cas9 screening, and organoid modeling to dissect this process. Single-cell analysis of patient samples revealed progressive activation of rat sarcoma virus (RAS) and proliferation programs along epithelial differentiation paths. A focused CRISPR screen in HPV-positive pretumoroids identified neurofibromin 1 (NF1) as the top suppressor of malignant transition. NF1 loss accelerated carcinogenesis in organoids, substantially shortening the experimental interval required for the emergence of malignant phenotypes and recapitulating basal cell expansion, altered differentiation marker expression, and tumorigenicity. Mechanistically, NF1 loss enhanced RAS-mitogen-activated protein kinase and phosphoinositide 3-kinase-protein kinase B signaling, promoted proliferative programs, and remodeled chromatin accessibility at regulatory regions enriched for activator protein 1 motifs. Conversely, NF1 restoration in cancer organoids induced apoptosis and suppressed malignant maintenance. Artificial intelligence-guided modeling was used to design a minimal NF1-derived peptide predicted to interact with RAS GTP-binding protein. The NF1-GAP-mimetic peptide reduced tumor organoid viability and cervical lesion-associated bioluminescence in an HPV16-driven mouse model and was associated with local immune-related changes without marked alterations in selected splenic T-cell populations. Together, these findings establish NF1 as a critical constraint on HPV-associated epithelial evolution and provide a time-compressed organoid model of cervical carcinogenesis, offering proof of concept for NF1-inspired therapeutic interception of RAS-associated signaling.
SIGNIFICANCE: Single-cell atlas and organoid screening identified NF1 loss as a driver of cervical carcinogenesis, which can be rescued with an AI-designed NF1 mimetic peptide that offers a therapeutic paradigm to intercept tumorigenesis.
Additional Links: PMID-42691240
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid42691240,
year = {2026},
author = {Hu, B and Chen, L and Wang, R and Zhou, Z and Zhang, G and Ruan, J and Xi, L and Zhang, Y and Li, Q and Liao, B and Li, L and Gao, C and Ma, D and Li, M and Liao, S},
title = {Integrated Organoid CRISPR Screening Reveals NF1 as a Gatekeeper of Cervical Squamous Malignant Transformation.},
journal = {Cancer research},
volume = {86},
number = {22},
pages = {5641-5666},
doi = {10.1158/0008-5472.CAN-25-5315},
pmid = {42691240},
issn = {1538-7445},
support = {82672922//National Natural Science Foundation of China (NSFC)/ ; 82341120//National Natural Science Foundation of China (NSFC)/ ; 82372354//National Natural Science Foundation of China (NSFC)/ ; 82501971//National Natural Science Foundation of China (NSFC)/ ; 2026ZD0552900//Noncommunicable Chronic Diseases-National Science and Technology Major Project/ ; },
mesh = {Female ; *Uterine Cervical Neoplasms/genetics/pathology/virology/metabolism ; Humans ; *Cell Transformation, Neoplastic/genetics/metabolism/pathology ; *Neurofibromin 1/genetics/metabolism ; Animals ; *Organoids/metabolism/pathology ; Mice ; CRISPR-Cas Systems ; Papillomavirus Infections/virology/genetics/complications ; *Carcinoma, Squamous Cell/genetics/pathology/virology ; Human Papillomavirus Viruses ; },
abstract = {UNLABELLED: Cervical cancer can progress from high-grade squamous intraepithelial lesions driven by persistent human papillomavirus (HPV) infection. Identifying the gatekeepers restraining malignant transformation could reveal strategies to prevent and treat cervical cancer. In this study, we integrated single-cell transcriptomics, CRISPR-Cas9 screening, and organoid modeling to dissect this process. Single-cell analysis of patient samples revealed progressive activation of rat sarcoma virus (RAS) and proliferation programs along epithelial differentiation paths. A focused CRISPR screen in HPV-positive pretumoroids identified neurofibromin 1 (NF1) as the top suppressor of malignant transition. NF1 loss accelerated carcinogenesis in organoids, substantially shortening the experimental interval required for the emergence of malignant phenotypes and recapitulating basal cell expansion, altered differentiation marker expression, and tumorigenicity. Mechanistically, NF1 loss enhanced RAS-mitogen-activated protein kinase and phosphoinositide 3-kinase-protein kinase B signaling, promoted proliferative programs, and remodeled chromatin accessibility at regulatory regions enriched for activator protein 1 motifs. Conversely, NF1 restoration in cancer organoids induced apoptosis and suppressed malignant maintenance. Artificial intelligence-guided modeling was used to design a minimal NF1-derived peptide predicted to interact with RAS GTP-binding protein. The NF1-GAP-mimetic peptide reduced tumor organoid viability and cervical lesion-associated bioluminescence in an HPV16-driven mouse model and was associated with local immune-related changes without marked alterations in selected splenic T-cell populations. Together, these findings establish NF1 as a critical constraint on HPV-associated epithelial evolution and provide a time-compressed organoid model of cervical carcinogenesis, offering proof of concept for NF1-inspired therapeutic interception of RAS-associated signaling.
SIGNIFICANCE: Single-cell atlas and organoid screening identified NF1 loss as a driver of cervical carcinogenesis, which can be rescued with an AI-designed NF1 mimetic peptide that offers a therapeutic paradigm to intercept tumorigenesis.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Female
*Uterine Cervical Neoplasms/genetics/pathology/virology/metabolism
Humans
*Cell Transformation, Neoplastic/genetics/metabolism/pathology
*Neurofibromin 1/genetics/metabolism
Animals
*Organoids/metabolism/pathology
Mice
CRISPR-Cas Systems
Papillomavirus Infections/virology/genetics/complications
*Carcinoma, Squamous Cell/genetics/pathology/virology
Human Papillomavirus Viruses
RevDate: 2026-11-16
CmpDate: 2026-11-16
Hybridization-Mediated Reversible sgRNA Caging Enables Tumor-Selective Gene Editing for Potentiating Antitumor Immunity via cGAS Demethylation.
Angewandte Chemie (International ed. in English), 65(47):.
Spatiotemporal precision remains a critical challenge against the gene editing technology used for disease treatment. We herein developed a tumor cell-selective CRISPR/Cas9 gene editing system by introducing a complementary single-stranded DNA (ssDNA) containing apurinic/apyrimidinic (AP) sites (AP-ssDNA) along the target region of single-guided RNA (sgRNA). The engineered hybrid (AP-ssDNA/sgRNA) could tracelessly release the native sgRNA in tumor cells due to cleavage of AP-ssDNA by the overexpressed apurinic/apyrimidinic endonuclease 1 (APE1), thus enabling tumor-selective gene editing. Subsequently, a biodegradable lipid nanoparticle based on dynamic covalent bonding was developed to codeliver Cas9-encoding mRNA (mCas9) with AP-ssDNA/sgRNA targeting the SUV39H1 gene, which mediated silence of cyclic GMP-AMP synthase (cGAS) methylation to activate stimulator of interferon genes (STING) and enhanced antitumor immunity. As thus, when coupled with radiotherapy, the gene editing platform provoked robust antitumor efficacy in B16F10 xenograft tumor-bearing mice. This study provides a versatile paradigm for conditionally controlled gene editing and highlights the therapeutic potential of cGAS demethylation in reactivating cGAS-STING pathway for antitumor immunotherapy.
Additional Links: PMID-42866891
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid42866891,
year = {2026},
author = {Zhang, H and Li, Y and Wang, Y and Zhao, Z and Yang, H and Hu, J and Cao, D and Wang, G and Zhu, R and Liu, X and Yin, L},
title = {Hybridization-Mediated Reversible sgRNA Caging Enables Tumor-Selective Gene Editing for Potentiating Antitumor Immunity via cGAS Demethylation.},
journal = {Angewandte Chemie (International ed. in English)},
volume = {65},
number = {47},
pages = {},
doi = {10.1002/anie.6610006},
pmid = {42866891},
issn = {1521-3773},
support = {52325305//National Natural Science Foundation of China/ ; 52303200//National Natural Science Foundation of China/ ; 52573340//National Natural Science Foundation of China/ ; ZXL2024384//Suzhou Science and Technology Development Project/ ; SKY2023052//Suzhou Science and Technology Development Project/ ; //Collaborative Innovation Center of Suzhou Nano Science & Technology/ ; //111 project, and Joint International Research Laboratory of Carbon-Based Functional Materials and Devices/ ; },
mesh = {Animals ; Humans ; Mice ; Cyclic Guanosine Monophosphate-Adenosine Monophosphate Synthase ; *Gene Editing ; *Nucleotidyltransferases/metabolism/genetics ; *RNA, Guide, CRISPR-Cas Systems/genetics/metabolism ; cGAS-STING Signaling Pathway ; CRISPR-Cas Systems ; Cell Line, Tumor ; DNA, Single-Stranded/genetics/chemistry ; },
abstract = {Spatiotemporal precision remains a critical challenge against the gene editing technology used for disease treatment. We herein developed a tumor cell-selective CRISPR/Cas9 gene editing system by introducing a complementary single-stranded DNA (ssDNA) containing apurinic/apyrimidinic (AP) sites (AP-ssDNA) along the target region of single-guided RNA (sgRNA). The engineered hybrid (AP-ssDNA/sgRNA) could tracelessly release the native sgRNA in tumor cells due to cleavage of AP-ssDNA by the overexpressed apurinic/apyrimidinic endonuclease 1 (APE1), thus enabling tumor-selective gene editing. Subsequently, a biodegradable lipid nanoparticle based on dynamic covalent bonding was developed to codeliver Cas9-encoding mRNA (mCas9) with AP-ssDNA/sgRNA targeting the SUV39H1 gene, which mediated silence of cyclic GMP-AMP synthase (cGAS) methylation to activate stimulator of interferon genes (STING) and enhanced antitumor immunity. As thus, when coupled with radiotherapy, the gene editing platform provoked robust antitumor efficacy in B16F10 xenograft tumor-bearing mice. This study provides a versatile paradigm for conditionally controlled gene editing and highlights the therapeutic potential of cGAS demethylation in reactivating cGAS-STING pathway for antitumor immunotherapy.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Animals
Humans
Mice
Cyclic Guanosine Monophosphate-Adenosine Monophosphate Synthase
*Gene Editing
*Nucleotidyltransferases/metabolism/genetics
*RNA, Guide, CRISPR-Cas Systems/genetics/metabolism
cGAS-STING Signaling Pathway
CRISPR-Cas Systems
Cell Line, Tumor
DNA, Single-Stranded/genetics/chemistry
RevDate: 2026-11-11
CmpDate: 2026-11-12
Quantification of Prime Editor-Corrected Frameshift Mutations Using Bioluminescence Resonance Energy Transfer (BRET).
Methods in molecular biology (Clifton, N.J.), 3099:177-186.
Frameshift mutations, caused by insertions or deletions of nucleotides that disrupt the coding reading frame, often result in premature stop codons, terminating protein translation. Prime editing, a precise genome-editing tool, has demonstrated remarkable efficiency in correcting such mutations even in living organisms. Prime editors are fusion proteins that combine a nickase variant of Cas9 (nCas9; H840A), which induces single-strand nicks in double-stranded DNA, with a modified reverse transcriptase. This system uses an extended guide RNA (pegRNA) that includes a primer-binding site and a reverse transcriptase template for the desired edit. Bioluminescence Resonance Energy Transfer (BRET) quantifies molecular interactions via energy transfer from a luminescent donor to a fluorescent acceptor. In this context, BRET is employed to measure the correction of frameshift mutations by restoring acceptor fluorophore expression. The donor luciferase coding sequence, located upstream of the frameshift mutation, remains unaffected and serves as an internal standard, ensuring reliable quantification independently of experimental fluctuations.
Additional Links: PMID-43015549
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43015549,
year = {2027},
author = {Wimmer, T and Arbeiter, ML and Lytvynchuk, L and Stieger, K},
title = {Quantification of Prime Editor-Corrected Frameshift Mutations Using Bioluminescence Resonance Energy Transfer (BRET).},
journal = {Methods in molecular biology (Clifton, N.J.)},
volume = {3099},
number = {},
pages = {177-186},
pmid = {43015549},
issn = {1940-6029},
mesh = {*Frameshift Mutation ; Humans ; *Bioluminescence Resonance Energy Transfer Techniques/methods ; *Gene Editing/methods ; CRISPR-Cas Systems ; RNA, Guide, CRISPR-Cas Systems/genetics ; },
abstract = {Frameshift mutations, caused by insertions or deletions of nucleotides that disrupt the coding reading frame, often result in premature stop codons, terminating protein translation. Prime editing, a precise genome-editing tool, has demonstrated remarkable efficiency in correcting such mutations even in living organisms. Prime editors are fusion proteins that combine a nickase variant of Cas9 (nCas9; H840A), which induces single-strand nicks in double-stranded DNA, with a modified reverse transcriptase. This system uses an extended guide RNA (pegRNA) that includes a primer-binding site and a reverse transcriptase template for the desired edit. Bioluminescence Resonance Energy Transfer (BRET) quantifies molecular interactions via energy transfer from a luminescent donor to a fluorescent acceptor. In this context, BRET is employed to measure the correction of frameshift mutations by restoring acceptor fluorophore expression. The donor luciferase coding sequence, located upstream of the frameshift mutation, remains unaffected and serves as an internal standard, ensuring reliable quantification independently of experimental fluctuations.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Frameshift Mutation
Humans
*Bioluminescence Resonance Energy Transfer Techniques/methods
*Gene Editing/methods
CRISPR-Cas Systems
RNA, Guide, CRISPR-Cas Systems/genetics
RevDate: 2026-11-11
CmpDate: 2026-11-12
Functional Analysis of Genetic Variants Using High-Throughput Prime Editing Screening.
Methods in molecular biology (Clifton, N.J.), 3099:187-199.
Prime editing is a precise genome editing technology that introduces edits, deletions, and insertions at single-base resolution. This protocol describes the design and execution of pooled high-throughput prime editing screens in mammalian cells. Using this approach, thousands of genetic variants can be tested simultaneously. The effects of tested genetic variants on cellular phenotypes are measured using high-throughput DNA sequencing of pegRNAs/ngRNAs as barcodes.
Additional Links: PMID-43015550
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43015550,
year = {2027},
author = {Ren, X},
title = {Functional Analysis of Genetic Variants Using High-Throughput Prime Editing Screening.},
journal = {Methods in molecular biology (Clifton, N.J.)},
volume = {3099},
number = {},
pages = {187-199},
pmid = {43015550},
issn = {1940-6029},
mesh = {*Gene Editing/methods ; Humans ; *Genetic Variation ; *High-Throughput Nucleotide Sequencing/methods ; CRISPR-Cas Systems ; Animals ; *High-Throughput Screening Assays/methods ; },
abstract = {Prime editing is a precise genome editing technology that introduces edits, deletions, and insertions at single-base resolution. This protocol describes the design and execution of pooled high-throughput prime editing screens in mammalian cells. Using this approach, thousands of genetic variants can be tested simultaneously. The effects of tested genetic variants on cellular phenotypes are measured using high-throughput DNA sequencing of pegRNAs/ngRNAs as barcodes.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Gene Editing/methods
Humans
*Genetic Variation
*High-Throughput Nucleotide Sequencing/methods
CRISPR-Cas Systems
Animals
*High-Throughput Screening Assays/methods
RevDate: 2026-11-11
CmpDate: 2026-11-12
TAPE-seq: A Cell-Based Method for Genome-Wide Off-Target Prediction in Prime Editing.
Methods in molecular biology (Clifton, N.J.), 3099:213-225.
Prime editors are powerful genome-editing tools that enables precise sequence modifications without the need for double-strand breaks or donor DNA templates. Given their distinct mechanism of action, evaluating their off-target activities is essential for ensuring safety in ongoing clinical development. Unlike Cas9-based tools that predict off-target effects indirectly, TAPE-seq directly leverages PE activity to map genome-wide off-target sites with high sensitivity and specificity. This detailed protocol provides a robust framework for evaluating the safety of PE-based genome-editing applications.
Additional Links: PMID-43015552
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43015552,
year = {2027},
author = {Prajogo, RC and Han, MLB and Lee, JK},
title = {TAPE-seq: A Cell-Based Method for Genome-Wide Off-Target Prediction in Prime Editing.},
journal = {Methods in molecular biology (Clifton, N.J.)},
volume = {3099},
number = {},
pages = {213-225},
pmid = {43015552},
issn = {1940-6029},
mesh = {*Gene Editing/methods ; Humans ; CRISPR-Cas Systems ; High-Throughput Nucleotide Sequencing/methods ; Genome ; Animals ; },
abstract = {Prime editors are powerful genome-editing tools that enables precise sequence modifications without the need for double-strand breaks or donor DNA templates. Given their distinct mechanism of action, evaluating their off-target activities is essential for ensuring safety in ongoing clinical development. Unlike Cas9-based tools that predict off-target effects indirectly, TAPE-seq directly leverages PE activity to map genome-wide off-target sites with high sensitivity and specificity. This detailed protocol provides a robust framework for evaluating the safety of PE-based genome-editing applications.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Gene Editing/methods
Humans
CRISPR-Cas Systems
High-Throughput Nucleotide Sequencing/methods
Genome
Animals
RevDate: 2026-11-11
CmpDate: 2026-11-12
Plant Prime Editing: Design, Assembly, and Application.
Methods in molecular biology (Clifton, N.J.), 3099:243-252.
Prime Editing (PE) is the latest technological advancement in genome editing. With the capabilities of altering the genome with precision and efficiency, PE offers great advantages over conventional CRISPR-Cas9 as well as base editors to achieve all 12 possible base changes and small indels. However, the complicated design and assembly of prime editing constructs is a limiting step in the wider applicability of the technology. In this chapter, we set forth step-by-step protocols aimed at helping the scientific community in designing their constructs as well as assembling them to target up to four genes. With the availability of PE plasmids and design/assembly protocols, PE in plants can be carried out by more labs across the globe to recognize the great potential of PE in their research.
Additional Links: PMID-43015554
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43015554,
year = {2027},
author = {Gupta, A and Yang, B},
title = {Plant Prime Editing: Design, Assembly, and Application.},
journal = {Methods in molecular biology (Clifton, N.J.)},
volume = {3099},
number = {},
pages = {243-252},
pmid = {43015554},
issn = {1940-6029},
mesh = {*Gene Editing/methods ; *CRISPR-Cas Systems ; *Genome, Plant ; Plants, Genetically Modified/genetics ; Oryza/genetics ; *Plants/genetics ; Plasmids/genetics ; RNA, Guide, CRISPR-Cas Systems/genetics ; },
abstract = {Prime Editing (PE) is the latest technological advancement in genome editing. With the capabilities of altering the genome with precision and efficiency, PE offers great advantages over conventional CRISPR-Cas9 as well as base editors to achieve all 12 possible base changes and small indels. However, the complicated design and assembly of prime editing constructs is a limiting step in the wider applicability of the technology. In this chapter, we set forth step-by-step protocols aimed at helping the scientific community in designing their constructs as well as assembling them to target up to four genes. With the availability of PE plasmids and design/assembly protocols, PE in plants can be carried out by more labs across the globe to recognize the great potential of PE in their research.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Gene Editing/methods
*CRISPR-Cas Systems
*Genome, Plant
Plants, Genetically Modified/genetics
Oryza/genetics
*Plants/genetics
Plasmids/genetics
RNA, Guide, CRISPR-Cas Systems/genetics
RevDate: 2026-11-15
CmpDate: 2026-11-15
Replicon engineering-driven modular synthetic biology toolkit for efficiently iterative genome editing in Fusarium venenatum.
Metabolic engineering, 99:102559.
Fusarium venenatum is the most widely used filamentous fungus for biomass-based microbial protein production mainly used as meat analogs. However, insufficient iterative genome editing and lack of synthetic biology tools for fine-tuning gene expression limited engineering of F. venenatum for improved traits. Here, replicon engineering-based modular synthetic biology toolkit in F. venenatum was established. Specifically, stable and curable mitochondrial DNA-derived replicons were firstly identified and characterized. The curable replicon MT07 enabled CRISPR/Cas9 genome editing system with efficient plasmid curing, shortening curing time from 22 to 8 days. Based on genome editing system, six neutral genomic integration sites were identified for gene integration expression. In contrast, the stable replicon MT071 enabled stable episomal expression system construction, facilitating the characterization of modular transcriptional and translational regulatory elements, including 21 promoters, 8 terminators, 9 Kozak sequences, and 2A peptide-mediated polycistronic expression modules, yielding 662.9-fold gene expression dynamic range. As a proof of concept, this toolkit was applied to engineering the chassis cell and construct 3-hydroxy-3-methylbutyrate (HMB) biosynthetic pathway, enabling efficient co-production of microbial protein and HMB, with titers reaching 36.2 g/L and 6.2 g/L, respectively. Overall, this work establishes a replicon engineering-driven synthetic biology platform to engineer filamentous fungi for sustainable food biomanufacturing.
Additional Links: PMID-42822642
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid42822642,
year = {2027},
author = {Gu, S and Wang, N and Tu, Y and Li, J and Li, H and Bao, J and Wu, Y and Lv, X and Liu, L and Du, G and Chen, J and Liu, Y},
title = {Replicon engineering-driven modular synthetic biology toolkit for efficiently iterative genome editing in Fusarium venenatum.},
journal = {Metabolic engineering},
volume = {99},
number = {},
pages = {102559},
doi = {10.1016/j.ymben.2026.102559},
pmid = {42822642},
issn = {1096-7184},
mesh = {*Fusarium/genetics/metabolism ; *Replicon/genetics ; *Gene Editing/methods ; *Synthetic Biology/methods ; *CRISPR-Cas Systems ; *Metabolic Engineering ; },
abstract = {Fusarium venenatum is the most widely used filamentous fungus for biomass-based microbial protein production mainly used as meat analogs. However, insufficient iterative genome editing and lack of synthetic biology tools for fine-tuning gene expression limited engineering of F. venenatum for improved traits. Here, replicon engineering-based modular synthetic biology toolkit in F. venenatum was established. Specifically, stable and curable mitochondrial DNA-derived replicons were firstly identified and characterized. The curable replicon MT07 enabled CRISPR/Cas9 genome editing system with efficient plasmid curing, shortening curing time from 22 to 8 days. Based on genome editing system, six neutral genomic integration sites were identified for gene integration expression. In contrast, the stable replicon MT071 enabled stable episomal expression system construction, facilitating the characterization of modular transcriptional and translational regulatory elements, including 21 promoters, 8 terminators, 9 Kozak sequences, and 2A peptide-mediated polycistronic expression modules, yielding 662.9-fold gene expression dynamic range. As a proof of concept, this toolkit was applied to engineering the chassis cell and construct 3-hydroxy-3-methylbutyrate (HMB) biosynthetic pathway, enabling efficient co-production of microbial protein and HMB, with titers reaching 36.2 g/L and 6.2 g/L, respectively. Overall, this work establishes a replicon engineering-driven synthetic biology platform to engineer filamentous fungi for sustainable food biomanufacturing.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Fusarium/genetics/metabolism
*Replicon/genetics
*Gene Editing/methods
*Synthetic Biology/methods
*CRISPR-Cas Systems
*Metabolic Engineering
RevDate: 2026-11-11
CmpDate: 2026-11-12
Large Insertion Using Template-Jumping Prime Editing.
Methods in molecular biology (Clifton, N.J.), 3099:145-151.
Prime editors (PEs) are advanced gene-editing tools capable of a wide spectrum of genomic modifications, offering significant potential for gene therapy. The template-jumping prime editing (TJ-PE) system employs template-jumping prime editing guide RNAs (TJ-pegRNAs) with a dual primer binding site (PBS) sequence. One PBS anneals to the DNA flap generated by the TJ-pegRNA, while the other binds to the DNA flap generated by the nicking sgRNA, enabling the accurate insertion of large DNA fragments.
Additional Links: PMID-43015547
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43015547,
year = {2027},
author = {Zheng, C and Xue, W},
title = {Large Insertion Using Template-Jumping Prime Editing.},
journal = {Methods in molecular biology (Clifton, N.J.)},
volume = {3099},
number = {},
pages = {145-151},
pmid = {43015547},
issn = {1940-6029},
mesh = {RNA, Guide, CRISPR-Cas Systems/genetics ; Humans ; DNA/genetics ; CRISPR-Cas Systems ; *Mutagenesis, Insertional/methods ; Templates, Genetic ; *Gene Editing/methods ; },
abstract = {Prime editors (PEs) are advanced gene-editing tools capable of a wide spectrum of genomic modifications, offering significant potential for gene therapy. The template-jumping prime editing (TJ-PE) system employs template-jumping prime editing guide RNAs (TJ-pegRNAs) with a dual primer binding site (PBS) sequence. One PBS anneals to the DNA flap generated by the TJ-pegRNA, while the other binds to the DNA flap generated by the nicking sgRNA, enabling the accurate insertion of large DNA fragments.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
RNA, Guide, CRISPR-Cas Systems/genetics
Humans
DNA/genetics
CRISPR-Cas Systems
*Mutagenesis, Insertional/methods
Templates, Genetic
*Gene Editing/methods
RevDate: 2026-11-14
CmpDate: 2026-11-14
Dual-site CRISPR/Cas9-mediated mutations in Toll-like receptor 4 (TLR4): complete characterization reveals divergent autophagic reprogramming of LPS-related downstream activities.
International journal of biological macromolecules, 381(Pt 1):153947.
Lipopolysaccharide (LPS) initiates hyperinflammatory cascade via the LBP-CD14-MD2-TLR4 complex which can precipitate fatal cytokine storms and septic shock. We aim to develop molecular strategies that selectively dampen TLR4-driven inflammation without eliminating host defense. Here, we demonstrate that CRISPR-Cas9-mediated dual-site editing of the TLR4 gene, by introducing specific disruptions in both the extracellular domain (ECD) and the intracellular Toll/IL-1 receptor (TIR) domain, can generate a partially uncoupled signaling phenotype that selectively attenuates acute inflammation while preserving baseline stress-adaptive mechanisms. By combining whole-genome and amplicon-based next-generation sequencing, RNA-Seq, molecular dynamics simulations, transmission electron microscopy (TEM), GSEA, and functional reporter assays, we show that targeted mutations near the LPS-binding interface within the LRR modules of the ECD (M209I, V254I, E593D) and within the CD loop of the TIR domain (R761H) reduce ligand binding-pocket volume by ~17% (688.19Å[3] vs. 825.41Å[3]) within TLR4 loci, leading to partial signal propagation and altered LPS trafficking to lysosomal compartments through autophagosome sequestration. Immunofluorescence profiling revealed broad attenuation of TLR-signaling networks, MyD88/TRAF6 recruitment, and downstream NFκB-MAPK-PI3K-AKT-JAK-STAT-mTOR cascades alongside decreased CD14 expression, suppressed ROS generation, and diminished caspase-3 activity. While complementary NFκB and LC3-HiBiT reporter assays confirmed interrupted LPS-induced inflammatory transcription and conventional autophagic flux activation, TFEB reporters revealed that edited macrophages remain highly sensitive and responsive to direct metabolic mTOR-dependent metabolic inhibition via Rapamycin. Collectively, our findings establish TLR4 as a central molecular switch and suggest that CRISPR-Cas9-mediated dual-site editing reprograms macrophages into repair-oriented, adaptive phenotype with implications for therapeutic strategies targeting inflammation, sepsis, and autophagy-driven tissue protection.
Additional Links: PMID-42570828
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid42570828,
year = {2026},
author = {Fagbohun, OF and Olawoye, B and Oriyomi, OV and McDougle, X and Iragena, O and Kellenbarger, R and Joseph, JS and Fadare, O and Kincaid, R},
title = {Dual-site CRISPR/Cas9-mediated mutations in Toll-like receptor 4 (TLR4): complete characterization reveals divergent autophagic reprogramming of LPS-related downstream activities.},
journal = {International journal of biological macromolecules},
volume = {381},
number = {Pt 1},
pages = {153947},
doi = {10.1016/j.ijbiomac.2026.153947},
pmid = {42570828},
issn = {1879-0003},
mesh = {*Lipopolysaccharides/pharmacology ; *Toll-Like Receptor 4/genetics/chemistry/metabolism ; *Autophagy/drug effects/genetics ; Animals ; *CRISPR-Cas Systems/genetics ; *Mutation ; Signal Transduction/drug effects ; Mice ; Humans ; Gene Editing ; },
abstract = {Lipopolysaccharide (LPS) initiates hyperinflammatory cascade via the LBP-CD14-MD2-TLR4 complex which can precipitate fatal cytokine storms and septic shock. We aim to develop molecular strategies that selectively dampen TLR4-driven inflammation without eliminating host defense. Here, we demonstrate that CRISPR-Cas9-mediated dual-site editing of the TLR4 gene, by introducing specific disruptions in both the extracellular domain (ECD) and the intracellular Toll/IL-1 receptor (TIR) domain, can generate a partially uncoupled signaling phenotype that selectively attenuates acute inflammation while preserving baseline stress-adaptive mechanisms. By combining whole-genome and amplicon-based next-generation sequencing, RNA-Seq, molecular dynamics simulations, transmission electron microscopy (TEM), GSEA, and functional reporter assays, we show that targeted mutations near the LPS-binding interface within the LRR modules of the ECD (M209I, V254I, E593D) and within the CD loop of the TIR domain (R761H) reduce ligand binding-pocket volume by ~17% (688.19Å[3] vs. 825.41Å[3]) within TLR4 loci, leading to partial signal propagation and altered LPS trafficking to lysosomal compartments through autophagosome sequestration. Immunofluorescence profiling revealed broad attenuation of TLR-signaling networks, MyD88/TRAF6 recruitment, and downstream NFκB-MAPK-PI3K-AKT-JAK-STAT-mTOR cascades alongside decreased CD14 expression, suppressed ROS generation, and diminished caspase-3 activity. While complementary NFκB and LC3-HiBiT reporter assays confirmed interrupted LPS-induced inflammatory transcription and conventional autophagic flux activation, TFEB reporters revealed that edited macrophages remain highly sensitive and responsive to direct metabolic mTOR-dependent metabolic inhibition via Rapamycin. Collectively, our findings establish TLR4 as a central molecular switch and suggest that CRISPR-Cas9-mediated dual-site editing reprograms macrophages into repair-oriented, adaptive phenotype with implications for therapeutic strategies targeting inflammation, sepsis, and autophagy-driven tissue protection.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Lipopolysaccharides/pharmacology
*Toll-Like Receptor 4/genetics/chemistry/metabolism
*Autophagy/drug effects/genetics
Animals
*CRISPR-Cas Systems/genetics
*Mutation
Signal Transduction/drug effects
Mice
Humans
Gene Editing
RevDate: 2026-11-14
CmpDate: 2026-11-14
CRISPGen: A deep generative framework for multi-objective CRISPR/Cas9 guide RNA design via Conditional Latent Diffusion and Dual-Critic Reinforcement Learning.
Computational biology and chemistry, 126(Pt 1):109328.
MOTIVATION: The CRISPR-Cas9 system offers transformative potential for precision genome editing, yet its clinical translation remains constrained by the risk of unintended off-target double-strand breaks. While current discriminative models excel at evaluating pre-specified candidate guides, resolving the fundamental antagonism between on-target cleavage efficiency and off-target specificity within a fixed sequence search space remains a major challenge.
RESULTS: We present CRISPGen, a unified deep generative framework that reframes sgRNA design as a multi-objective constrained sequence synthesis problem. It integrates (i) DNABERT-2 genomic-language embeddings, (ii) a conditional latent diffusion generator conditioned on a user-specified on-target efficiency target, and (iii) a dual-critic reinforcement-learning (RL) stage that couples a frozen on-target efficiency critic with a cross-attention off-target discriminator (validation Pearson R=0.8157) trained on a unified corpus of experimental off-target events from six detection platforms. Across 1000 generated sgRNAs, CRISPGen reduces the mean off-target discriminator score by 99.7% relative to the pre-RL baseline and, under an exhaustive whole-genome screen of all 302,631,056 NGG PAM sites in GRCh38, yields zero perfect-match and only 55 one-mismatch genomic hits. We further show, transparently, that the internal on-target critic saturates under RL optimization - an instance of Goodhart's Law - and therefore assess on-target viability using an independent external CRISPRon screen (mean 47.10/100). Repeating the RL fine-tuning stage under three random seeds (with the diffusion generator, DNABERT-2 embeddings, and off-target discriminator held fixed) yields a stable operating point across seeds. Full diversity, per-mismatch, and reproducibility statistics are reported in the Results.
AVAILABILITY: Source code is available at https://github.com/malekpouri/CRISPGen; the pre-trained checkpoints and the 3,000,000-sequence library are hosted on Hugging Face (https://huggingface.co/malekpouri/CRISPGen-Checkpoints) and archived on Zenodo under DOI 10.5281/zenodo.21428641.
Additional Links: PMID-42705098
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid42705098,
year = {2027},
author = {Malekpouri, M and Lotfi, S},
title = {CRISPGen: A deep generative framework for multi-objective CRISPR/Cas9 guide RNA design via Conditional Latent Diffusion and Dual-Critic Reinforcement Learning.},
journal = {Computational biology and chemistry},
volume = {126},
number = {Pt 1},
pages = {109328},
doi = {10.1016/j.compbiolchem.2026.109328},
pmid = {42705098},
issn = {1476-928X},
mesh = {*CRISPR-Cas Systems/genetics ; Reinforcement Machine Learning ; *RNA, Guide, CRISPR-Cas Systems/genetics ; Generative Artificial Intelligence ; *Gene Editing ; },
abstract = {MOTIVATION: The CRISPR-Cas9 system offers transformative potential for precision genome editing, yet its clinical translation remains constrained by the risk of unintended off-target double-strand breaks. While current discriminative models excel at evaluating pre-specified candidate guides, resolving the fundamental antagonism between on-target cleavage efficiency and off-target specificity within a fixed sequence search space remains a major challenge.
RESULTS: We present CRISPGen, a unified deep generative framework that reframes sgRNA design as a multi-objective constrained sequence synthesis problem. It integrates (i) DNABERT-2 genomic-language embeddings, (ii) a conditional latent diffusion generator conditioned on a user-specified on-target efficiency target, and (iii) a dual-critic reinforcement-learning (RL) stage that couples a frozen on-target efficiency critic with a cross-attention off-target discriminator (validation Pearson R=0.8157) trained on a unified corpus of experimental off-target events from six detection platforms. Across 1000 generated sgRNAs, CRISPGen reduces the mean off-target discriminator score by 99.7% relative to the pre-RL baseline and, under an exhaustive whole-genome screen of all 302,631,056 NGG PAM sites in GRCh38, yields zero perfect-match and only 55 one-mismatch genomic hits. We further show, transparently, that the internal on-target critic saturates under RL optimization - an instance of Goodhart's Law - and therefore assess on-target viability using an independent external CRISPRon screen (mean 47.10/100). Repeating the RL fine-tuning stage under three random seeds (with the diffusion generator, DNABERT-2 embeddings, and off-target discriminator held fixed) yields a stable operating point across seeds. Full diversity, per-mismatch, and reproducibility statistics are reported in the Results.
AVAILABILITY: Source code is available at https://github.com/malekpouri/CRISPGen; the pre-trained checkpoints and the 3,000,000-sequence library are hosted on Hugging Face (https://huggingface.co/malekpouri/CRISPGen-Checkpoints) and archived on Zenodo under DOI 10.5281/zenodo.21428641.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*CRISPR-Cas Systems/genetics
Reinforcement Machine Learning
*RNA, Guide, CRISPR-Cas Systems/genetics
Generative Artificial Intelligence
*Gene Editing
RevDate: 2026-11-14
CmpDate: 2026-11-14
T7 Ribonucleic Acid Polymerase-Triggered CRISPR/Cas13a and Branched HCR Cascade Amplification with Machine Learning for SERS Detection of Cardiac Troponin I.
ACS applied materials & interfaces, 18(44):61616-61628.
Cardiac troponin I (cTnI) serves as a critical biomarker of acute myocardial infarction (AMI). Its serum level is extremely sparse, and the clinical cut-off value reaches merely 0.2 ng mL-1. This poses a significant challenge, requiring highly sensitive analytical techniques for reliable quantification. This study proposes a powerful surface-enhanced Raman scattering (SERS) sensing strategy integrating multistage signal amplification and machine learning to enhance detection performance. By combining T7 RNA polymerase, CRISPR/Cas13a, branched hybridization chain reaction (bHCR), and Fe3O4@COF@Ag magnetic substrate, the strategy constructs an efficient "recognition-amplification-signal output" closed loop for cTnI detection. Experimental results demonstrate that the platform has a linear calibration range of 0.1-104 pg/mL for cTnI, with an estimated limit of detection (LOD) of 0.1 pg/mL, holding promise for future AMI-related biomarker analysis. It also shows excellent selectivity against common serum interferents, good reproducibility (intra-batch RSD = 2.87%, inter-batch RSD = 7.96%), and reliable recovery (100.1%-110%) in human serum samples. Based on Raman signals, the k-nearest neighbor (kNN) classifier demonstrated high accuracy in classifying cTnI concentration levels, while the artificial neural network (ANN) model exhibited strong quantitative predictive performance with an R2 of 0.9997. This platform overcomes the limitations of conventional cTnI assays in terms of sensitivity and signal amplification efficiency, providing a promising analytical platform for future AMI-related biomarker studies.
Additional Links: PMID-42932909
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid42932909,
year = {2026},
author = {Zhou, N and Ma, Y and Wang, Y and Zhai, F and Li, Y and Luo, X and Shao, B},
title = {T7 Ribonucleic Acid Polymerase-Triggered CRISPR/Cas13a and Branched HCR Cascade Amplification with Machine Learning for SERS Detection of Cardiac Troponin I.},
journal = {ACS applied materials & interfaces},
volume = {18},
number = {44},
pages = {61616-61628},
doi = {10.1021/acsami.6c17334},
pmid = {42932909},
issn = {1944-8252},
support = {2025YFHZ0074//Science and Technology Department of Sichuan Province/ ; 2026NSFC0156//Science and Technology Department of Sichuan Province/ ; },
mesh = {*Troponin I/blood ; Spectrum Analysis, Raman/methods ; Humans ; *Machine Learning ; *CRISPR-Cas Systems/genetics ; *DNA-Directed RNA Polymerases/metabolism/chemistry ; *Viral Proteins/metabolism/chemistry ; *Biosensing Techniques/methods ; Limit of Detection ; Silver/chemistry ; Cobalt/chemistry ; Biomarkers/blood ; Nucleic Acid Amplification Techniques ; },
abstract = {Cardiac troponin I (cTnI) serves as a critical biomarker of acute myocardial infarction (AMI). Its serum level is extremely sparse, and the clinical cut-off value reaches merely 0.2 ng mL-1. This poses a significant challenge, requiring highly sensitive analytical techniques for reliable quantification. This study proposes a powerful surface-enhanced Raman scattering (SERS) sensing strategy integrating multistage signal amplification and machine learning to enhance detection performance. By combining T7 RNA polymerase, CRISPR/Cas13a, branched hybridization chain reaction (bHCR), and Fe3O4@COF@Ag magnetic substrate, the strategy constructs an efficient "recognition-amplification-signal output" closed loop for cTnI detection. Experimental results demonstrate that the platform has a linear calibration range of 0.1-104 pg/mL for cTnI, with an estimated limit of detection (LOD) of 0.1 pg/mL, holding promise for future AMI-related biomarker analysis. It also shows excellent selectivity against common serum interferents, good reproducibility (intra-batch RSD = 2.87%, inter-batch RSD = 7.96%), and reliable recovery (100.1%-110%) in human serum samples. Based on Raman signals, the k-nearest neighbor (kNN) classifier demonstrated high accuracy in classifying cTnI concentration levels, while the artificial neural network (ANN) model exhibited strong quantitative predictive performance with an R2 of 0.9997. This platform overcomes the limitations of conventional cTnI assays in terms of sensitivity and signal amplification efficiency, providing a promising analytical platform for future AMI-related biomarker studies.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Troponin I/blood
Spectrum Analysis, Raman/methods
Humans
*Machine Learning
*CRISPR-Cas Systems/genetics
*DNA-Directed RNA Polymerases/metabolism/chemistry
*Viral Proteins/metabolism/chemistry
*Biosensing Techniques/methods
Limit of Detection
Silver/chemistry
Cobalt/chemistry
Biomarkers/blood
Nucleic Acid Amplification Techniques
RevDate: 2026-11-14
CmpDate: 2026-11-14
Development of an accurate CRISPR/Cas13 diagnostic system for Wuchereria bancrofti.
Emerging microbes & infections, 15(1):2761170.
Disease surveillance is critical for WHO's Global Programme to Eliminate Lymphatic Filariasis (LF), but current field-ready diagnostics exhibit insufficient sensitivity and/or specificity in low-endemic settings. We aim to develop an ultra-sensitive and field-friendly CRISPR/Cas13-based SHERLOCK (Specific High-sensitivity Enzymatic Reporter unLOCKing) tool for point-of-care detection of Wuchereria bancrofti infection. The SHERLOCK assay, combining recombinase polymerase amplification (RPA) with CRISPR/Cas13a detection, was performed in two-step and one-pot formats, with sensitivity compared to qPCR (the emerging gold standard). The W. bancrofti SHERLOCK assays achieved a detection limit of 0.1 fg/μL gBlock DNA and showed no cross-reaction with five other filarial species. Assays were validated using 149 pooled mosquito and 185 human blood samples from Samoa, which were previously tested for LF antigen using WHO-recommended Filariasis Test Strips (FTS) and microscopically examined for microfilariae (Mf). For both mosquito and human samples, the two-step SHERLOCK assay reached 100% sensitivity and specificity, while one-pot SHERLOCK showed 94.0-96.4% sensitivity and 100% specificity. To improve the field deployability of the assay, we also used lyophilized one-pot SHERLOCK master mix and assessed its thermostability after storage at 25, 4, and -20°C. The lyophilized one-pot SHERLOCK mix maintained a detection limit of 10 fg/μL W. bancrofti gBlock after 10 days at 25°C, indicating reduced reliance on cold-chain for reagent storage and transport. However, when testing human blood samples with lyophilized SHERLOCK, reduced sensitivity (59.7%) was observed. This CRISPR-based platform offers a promising field-ready next-generation approach to LF diagnostics, potentially addressing current limitations, enhancing surveillance, and elimination efforts.
Additional Links: PMID-42992530
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid42992530,
year = {2026},
author = {MacGregor, SR and Bradbury, RS and Jones, MK and Seeler, A and Mayfield, HJ and Graves, PM and Rigby, L and Hedtke, SM and Colella, V and Martine, BM and Bi, Y and Thomsen, R and Viali, S and Lau, CL and You, H},
title = {Development of an accurate CRISPR/Cas13 diagnostic system for Wuchereria bancrofti.},
journal = {Emerging microbes & infections},
volume = {15},
number = {1},
pages = {2761170},
doi = {10.1080/22221751.2026.2761170},
pmid = {42992530},
issn = {2222-1751},
mesh = {*Wuchereria bancrofti/genetics/isolation & purification ; Animals ; Humans ; *CRISPR-Cas Systems ; Sensitivity and Specificity ; *Elephantiasis, Filarial/diagnosis/parasitology ; Rapid Diagnostic Tests ; DNA, Helminth/genetics ; *Molecular Diagnostic Techniques/methods ; Nucleic Acid Amplification Techniques/methods ; Culicidae/parasitology ; },
abstract = {Disease surveillance is critical for WHO's Global Programme to Eliminate Lymphatic Filariasis (LF), but current field-ready diagnostics exhibit insufficient sensitivity and/or specificity in low-endemic settings. We aim to develop an ultra-sensitive and field-friendly CRISPR/Cas13-based SHERLOCK (Specific High-sensitivity Enzymatic Reporter unLOCKing) tool for point-of-care detection of Wuchereria bancrofti infection. The SHERLOCK assay, combining recombinase polymerase amplification (RPA) with CRISPR/Cas13a detection, was performed in two-step and one-pot formats, with sensitivity compared to qPCR (the emerging gold standard). The W. bancrofti SHERLOCK assays achieved a detection limit of 0.1 fg/μL gBlock DNA and showed no cross-reaction with five other filarial species. Assays were validated using 149 pooled mosquito and 185 human blood samples from Samoa, which were previously tested for LF antigen using WHO-recommended Filariasis Test Strips (FTS) and microscopically examined for microfilariae (Mf). For both mosquito and human samples, the two-step SHERLOCK assay reached 100% sensitivity and specificity, while one-pot SHERLOCK showed 94.0-96.4% sensitivity and 100% specificity. To improve the field deployability of the assay, we also used lyophilized one-pot SHERLOCK master mix and assessed its thermostability after storage at 25, 4, and -20°C. The lyophilized one-pot SHERLOCK mix maintained a detection limit of 10 fg/μL W. bancrofti gBlock after 10 days at 25°C, indicating reduced reliance on cold-chain for reagent storage and transport. However, when testing human blood samples with lyophilized SHERLOCK, reduced sensitivity (59.7%) was observed. This CRISPR-based platform offers a promising field-ready next-generation approach to LF diagnostics, potentially addressing current limitations, enhancing surveillance, and elimination efforts.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Wuchereria bancrofti/genetics/isolation & purification
Animals
Humans
*CRISPR-Cas Systems
Sensitivity and Specificity
*Elephantiasis, Filarial/diagnosis/parasitology
Rapid Diagnostic Tests
DNA, Helminth/genetics
*Molecular Diagnostic Techniques/methods
Nucleic Acid Amplification Techniques/methods
Culicidae/parasitology
RevDate: 2026-11-11
CmpDate: 2026-11-12
pegRNA Online Tool Design and Experimental Assembly: Exploring the Practical Use of PE-Designer for Prime Editing.
Methods in molecular biology (Clifton, N.J.), 3099:9-29.
Prime editing (PE) is an innovative genome-editing technology that enables precise genetic modifications with greater efficiency compared to traditional CRISPR/Cas9-based systems. The successful application of this method heavily depends on the design of prime editing guide RNAs (pegRNAs). Efficient design of pegRNAs is facilitated by online tools like PE-Designer (www.rgenome.net/pe-designer/) , which offers a user-friendly interface for designing pegRNA and nicking single-guide RNA (sgRNA) sequences. Notable features of PE-Designer include its flexibility in adjusting the prime binding site (PBS) and reverse transcription template (RTT) lengths of pegRNAs, as well as its ability to assess potential off-target effects across various genomes. This chapter focuses on using PE-Designer for pegRNA design, providing a step-by-step guide to the tool while addressing frequent challenges. Furthermore, using the SnapGene software, we explore the assembly of both the pegRNA and sgRNA construct maps. Finally, the chapter presents the experimental protocol for constructing both the pegRNA and sgRNA vectors, with a detailed explanation of the Golden Gate assembly technique.
Additional Links: PMID-43015538
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43015538,
year = {2027},
author = {Santos Sousa, I and Patrício, D and Torres, M and Marques, JP and Ambrósio, AF and Alves, CH},
title = {pegRNA Online Tool Design and Experimental Assembly: Exploring the Practical Use of PE-Designer for Prime Editing.},
journal = {Methods in molecular biology (Clifton, N.J.)},
volume = {3099},
number = {},
pages = {9-29},
pmid = {43015538},
issn = {1940-6029},
mesh = {*Gene Editing/methods ; *RNA, Guide, CRISPR-Cas Systems/genetics ; *Software ; CRISPR-Cas Systems ; Internet ; },
abstract = {Prime editing (PE) is an innovative genome-editing technology that enables precise genetic modifications with greater efficiency compared to traditional CRISPR/Cas9-based systems. The successful application of this method heavily depends on the design of prime editing guide RNAs (pegRNAs). Efficient design of pegRNAs is facilitated by online tools like PE-Designer (www.rgenome.net/pe-designer/) , which offers a user-friendly interface for designing pegRNA and nicking single-guide RNA (sgRNA) sequences. Notable features of PE-Designer include its flexibility in adjusting the prime binding site (PBS) and reverse transcription template (RTT) lengths of pegRNAs, as well as its ability to assess potential off-target effects across various genomes. This chapter focuses on using PE-Designer for pegRNA design, providing a step-by-step guide to the tool while addressing frequent challenges. Furthermore, using the SnapGene software, we explore the assembly of both the pegRNA and sgRNA construct maps. Finally, the chapter presents the experimental protocol for constructing both the pegRNA and sgRNA vectors, with a detailed explanation of the Golden Gate assembly technique.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Gene Editing/methods
*RNA, Guide, CRISPR-Cas Systems/genetics
*Software
CRISPR-Cas Systems
Internet
RevDate: 2026-11-11
CmpDate: 2026-11-12
Design of Highly Efficient pegRNAs with Minimized Off-Target Effects Using DeepPrime.
Methods in molecular biology (Clifton, N.J.), 3099:31-40.
Prime editors are newly developed genome editing tools capable of installing various types of mutations without introducing double-strand DNA breaks (DSBs) or requiring donor DNA templates. Prime editors consist of a Cas9 nickase fused to a reverse transcriptase (RT) domain and function as a ribonucleoprotein complex with prime editing guide RNA (pegRNA). Unlike the single guide RNA (sgRNA) used with Cas9 or base editors, the editing efficiency of pegRNAs is determined by the sequence composition and length of the guide sequence, primer binding site (PBS), and reverse transcription template (RTT). The high design flexibility of pegRNAs presents both opportunities and challenges. Therefore, designing pegRNAs with high efficacy has been a significant hurdle for the application of prime editing. Here, we present a step-by-step protocol for designing optimal pegRNAs to introduce desired edits using a deep learning-based algorithm, DeepPrime.
Additional Links: PMID-43015539
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43015539,
year = {2027},
author = {Lee, G and Kim, HK},
title = {Design of Highly Efficient pegRNAs with Minimized Off-Target Effects Using DeepPrime.},
journal = {Methods in molecular biology (Clifton, N.J.)},
volume = {3099},
number = {},
pages = {31-40},
pmid = {43015539},
issn = {1940-6029},
mesh = {*RNA, Guide, CRISPR-Cas Systems/genetics ; *Gene Editing/methods ; CRISPR-Cas Systems ; Deep Learning ; Humans ; Algorithms ; },
abstract = {Prime editors are newly developed genome editing tools capable of installing various types of mutations without introducing double-strand DNA breaks (DSBs) or requiring donor DNA templates. Prime editors consist of a Cas9 nickase fused to a reverse transcriptase (RT) domain and function as a ribonucleoprotein complex with prime editing guide RNA (pegRNA). Unlike the single guide RNA (sgRNA) used with Cas9 or base editors, the editing efficiency of pegRNAs is determined by the sequence composition and length of the guide sequence, primer binding site (PBS), and reverse transcription template (RTT). The high design flexibility of pegRNAs presents both opportunities and challenges. Therefore, designing pegRNAs with high efficacy has been a significant hurdle for the application of prime editing. Here, we present a step-by-step protocol for designing optimal pegRNAs to introduce desired edits using a deep learning-based algorithm, DeepPrime.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*RNA, Guide, CRISPR-Cas Systems/genetics
*Gene Editing/methods
CRISPR-Cas Systems
Deep Learning
Humans
Algorithms
RevDate: 2026-11-11
CmpDate: 2026-11-12
Using Prime Editing Guide Generator (PEGG) for High-Throughput Generation of Prime Editing Sensor Libraries.
Methods in molecular biology (Clifton, N.J.), 3099:41-54.
Prime editing enables the generation of nearly any small genetic variant. However, the process of prime editing guide RNA (pegRNA) design is challenging and requires automated computational design tools. We developed Prime Editing Guide Generator (PEGG), a fast, flexible, and user-friendly Python package that enables the rapid generation of pegRNA and pegRNA-sensor libraries. Here, we describe the installation and use of PEGG (https://pegg.readthedocs.io) to rapidly generate custom pegRNA-sensor libraries for use in high-throughput prime editing screens.
Additional Links: PMID-43015540
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43015540,
year = {2027},
author = {Gould, SI and Sánchez-Rivera, FJ},
title = {Using Prime Editing Guide Generator (PEGG) for High-Throughput Generation of Prime Editing Sensor Libraries.},
journal = {Methods in molecular biology (Clifton, N.J.)},
volume = {3099},
number = {},
pages = {41-54},
pmid = {43015540},
issn = {1940-6029},
mesh = {*Gene Editing/methods ; *Software ; *Gene Library ; *RNA, Guide, CRISPR-Cas Systems/genetics ; CRISPR-Cas Systems ; Humans ; },
abstract = {Prime editing enables the generation of nearly any small genetic variant. However, the process of prime editing guide RNA (pegRNA) design is challenging and requires automated computational design tools. We developed Prime Editing Guide Generator (PEGG), a fast, flexible, and user-friendly Python package that enables the rapid generation of pegRNA and pegRNA-sensor libraries. Here, we describe the installation and use of PEGG (https://pegg.readthedocs.io) to rapidly generate custom pegRNA-sensor libraries for use in high-throughput prime editing screens.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Gene Editing/methods
*Software
*Gene Library
*RNA, Guide, CRISPR-Cas Systems/genetics
CRISPR-Cas Systems
Humans
RevDate: 2026-11-11
CmpDate: 2026-11-12
Rapid Cell-Free Preparation of Circular Vector DNA for pegRNA Expression in Prime Editing.
Methods in molecular biology (Clifton, N.J.), 3099:55-66.
The expression of prime editing guide RNA (pegRNA) is crucial for effective CRISPR-Cas9 prime genome editing, traditionally facilitated by DNA plasmids, which require a time-consuming process of bacterial cloning, validation, and purification. The Circular Vector (CV) protocol represents an efficient, fully synthetic, cell-free method that bypasses these traditional steps, allowing for the preparation of pegRNA expression vectors within 3 h. This approach involves circularizing and purifying linear double-stranded DNA (dsDNA) templates containing a promoter with pegRNA elements into compact, bacterial-backbone-free vectors. These CVs offer significant advantages: absence of a bacterial backbone, absence of endotoxins, and no contamination by bacterial nucleic acids, making them a superior choice for transfection in cell culture experiments, where they have shown performance equal to or better than that of traditional plasmids. The CV protocol not only speeds up the preparation process but also reduces costs and complexity, making it an ideal tool for rapid and efficient pegRNA expression in research settings.
Additional Links: PMID-43015541
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43015541,
year = {2027},
author = {Oliynyk, RT and Church, GM},
title = {Rapid Cell-Free Preparation of Circular Vector DNA for pegRNA Expression in Prime Editing.},
journal = {Methods in molecular biology (Clifton, N.J.)},
volume = {3099},
number = {},
pages = {55-66},
pmid = {43015541},
issn = {1940-6029},
mesh = {*Genetic Vectors/genetics ; *DNA, Circular/genetics ; *Gene Editing/methods ; *RNA, Guide, CRISPR-Cas Systems/genetics ; Plasmids/genetics ; CRISPR-Cas Systems ; Cloning, Molecular/methods ; },
abstract = {The expression of prime editing guide RNA (pegRNA) is crucial for effective CRISPR-Cas9 prime genome editing, traditionally facilitated by DNA plasmids, which require a time-consuming process of bacterial cloning, validation, and purification. The Circular Vector (CV) protocol represents an efficient, fully synthetic, cell-free method that bypasses these traditional steps, allowing for the preparation of pegRNA expression vectors within 3 h. This approach involves circularizing and purifying linear double-stranded DNA (dsDNA) templates containing a promoter with pegRNA elements into compact, bacterial-backbone-free vectors. These CVs offer significant advantages: absence of a bacterial backbone, absence of endotoxins, and no contamination by bacterial nucleic acids, making them a superior choice for transfection in cell culture experiments, where they have shown performance equal to or better than that of traditional plasmids. The CV protocol not only speeds up the preparation process but also reduces costs and complexity, making it an ideal tool for rapid and efficient pegRNA expression in research settings.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Genetic Vectors/genetics
*DNA, Circular/genetics
*Gene Editing/methods
*RNA, Guide, CRISPR-Cas Systems/genetics
Plasmids/genetics
CRISPR-Cas Systems
Cloning, Molecular/methods
RevDate: 2026-11-11
CmpDate: 2026-11-12
Construction of the p2PE3 Platform Based on RNA-Pol-II-Driven Engineered pegRNA.
Methods in molecular biology (Clifton, N.J.), 3099:67-85.
Prime editor (PE) is a versatile tool capable of precisely installing programmed genetic information into eukaryotic genomes. The canonical PE3 system uses a constitutive RNA polymerase III (RNA-Pol-III) promoter to drive RNA expression. However, RNA-Pol-III is unable to efficiently transcribe RNA sequences containing poly(T) motifs or gRNAs expressed in tandem, which restricts the application of PE. Here, we detail the use of an RNA polymerase II (RNA-Pol-II) promoter to drive RNA expression, coupled with Csy4 for RNA processing. This approach enabled efficient editing with poly(T)-containing pegRNAs, multiple gRNA editing combinations, and conditionally inducible gRNA. These findings overcome the limitations of RNA-Pol-III-driven RNA systems and broaden the applications of prime editing.
Additional Links: PMID-43015542
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43015542,
year = {2027},
author = {Zhang, G and Huang, X and Liu, J},
title = {Construction of the p2PE3 Platform Based on RNA-Pol-II-Driven Engineered pegRNA.},
journal = {Methods in molecular biology (Clifton, N.J.)},
volume = {3099},
number = {},
pages = {67-85},
pmid = {43015542},
issn = {1940-6029},
mesh = {*RNA Polymerase II/genetics/metabolism ; *Gene Editing/methods ; RNA Polymerase III/genetics ; RNA Editing ; RNA, Guide, CRISPR-Cas Systems/genetics ; Promoter Regions, Genetic ; Humans ; *RNA/genetics ; },
abstract = {Prime editor (PE) is a versatile tool capable of precisely installing programmed genetic information into eukaryotic genomes. The canonical PE3 system uses a constitutive RNA polymerase III (RNA-Pol-III) promoter to drive RNA expression. However, RNA-Pol-III is unable to efficiently transcribe RNA sequences containing poly(T) motifs or gRNAs expressed in tandem, which restricts the application of PE. Here, we detail the use of an RNA polymerase II (RNA-Pol-II) promoter to drive RNA expression, coupled with Csy4 for RNA processing. This approach enabled efficient editing with poly(T)-containing pegRNAs, multiple gRNA editing combinations, and conditionally inducible gRNA. These findings overcome the limitations of RNA-Pol-III-driven RNA systems and broaden the applications of prime editing.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*RNA Polymerase II/genetics/metabolism
*Gene Editing/methods
RNA Polymerase III/genetics
RNA Editing
RNA, Guide, CRISPR-Cas Systems/genetics
Promoter Regions, Genetic
Humans
*RNA/genetics
RevDate: 2026-11-11
CmpDate: 2026-11-12
Protocol for Prime Editing with Engineered PAM-Flexible Cas9 Variants.
Methods in molecular biology (Clifton, N.J.), 3099:87-104.
Prime editing (PE) is a precision genome-editing technology that allows all types of editing, such as substitutions, insertions, and deletions, at the target site in the genome of a cell without double-strand breaks (DSBs) or donor DNA. However, the targeting range of existing prime editing systems is limited due to their dependence on the NGG protospacer adjacent motif (PAM) recognized by Streptococcus pyogenes Cas9 (spCas9). To address this limitation, we have engineered prime editor variants incorporating PAM-flexible Cas9 proteins. These variants significantly expand the range of targetable genomic sites, allowing for the introduction of mutations previously inaccessible to standard editing methods. Here, we provide detailed methods for applying these PAM-flexible PE variants in human cell lines.
Additional Links: PMID-43015543
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43015543,
year = {2027},
author = {Jang, G and Kweon, J and Kim, Y},
title = {Protocol for Prime Editing with Engineered PAM-Flexible Cas9 Variants.},
journal = {Methods in molecular biology (Clifton, N.J.)},
volume = {3099},
number = {},
pages = {87-104},
pmid = {43015543},
issn = {1940-6029},
mesh = {*Gene Editing/methods ; Humans ; *CRISPR-Associated Protein 9/genetics/metabolism ; *CRISPR-Cas Systems ; Streptococcus pyogenes/genetics/enzymology ; RNA, Guide, CRISPR-Cas Systems/genetics ; Nucleotide Motifs ; HEK293 Cells ; },
abstract = {Prime editing (PE) is a precision genome-editing technology that allows all types of editing, such as substitutions, insertions, and deletions, at the target site in the genome of a cell without double-strand breaks (DSBs) or donor DNA. However, the targeting range of existing prime editing systems is limited due to their dependence on the NGG protospacer adjacent motif (PAM) recognized by Streptococcus pyogenes Cas9 (spCas9). To address this limitation, we have engineered prime editor variants incorporating PAM-flexible Cas9 proteins. These variants significantly expand the range of targetable genomic sites, allowing for the introduction of mutations previously inaccessible to standard editing methods. Here, we provide detailed methods for applying these PAM-flexible PE variants in human cell lines.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Gene Editing/methods
Humans
*CRISPR-Associated Protein 9/genetics/metabolism
*CRISPR-Cas Systems
Streptococcus pyogenes/genetics/enzymology
RNA, Guide, CRISPR-Cas Systems/genetics
Nucleotide Motifs
HEK293 Cells
RevDate: 2026-11-11
CmpDate: 2026-11-12
Improvement of Genome Editing Efficiency in Mammalian Cells by a Refined Uni-Vector Prime Editing System.
Methods in molecular biology (Clifton, N.J.), 3099:105-113.
Prime editing is an advanced technology in the CRISPR/Cas genome editing field. The original multi-vector method utilized in prime editing has less efficiency and precision and is also inherently difficult in generating homozygous mutations in mammalian cells. To overcome these technical difficulties, a Uni-vector prime editing system containing the major components for prime editing has been constructed in two all-in-one plasmids, pPE3-pPuro and pePE5max-pPuro. The Uni-vector prime editing plasmids enhance the editing efficiency of prime editing and improve the generation of homozygous mutated mammalian cell lines. The editing efficiency depends on the transfection efficiency. Remarkably, the Uni-vector ePE5max system can achieve a high editing rate even in cell lines that are traditionally difficult to transfect. This Uni-vector approach simplifies the delivery of all the necessary editing components and greatly improves the editing efficiency. This approach represents an advanced progress in the field of prime editing.
Additional Links: PMID-43015544
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43015544,
year = {2027},
author = {Liao, LZ and Wu, KJ},
title = {Improvement of Genome Editing Efficiency in Mammalian Cells by a Refined Uni-Vector Prime Editing System.},
journal = {Methods in molecular biology (Clifton, N.J.)},
volume = {3099},
number = {},
pages = {105-113},
pmid = {43015544},
issn = {1940-6029},
mesh = {*Gene Editing/methods ; *Genetic Vectors/genetics ; Animals ; Humans ; *CRISPR-Cas Systems ; Plasmids/genetics ; Transfection/methods ; HEK293 Cells ; Cell Line ; },
abstract = {Prime editing is an advanced technology in the CRISPR/Cas genome editing field. The original multi-vector method utilized in prime editing has less efficiency and precision and is also inherently difficult in generating homozygous mutations in mammalian cells. To overcome these technical difficulties, a Uni-vector prime editing system containing the major components for prime editing has been constructed in two all-in-one plasmids, pPE3-pPuro and pePE5max-pPuro. The Uni-vector prime editing plasmids enhance the editing efficiency of prime editing and improve the generation of homozygous mutated mammalian cell lines. The editing efficiency depends on the transfection efficiency. Remarkably, the Uni-vector ePE5max system can achieve a high editing rate even in cell lines that are traditionally difficult to transfect. This Uni-vector approach simplifies the delivery of all the necessary editing components and greatly improves the editing efficiency. This approach represents an advanced progress in the field of prime editing.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Gene Editing/methods
*Genetic Vectors/genetics
Animals
Humans
*CRISPR-Cas Systems
Plasmids/genetics
Transfection/methods
HEK293 Cells
Cell Line
RevDate: 2026-11-11
CmpDate: 2026-11-12
Optimization and Evaluation of Prime Editing Activity in Human iPSCs.
Methods in molecular biology (Clifton, N.J.), 3099:115-132.
Human induced pluripotent stem cells (iPSCs) retain the genetic information of their donors, making them invaluable for modeling genetic diseases and for isogenic controls. Precise genome editing in iPSCs is essential to realizing this potential. However, efficient precision editing of iPSCs remains challenging due to the lack of direct enrichment strategies for edited cells carrying subtle mutations such as small insertions and deletions (indels) or single-nucleotide variants (SNVs). Previously, we demonstrated that fluorescence-activated cell sorting (FACS) can indirectly enrich cells with ssODN-templated edits by selecting those with high plasmid-based co-expression of Cas9 and mCherry. While effective, editing approaches relying on Cas9-induced double-strand breaks (DSBs) increase the risk of on-target byproducts, emphasizing the need for alternative strategies. Prime editing offers DSB-free precision editing by using a Cas9 nickase fused to a reverse transcriptase to install edits encoded in prime editing guide RNAs (pegRNAs). Here, we present both plasmid-based and mRNA-based prime editing protocols to generate precise edits evaluated using a GFP-to-BFP conversion assay. The plasmid method is cost-effective and allows for FACS-based enrichment of edited cells, while the mRNA method minimizes genomic integration risk while improving editing efficiencies without the need for enrichment. Together, these methods provide robust platforms for efficient precision editing in human iPSCs, facilitating downstream functional genomics and therapeutic applications.
Additional Links: PMID-43015545
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43015545,
year = {2027},
author = {Matsui, K and Niwa, R and Endo, S and Kayumi, S and Woltjen, K},
title = {Optimization and Evaluation of Prime Editing Activity in Human iPSCs.},
journal = {Methods in molecular biology (Clifton, N.J.)},
volume = {3099},
number = {},
pages = {115-132},
pmid = {43015545},
issn = {1940-6029},
mesh = {Humans ; *Induced Pluripotent Stem Cells/metabolism/cytology ; *Gene Editing/methods ; RNA, Guide, CRISPR-Cas Systems/genetics ; Flow Cytometry ; CRISPR-Cas Systems ; Plasmids/genetics ; },
abstract = {Human induced pluripotent stem cells (iPSCs) retain the genetic information of their donors, making them invaluable for modeling genetic diseases and for isogenic controls. Precise genome editing in iPSCs is essential to realizing this potential. However, efficient precision editing of iPSCs remains challenging due to the lack of direct enrichment strategies for edited cells carrying subtle mutations such as small insertions and deletions (indels) or single-nucleotide variants (SNVs). Previously, we demonstrated that fluorescence-activated cell sorting (FACS) can indirectly enrich cells with ssODN-templated edits by selecting those with high plasmid-based co-expression of Cas9 and mCherry. While effective, editing approaches relying on Cas9-induced double-strand breaks (DSBs) increase the risk of on-target byproducts, emphasizing the need for alternative strategies. Prime editing offers DSB-free precision editing by using a Cas9 nickase fused to a reverse transcriptase to install edits encoded in prime editing guide RNAs (pegRNAs). Here, we present both plasmid-based and mRNA-based prime editing protocols to generate precise edits evaluated using a GFP-to-BFP conversion assay. The plasmid method is cost-effective and allows for FACS-based enrichment of edited cells, while the mRNA method minimizes genomic integration risk while improving editing efficiencies without the need for enrichment. Together, these methods provide robust platforms for efficient precision editing in human iPSCs, facilitating downstream functional genomics and therapeutic applications.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Humans
*Induced Pluripotent Stem Cells/metabolism/cytology
*Gene Editing/methods
RNA, Guide, CRISPR-Cas Systems/genetics
Flow Cytometry
CRISPR-Cas Systems
Plasmids/genetics
RevDate: 2026-11-11
CmpDate: 2026-11-12
All-in-One Prime Editing System for Efficient Generation and Isolation of Single Edited hiPSC Clones.
Methods in molecular biology (Clifton, N.J.), 3099:133-143.
Prime editing has emerged as the preferred gene-editing technique due to its versatility and precision in introducing genetic modifications such as single-base pair substitutions, insertions, and deletions without the need for double-strand breaks (DSBs) and a donor template. Thus, substantially reduces the likelihood of off-target effects that are generally produced when using the traditional CRISPR-Cas9 system. Here, we describe an in-depth protocol for the generation and isolation of prime-edited single human induced pluripotent stem cell (hiPSC) clones. In this example, we transfect a commercial hiPSC line with an all-in-one prime editor plasmid to install a pathogenic PRPH2 mutation using the PE3 approach.
Additional Links: PMID-43015546
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43015546,
year = {2027},
author = {Theodore, K and Tahir, S and Costa, BLD and Quinn, PMJ},
title = {All-in-One Prime Editing System for Efficient Generation and Isolation of Single Edited hiPSC Clones.},
journal = {Methods in molecular biology (Clifton, N.J.)},
volume = {3099},
number = {},
pages = {133-143},
pmid = {43015546},
issn = {1940-6029},
mesh = {Humans ; *Induced Pluripotent Stem Cells/cytology/metabolism ; *CRISPR-Cas Systems ; *Gene Editing/methods ; Transfection ; Cell Line ; Plasmids/genetics ; Clone Cells ; },
abstract = {Prime editing has emerged as the preferred gene-editing technique due to its versatility and precision in introducing genetic modifications such as single-base pair substitutions, insertions, and deletions without the need for double-strand breaks (DSBs) and a donor template. Thus, substantially reduces the likelihood of off-target effects that are generally produced when using the traditional CRISPR-Cas9 system. Here, we describe an in-depth protocol for the generation and isolation of prime-edited single human induced pluripotent stem cell (hiPSC) clones. In this example, we transfect a commercial hiPSC line with an all-in-one prime editor plasmid to install a pathogenic PRPH2 mutation using the PE3 approach.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Humans
*Induced Pluripotent Stem Cells/cytology/metabolism
*CRISPR-Cas Systems
*Gene Editing/methods
Transfection
Cell Line
Plasmids/genetics
Clone Cells
RevDate: 2026-11-12
CmpDate: 2026-11-12
High-efficiency TadA cytosine base editors for precise modelling of human disease variants.
Nature biomedical engineering, 10(11):2363-2378.
Many missense mutations identified in genetic testing are variants of uncertain significance (VUS), not yet classified as either benign or pathogenic. Systematic determination of their functional relevance is a pressing clinical need. CRISPR-mediated base editing can precisely introduce precise variants into model organisms for functional testing, but current editors face efficiency and targeting constraints. We developed TCBE-Umax, a family of TadA-derived cytosine base editors optimized for zebrafish. Engineering the TadA deaminase domain improved editing efficiency and reduced sequence-context bias, expanded PAM compatibility, and minimized bystander edits and indel formation. Our editors achieved efficient biallelic editing, enabling rapid functional assessment of genetic variants in the F0 (founding) zebrafish. As a proof of concept, we evaluated 15 VUS linked to hereditary hearing loss, determining pathogenicity through phenotypic analysis. With high efficiency and versatility, TCBE-Umax base editors provide a powerful platform for studying genetic variants and disease in vivo.
Additional Links: PMID-41606292
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid41606292,
year = {2026},
author = {Qin, W and Lin, SJ and Zhang, Y and Huang, K and Petree, C and Varshney, P and Varshney, GK},
title = {High-efficiency TadA cytosine base editors for precise modelling of human disease variants.},
journal = {Nature biomedical engineering},
volume = {10},
number = {11},
pages = {2363-2378},
pmid = {41606292},
issn = {2157-846X},
support = {R24 OD034438/OD/NIH HHS/United States ; R24OD034438P//U.S. Department of Health & Human Services | National Institutes of Health (NIH)/ ; },
mesh = {Animals ; Zebrafish/genetics ; Humans ; *Cytosine/metabolism ; CRISPR-Cas Systems/genetics ; Mutation, Missense/genetics ; Hearing Loss/genetics ; Genetic Variation ; },
abstract = {Many missense mutations identified in genetic testing are variants of uncertain significance (VUS), not yet classified as either benign or pathogenic. Systematic determination of their functional relevance is a pressing clinical need. CRISPR-mediated base editing can precisely introduce precise variants into model organisms for functional testing, but current editors face efficiency and targeting constraints. We developed TCBE-Umax, a family of TadA-derived cytosine base editors optimized for zebrafish. Engineering the TadA deaminase domain improved editing efficiency and reduced sequence-context bias, expanded PAM compatibility, and minimized bystander edits and indel formation. Our editors achieved efficient biallelic editing, enabling rapid functional assessment of genetic variants in the F0 (founding) zebrafish. As a proof of concept, we evaluated 15 VUS linked to hereditary hearing loss, determining pathogenicity through phenotypic analysis. With high efficiency and versatility, TCBE-Umax base editors provide a powerful platform for studying genetic variants and disease in vivo.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Animals
Zebrafish/genetics
Humans
*Cytosine/metabolism
CRISPR-Cas Systems/genetics
Mutation, Missense/genetics
Hearing Loss/genetics
Genetic Variation
RevDate: 2026-11-12
CmpDate: 2026-11-12
Structure-guided discovery and engineering of miniature CRISPR-Cas12m for epigenome editing.
Nature structural & molecular biology, 33(11):1624-1639.
CRISPR-based epigenome editing represents a programmable strategy to precisely modulate gene expression, holding promise for therapeutic applications. However, the large size of dCas proteins substantially impedes delivery using adeno-associated virus (AAV) vectors. Here, through iterative bioinformatics analysis, structure-guided predictions and functional assays, we identified and characterized a miniature subtype V-M CRISPR-Cas12m from Pelomicrobium methylotrophicum. PmCas12m exhibited flexible 5'-YTN-3' PAM-dependent recognition and robust double-stranded DNA-binding properties while lacking DNA cleavage activity, thus rendering it a valuable tool for epigenome editing. Cryo-electron microscopy structures of PmCas12m unveiled its molecular mechanism of target DNA binding. Guided by these structural insights, we used deep mutational scanning and protein engineering to develop xCas12m, a hypercompact variant with highly potent and specific epigenome-editing capabilities in human cells. We further constructed the xCas12m-CRISPRoff platform in a single AAV vector, which achieved durable epigenetic silencing and effective inhibition of hepatitis B virus infection in a mouse model. Collectively, these findings establish xCas12m as a versatile epigenome-editing platform with notable potential for treating diseases, paving the way for clinical translation of epigenetic therapies.
Additional Links: PMID-42749924
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid42749924,
year = {2026},
author = {Yu, T and Ji, M and Yu, D and Guan, Z and Zhu, R and Jiang, Y and Yang, Z and Qiu, L and Zhang, Z and Mu, J and Mao, F and Xiang, K and Bai, L and Li, K},
title = {Structure-guided discovery and engineering of miniature CRISPR-Cas12m for epigenome editing.},
journal = {Nature structural & molecular biology},
volume = {33},
number = {11},
pages = {1624-1639},
pmid = {42749924},
issn = {1545-9985},
mesh = {*Epigenome Editing/methods ; *CRISPR-Cas Systems/genetics ; Animals ; Humans ; Mice ; Dependovirus/genetics ; Cryoelectron Microscopy ; Protein Engineering/methods ; *CRISPR-Associated Proteins/genetics/metabolism/chemistry ; DNA/metabolism ; Genetic Vectors ; HEK293 Cells ; },
abstract = {CRISPR-based epigenome editing represents a programmable strategy to precisely modulate gene expression, holding promise for therapeutic applications. However, the large size of dCas proteins substantially impedes delivery using adeno-associated virus (AAV) vectors. Here, through iterative bioinformatics analysis, structure-guided predictions and functional assays, we identified and characterized a miniature subtype V-M CRISPR-Cas12m from Pelomicrobium methylotrophicum. PmCas12m exhibited flexible 5'-YTN-3' PAM-dependent recognition and robust double-stranded DNA-binding properties while lacking DNA cleavage activity, thus rendering it a valuable tool for epigenome editing. Cryo-electron microscopy structures of PmCas12m unveiled its molecular mechanism of target DNA binding. Guided by these structural insights, we used deep mutational scanning and protein engineering to develop xCas12m, a hypercompact variant with highly potent and specific epigenome-editing capabilities in human cells. We further constructed the xCas12m-CRISPRoff platform in a single AAV vector, which achieved durable epigenetic silencing and effective inhibition of hepatitis B virus infection in a mouse model. Collectively, these findings establish xCas12m as a versatile epigenome-editing platform with notable potential for treating diseases, paving the way for clinical translation of epigenetic therapies.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Epigenome Editing/methods
*CRISPR-Cas Systems/genetics
Animals
Humans
Mice
Dependovirus/genetics
Cryoelectron Microscopy
Protein Engineering/methods
*CRISPR-Associated Proteins/genetics/metabolism/chemistry
DNA/metabolism
Genetic Vectors
HEK293 Cells
RevDate: 2026-11-13
CmpDate: 2026-11-13
A CRISPR-based humanized model reveals a cooperative role of STAG2 loss in familial GATA2-deficient MDS progression.
Blood advances, 10(22):7690-7701.
Myelodysplastic syndrome (MDS) is a heterogeneous myeloid malignant neoplasm driven by hematopoietic stem cell dysfunction, leading to ineffective hematopoiesis and cytopenias. Familial GATA2 deficiency is the most common cause of MDS in adolescents, with progression often accelerated by co-occurring mutations, notably STAG2 loss of function. Using CRISPR/Cas9-mediated genome engineering in primary human fetal liver-derived hematopoietic stem cells and xenotransplantation in mice, we modeled GATA2-deficient MDS with acquired STAG2 loss to investigate disease initiation and progression. Although GATA2 deficiency alone had minimal short-term impact in our model, combined GATA2 deficiency and STAG2 loss increased hematopoietic stem cell maintenance and self-renewal, induced a myeloid-lineage bias, and expanded primitive progenitors. Single-cell transcriptional profiling revealed upregulation of stemness-associated genes and inflammatory pathways. This humanized model faithfully recapitulates high-risk GATA2-deficient MDS, providing mechanistic insights into how cooperative mutations drive stem cell expansion, inflammatory signaling, and myeloid skewing.
Additional Links: PMID-42782284
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid42782284,
year = {2026},
author = {Freed, G and Quijada-Álamo, M and Lee, L and Wang, K and Poddar, N and Autar, S and Carcamo, S and Fiore, P and Kim, EK and Martinez, IG and Zhang, M and Saniei, S and Chao, C and Mekerishvili, L and Diaz, Z and Ma, S and Hasson, D and Wagenblast, E},
title = {A CRISPR-based humanized model reveals a cooperative role of STAG2 loss in familial GATA2-deficient MDS progression.},
journal = {Blood advances},
volume = {10},
number = {22},
pages = {7690-7701},
doi = {10.1182/bloodadvances.2026019911},
pmid = {42782284},
issn = {2473-9537},
mesh = {Humans ; Animals ; Mice ; *Myelodysplastic Syndromes/genetics/pathology/etiology/metabolism ; *GATA2 Deficiency/genetics ; Disease Models, Animal ; *GATA2 Transcription Factor/deficiency/genetics ; Disease Progression ; Hematopoietic Stem Cells/metabolism ; *CRISPR-Cas Systems ; },
abstract = {Myelodysplastic syndrome (MDS) is a heterogeneous myeloid malignant neoplasm driven by hematopoietic stem cell dysfunction, leading to ineffective hematopoiesis and cytopenias. Familial GATA2 deficiency is the most common cause of MDS in adolescents, with progression often accelerated by co-occurring mutations, notably STAG2 loss of function. Using CRISPR/Cas9-mediated genome engineering in primary human fetal liver-derived hematopoietic stem cells and xenotransplantation in mice, we modeled GATA2-deficient MDS with acquired STAG2 loss to investigate disease initiation and progression. Although GATA2 deficiency alone had minimal short-term impact in our model, combined GATA2 deficiency and STAG2 loss increased hematopoietic stem cell maintenance and self-renewal, induced a myeloid-lineage bias, and expanded primitive progenitors. Single-cell transcriptional profiling revealed upregulation of stemness-associated genes and inflammatory pathways. This humanized model faithfully recapitulates high-risk GATA2-deficient MDS, providing mechanistic insights into how cooperative mutations drive stem cell expansion, inflammatory signaling, and myeloid skewing.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Humans
Animals
Mice
*Myelodysplastic Syndromes/genetics/pathology/etiology/metabolism
*GATA2 Deficiency/genetics
Disease Models, Animal
*GATA2 Transcription Factor/deficiency/genetics
Disease Progression
Hematopoietic Stem Cells/metabolism
*CRISPR-Cas Systems
RevDate: 2026-11-13
CmpDate: 2026-11-13
Laparoscopic transfer of in vitro fertilized gene-edited embryos in pigs.
Theriogenology, 268:118244.
Laparoscopic embryo transfer in pigs has been explored as a minimally invasive alternative to conventional laparotomic methods, which often lead to surgical risks such as adhesions, prolonged recovery, and postoperative complications. This study is the first to report the generation of genetically modified pigs via embryo transfer using a laparoscopic approach. Gene-edited embryos were prepared by delivering the CRISPR/Cas9 system via electroporation to target the Coagulation Factor VIII, WDR45, and IL2RG genes and then transferred into the oviducts of five recipient gilts using a laparoscopic technique. Embryos putatively carrying modifications in the Coagulation Factor VIII and WDR45 genes were each transferred into a single recipient gilt, and both recipients became pregnant. In contrast, embryos putatively carrying a modification in the IL2RG gene were transferred into three recipient gilts, of which two became pregnant. In total, four recipient gilts were carried to full term, resulting in the birth of 9 live piglets. Genotyping confirmed that all of the offspring carried the genetic modifications, demonstrating this method may have potential for producing genetically modified pigs. The successful production of live gene-edited offspring demonstrates the feasibility of laparoscopic embryo transfer for genetically modified embryos. Although further research, including a large number of recipient pigs, as well as direct comparisons with conventional laparotomy, is needed to evaluate embryo survival, implantation efficiency, and animal welfare, laparoscopic embryo transfer represents a feasible approach for generating genetically modified pigs.
Additional Links: PMID-42843117
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid42843117,
year = {2027},
author = {Nagahara, M and Namula, Z and Hirata, M and Nguyen, ST and Nakayama, Y and Nakai, A and Kashiwakura, Y and Tsukida, K and Ohmori, T and Muramatsu, K and Otoi, T and Tanihara, F},
title = {Laparoscopic transfer of in vitro fertilized gene-edited embryos in pigs.},
journal = {Theriogenology},
volume = {268},
number = {},
pages = {118244},
doi = {10.1016/j.theriogenology.2026.118244},
pmid = {42843117},
issn = {1879-3231},
mesh = {Animals ; *Embryo Transfer/veterinary/methods ; Female ; Swine/genetics/embryology ; *Laparoscopy/veterinary/methods ; Pregnancy ; *Fertilization in Vitro/veterinary/methods ; *Gene Editing/veterinary ; CRISPR-Cas Systems ; *Animals, Genetically Modified ; },
abstract = {Laparoscopic embryo transfer in pigs has been explored as a minimally invasive alternative to conventional laparotomic methods, which often lead to surgical risks such as adhesions, prolonged recovery, and postoperative complications. This study is the first to report the generation of genetically modified pigs via embryo transfer using a laparoscopic approach. Gene-edited embryos were prepared by delivering the CRISPR/Cas9 system via electroporation to target the Coagulation Factor VIII, WDR45, and IL2RG genes and then transferred into the oviducts of five recipient gilts using a laparoscopic technique. Embryos putatively carrying modifications in the Coagulation Factor VIII and WDR45 genes were each transferred into a single recipient gilt, and both recipients became pregnant. In contrast, embryos putatively carrying a modification in the IL2RG gene were transferred into three recipient gilts, of which two became pregnant. In total, four recipient gilts were carried to full term, resulting in the birth of 9 live piglets. Genotyping confirmed that all of the offspring carried the genetic modifications, demonstrating this method may have potential for producing genetically modified pigs. The successful production of live gene-edited offspring demonstrates the feasibility of laparoscopic embryo transfer for genetically modified embryos. Although further research, including a large number of recipient pigs, as well as direct comparisons with conventional laparotomy, is needed to evaluate embryo survival, implantation efficiency, and animal welfare, laparoscopic embryo transfer represents a feasible approach for generating genetically modified pigs.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Animals
*Embryo Transfer/veterinary/methods
Female
Swine/genetics/embryology
*Laparoscopy/veterinary/methods
Pregnancy
*Fertilization in Vitro/veterinary/methods
*Gene Editing/veterinary
CRISPR-Cas Systems
*Animals, Genetically Modified
RevDate: 2026-11-12
CmpDate: 2026-11-12
Structural mechanism of programmable gene integration by the R2 retrotransposon coupled with CRISPR-Cas9.
Nature structural & molecular biology, 33(11):1640-1653.
R2 retroelements are non-long-terminal-repeat retrotransposons that primarily insert into 28S ribosomal DNA loci across diverse eukaryotes. R2 elements home to their target sites through target-primed reverse transcription (TPRT), in which the R2 protein recognizes and nicks the target DNA to prime reverse transcription using an R2-encoding RNA as the template. The avian R2 system from Taeniopygia guttata (R2Tg) can insert a payload sequence within an RNA template into 28S ribosomal DNA loci in human cells. Here, we present cryo-electron microscopy structures of the R2Tg-template RNA-target DNA complex in the TPRT initiation state, both alone and bound to a Cas9-guide RNA complex. These structures provide mechanistic insights into R2Tg-mediated TPRT in its natural context and in the programmable gene integration system STITCHR (site-specific target-primed insertion through targeted CRISPR homing of retroelements). Furthermore, we combine these structural insights with computational protein design methods to engineer an enhanced STITCHR system.
Additional Links: PMID-42951937
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid42951937,
year = {2026},
author = {Komatsu, D and Hiraizumi, M and Fell, CW and Fujimatsu, K and Nagahata, N and Yamada, S and Sapkota, S and Ramani, H and Arya, B and Shibata, M and Yamashita, K and Gootenberg, JS and Abudayyeh, OO and Nishimasu, H},
title = {Structural mechanism of programmable gene integration by the R2 retrotransposon coupled with CRISPR-Cas9.},
journal = {Nature structural & molecular biology},
volume = {33},
number = {11},
pages = {1640-1653},
pmid = {42951937},
issn = {1545-9985},
mesh = {Cryoelectron Microscopy ; *Retroelements/genetics ; *CRISPR-Cas Systems ; Models, Molecular ; Humans ; Animals ; RNA, Guide, CRISPR-Cas Systems/genetics/metabolism/chemistry ; DNA/chemistry ; Reverse Transcription ; },
abstract = {R2 retroelements are non-long-terminal-repeat retrotransposons that primarily insert into 28S ribosomal DNA loci across diverse eukaryotes. R2 elements home to their target sites through target-primed reverse transcription (TPRT), in which the R2 protein recognizes and nicks the target DNA to prime reverse transcription using an R2-encoding RNA as the template. The avian R2 system from Taeniopygia guttata (R2Tg) can insert a payload sequence within an RNA template into 28S ribosomal DNA loci in human cells. Here, we present cryo-electron microscopy structures of the R2Tg-template RNA-target DNA complex in the TPRT initiation state, both alone and bound to a Cas9-guide RNA complex. These structures provide mechanistic insights into R2Tg-mediated TPRT in its natural context and in the programmable gene integration system STITCHR (site-specific target-primed insertion through targeted CRISPR homing of retroelements). Furthermore, we combine these structural insights with computational protein design methods to engineer an enhanced STITCHR system.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Cryoelectron Microscopy
*Retroelements/genetics
*CRISPR-Cas Systems
Models, Molecular
Humans
Animals
RNA, Guide, CRISPR-Cas Systems/genetics/metabolism/chemistry
DNA/chemistry
Reverse Transcription
RevDate: 2026-11-11
CmpDate: 2026-11-11
Programming CRISPR Compartmentalization on DNA Origami for Multiplexed Biosensing.
Analytical chemistry, 98(44):31052-31062.
CRISPR-Cas12a has emerged as a transformative tool for nucleic acid detection and molecular diagnostics. However, achieving one-pot, orthogonal, multiplexed sensing remains challenging due to the nonspecific trans-cleavage activity of Cas12a. Here, we present a modular DNA origami-based platform that spatially confines and independently controls Cas12a activity, enabling simultaneous detection of multiple DNA targets within a single reaction. This spatial programming approach enables orthogonal one-pot detection of three DNA targets (EGFR L858R/Del19 mutations and HPV16) with minimal cross-talk, demonstrating 60% cleavage efficiency within 120 min at 100 nM. Through integrated molecular dynamics simulations and experimental validation, we identify an optimal ∼6 nm spatial window that maximizes cleavage efficiency, while the platform maintains robust performance in complex biological environments with a 10 nM detection limit in 20% serum. This compartmentalization strategy establishes a framework for spatially programming multi-enzyme systems on DNA nanostructures for synthetic biological circuits.
Additional Links: PMID-43010433
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43010433,
year = {2026},
author = {Capelli, L and Hao, Y and Shi, Q and Li, Q and Yan, Q and Li, J and Zhu, Y and Fan, C and Bertucci, A and Ge, Z},
title = {Programming CRISPR Compartmentalization on DNA Origami for Multiplexed Biosensing.},
journal = {Analytical chemistry},
volume = {98},
number = {44},
pages = {31052-31062},
doi = {10.1021/acs.analchem.6c04535},
pmid = {43010433},
issn = {1520-6882},
support = {22304114//National Natural Science Foundation of China (NSFC)/ ; 22374099//National Natural Science Foundation of China (NSFC)/ ; 22574100//National Natural Science Foundation of China (NSFC)/ ; U24A20497//National Natural Science Foundation of China (NSFC)/ ; //National Research Foundation Singapore/ ; //Shanghai Municipal Science and Technology Major Project/ ; //New Cornerstone Science Foundation/ ; 2023YFB3208200//National Basic Research Program of China (973 Program)/ ; 31108//Associazione Italiana per la Ricerca sul Cancro/ ; 31710//Associazione Italiana per la Ricerca sul Cancro/ ; 21TQ1400222//Shanghai Jiao Tong University/ ; JYB2025XDXM602//Ministry of Education of the People's Republic of China/ ; //National Center for Translational Medicine (Shanghai)/ ; },
mesh = {*DNA Nanostructures/chemistry ; *Biosensing Techniques/methods ; *DNA/chemistry/genetics ; Molecular Dynamics Simulation ; *CRISPR-Cas Systems ; CRISPR-Associated Proteins/metabolism ; },
abstract = {CRISPR-Cas12a has emerged as a transformative tool for nucleic acid detection and molecular diagnostics. However, achieving one-pot, orthogonal, multiplexed sensing remains challenging due to the nonspecific trans-cleavage activity of Cas12a. Here, we present a modular DNA origami-based platform that spatially confines and independently controls Cas12a activity, enabling simultaneous detection of multiple DNA targets within a single reaction. This spatial programming approach enables orthogonal one-pot detection of three DNA targets (EGFR L858R/Del19 mutations and HPV16) with minimal cross-talk, demonstrating 60% cleavage efficiency within 120 min at 100 nM. Through integrated molecular dynamics simulations and experimental validation, we identify an optimal ∼6 nm spatial window that maximizes cleavage efficiency, while the platform maintains robust performance in complex biological environments with a 10 nM detection limit in 20% serum. This compartmentalization strategy establishes a framework for spatially programming multi-enzyme systems on DNA nanostructures for synthetic biological circuits.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*DNA Nanostructures/chemistry
*Biosensing Techniques/methods
*DNA/chemistry/genetics
Molecular Dynamics Simulation
*CRISPR-Cas Systems
CRISPR-Associated Proteins/metabolism
RevDate: 2026-11-11
CmpDate: 2026-11-11
Decoupled Signal Transduction via a Non-Copper Laccase Mimic for CRISPR-Based Electrochemical Detection of Hepatocellular Carcinoma.
Analytical chemistry, 98(44):31469-31484.
Laccase-mimicking nanozymes have been overwhelmingly copper-dependent, and largely confined to environmental contexts, with clinical translation remaining unrealized. Here, we depart from this paradigm by designing a non-copper nanozyme, Mn-Trp NR, assembled through manganese-tryptophan coordination. Spectroscopic and theoretical analyses show that tryptophan coordination finely modulates the Mn electronic structure, strengthening O2 adsorption and lowering the reaction barrier, thereby conferring laccase-like activity, substrate affinity, and stability superior to the native enzyme. To overcome broad-substrate promiscuity that precludes specific biomarker recognition, we decoupled signal transduction from target identification: Mn-Trp NR serves as a universal amplifier, whereas CRISPR/Cas12a confers high specificity. Accordingly, a cascaded electrochemical biosensor was built on a DNA triangular prism integrating catalytic hairpin assembly, hybridization chain reaction, and CRISPR/Cas12a activation. The platform detects hepatocellular carcinoma (HCC) biomarkers microRNA-122 (miRNA-122) and alpha-fetoprotein (AFP) with limits of 11.98 aM and 10.31 fg/mL, respectively, in a streamlined 160 min, two-step procedure. In clinical sera, the biosensor perfectly distinguishes HCC patients from healthy donors (AUC = 1.00) and agrees strongly with benchmark methods (RT-qPCR for miRNA-122, ELISA for AFP, R2 > 0.97). By expanding laccase-mimic synthesis beyond copper via ligand-field engineering and establishing a decoupled architecture that reconciles broad-spectrum catalysis with high-specificity recognition, this work provides a generalizable strategy for deploying nanozymes in precision diagnostics.
Additional Links: PMID-43010442
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43010442,
year = {2026},
author = {Li, H and Zhou, Y and Yan, Y and Ye, J and Dong, X and Chen, M and Meng, T and Jiao, D and Wang, D and Zhu, L and Yang, X},
title = {Decoupled Signal Transduction via a Non-Copper Laccase Mimic for CRISPR-Based Electrochemical Detection of Hepatocellular Carcinoma.},
journal = {Analytical chemistry},
volume = {98},
number = {44},
pages = {31469-31484},
doi = {10.1021/acs.analchem.6c05197},
pmid = {43010442},
issn = {1520-6882},
support = {22404119//National Natural Science Foundation of China/ ; 32501984//National Natural Science Foundation of China/ ; 2024NSFSC1129//Sichuan Science and Technology Program/ ; 2025ZB395//Jiangsu Funding Program for Excellent Postdoctoral Talent/ ; },
mesh = {*Laccase/chemistry/metabolism ; Humans ; *Electrochemical Techniques/methods ; *Liver Neoplasms/diagnosis ; *Biosensing Techniques/methods ; *Carcinoma, Hepatocellular/diagnosis ; *CRISPR-Cas Systems/genetics ; alpha-Fetoproteins/analysis ; MicroRNAs/blood/analysis ; Signal Transduction ; Manganese/chemistry ; Tryptophan/chemistry ; Biomarkers, Tumor/blood/analysis ; Copper ; *Biomimetic Materials/chemistry ; },
abstract = {Laccase-mimicking nanozymes have been overwhelmingly copper-dependent, and largely confined to environmental contexts, with clinical translation remaining unrealized. Here, we depart from this paradigm by designing a non-copper nanozyme, Mn-Trp NR, assembled through manganese-tryptophan coordination. Spectroscopic and theoretical analyses show that tryptophan coordination finely modulates the Mn electronic structure, strengthening O2 adsorption and lowering the reaction barrier, thereby conferring laccase-like activity, substrate affinity, and stability superior to the native enzyme. To overcome broad-substrate promiscuity that precludes specific biomarker recognition, we decoupled signal transduction from target identification: Mn-Trp NR serves as a universal amplifier, whereas CRISPR/Cas12a confers high specificity. Accordingly, a cascaded electrochemical biosensor was built on a DNA triangular prism integrating catalytic hairpin assembly, hybridization chain reaction, and CRISPR/Cas12a activation. The platform detects hepatocellular carcinoma (HCC) biomarkers microRNA-122 (miRNA-122) and alpha-fetoprotein (AFP) with limits of 11.98 aM and 10.31 fg/mL, respectively, in a streamlined 160 min, two-step procedure. In clinical sera, the biosensor perfectly distinguishes HCC patients from healthy donors (AUC = 1.00) and agrees strongly with benchmark methods (RT-qPCR for miRNA-122, ELISA for AFP, R2 > 0.97). By expanding laccase-mimic synthesis beyond copper via ligand-field engineering and establishing a decoupled architecture that reconciles broad-spectrum catalysis with high-specificity recognition, this work provides a generalizable strategy for deploying nanozymes in precision diagnostics.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Laccase/chemistry/metabolism
Humans
*Electrochemical Techniques/methods
*Liver Neoplasms/diagnosis
*Biosensing Techniques/methods
*Carcinoma, Hepatocellular/diagnosis
*CRISPR-Cas Systems/genetics
alpha-Fetoproteins/analysis
MicroRNAs/blood/analysis
Signal Transduction
Manganese/chemistry
Tryptophan/chemistry
Biomarkers, Tumor/blood/analysis
Copper
*Biomimetic Materials/chemistry
RevDate: 2026-11-11
CmpDate: 2026-11-11
A Two-Step Strategy Based on Fpg Recognition and RCA-CRISPR/Cas12a for Ultrasensitive Detection of Gene Mutation.
Analytical chemistry, 98(44):30873-30882.
Accurate detection of gene mutations is crucial for acute myeloid leukaemia (AML) diagnosis and treatment. Although CRISPR/Cas systems enable sensitive mutation detection, their adaptability is constrained by dependence on restriction endonucleases. Herein, we propose a two-step strategy, termed Fpg-RCA-CRISPR/Cas12a for ultrasensitive detection of the p53 R175H, which integrates formamidopyrimidine DNA glycosylase (Fpg)-mediated recognition with rolling circle amplification (RCA)-coupled CRISPR/Cas12a technology. Validation confirmed that Fpg exhibits minimal activity when adenine (A) is opposite the damaged site. Based on this finding, we designed a padlock probe with a site-specific 8-oxoguanine (8-oxoG) modification. This modification enables selective recognition of G > A mutations. For the target TP53 c.524G > A (p53 R175H), the G > A substitution opposite the 8-oxoG site blocks Fpg cleavage, facilitating probe circularization and subsequent RCA. The resulting RCA products then activate the trans-cleavage activity of Cas12a, enabling cascade signal amplification and generating a strong fluorescence output. For wild-type p53, Fpg-mediated cleavage prevents circularization and amplification, yielding weak fluorescence. Taking advantage of the high specificity of the Fpg enzyme and the cascade amplification effect of the RCA-CRISPR/Cas12a system, this method achieves a limit of detection (LOD) of 0.29 fM and covers a linear range from 0.8 fM to 800 pM, along with high reproducibility, excellent selectivity, and negligible background interference. Notably, the assay can detect mutation frequencies as low as 0.1% in excess wild-type p53. Crucially, its clinical feasibility was confirmed by analyzing human serum samples, yielding results consistent with standard assays and thus demonstrating its practical reliability and translational potential.
Additional Links: PMID-43010510
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43010510,
year = {2026},
author = {Zhou, S and Xiang, T and Cha, Z and Song, J and Xiang, Y and Li, X and Huang, C and Mei, Q and Huang, X and Zhang, C and Wu, J},
title = {A Two-Step Strategy Based on Fpg Recognition and RCA-CRISPR/Cas12a for Ultrasensitive Detection of Gene Mutation.},
journal = {Analytical chemistry},
volume = {98},
number = {44},
pages = {30873-30882},
doi = {10.1021/acs.analchem.6c04145},
pmid = {43010510},
issn = {1520-6882},
support = {2026NSFSC2079//Sichuan Science and Technology Program/ ; 2025ZYD0025//Sichuan Provincial Central Government-Guided Local Scientific Research Project/ ; 2025JYJ034, 2024LZXNYDJ008//Luzhou Science and Technology Program/ ; 2025JBH004, 2025LZXNYDJC17//The Science and Technology Strategic Cooperation Programs of Luzhou Municipal People's Government and Southwest Medical University/ ; 2026NSFSC1552//Natural Science Foundation of Sichuan Province/ ; 82374073//National Natural Science Foundation of China (NSFC)/ ; },
mesh = {*CRISPR-Cas Systems/genetics ; Humans ; *Mutation ; *Tumor Suppressor Protein p53/genetics ; *DNA-Formamidopyrimidine Glycosylase/metabolism ; *Nucleic Acid Amplification Techniques/methods ; Limit of Detection ; Bacterial Proteins ; Endodeoxyribonucleases ; CRISPR-Associated Proteins ; },
abstract = {Accurate detection of gene mutations is crucial for acute myeloid leukaemia (AML) diagnosis and treatment. Although CRISPR/Cas systems enable sensitive mutation detection, their adaptability is constrained by dependence on restriction endonucleases. Herein, we propose a two-step strategy, termed Fpg-RCA-CRISPR/Cas12a for ultrasensitive detection of the p53 R175H, which integrates formamidopyrimidine DNA glycosylase (Fpg)-mediated recognition with rolling circle amplification (RCA)-coupled CRISPR/Cas12a technology. Validation confirmed that Fpg exhibits minimal activity when adenine (A) is opposite the damaged site. Based on this finding, we designed a padlock probe with a site-specific 8-oxoguanine (8-oxoG) modification. This modification enables selective recognition of G > A mutations. For the target TP53 c.524G > A (p53 R175H), the G > A substitution opposite the 8-oxoG site blocks Fpg cleavage, facilitating probe circularization and subsequent RCA. The resulting RCA products then activate the trans-cleavage activity of Cas12a, enabling cascade signal amplification and generating a strong fluorescence output. For wild-type p53, Fpg-mediated cleavage prevents circularization and amplification, yielding weak fluorescence. Taking advantage of the high specificity of the Fpg enzyme and the cascade amplification effect of the RCA-CRISPR/Cas12a system, this method achieves a limit of detection (LOD) of 0.29 fM and covers a linear range from 0.8 fM to 800 pM, along with high reproducibility, excellent selectivity, and negligible background interference. Notably, the assay can detect mutation frequencies as low as 0.1% in excess wild-type p53. Crucially, its clinical feasibility was confirmed by analyzing human serum samples, yielding results consistent with standard assays and thus demonstrating its practical reliability and translational potential.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*CRISPR-Cas Systems/genetics
Humans
*Mutation
*Tumor Suppressor Protein p53/genetics
*DNA-Formamidopyrimidine Glycosylase/metabolism
*Nucleic Acid Amplification Techniques/methods
Limit of Detection
Bacterial Proteins
Endodeoxyribonucleases
CRISPR-Associated Proteins
RevDate: 2026-11-11
CmpDate: 2026-11-11
Modular Cell-Surface-to-Solution CRISPR-Cas12a Platform for Wash-Free Quantification of Cell-Surface Proteins on Living Cells.
Analytical chemistry, 98(44):31528-31541.
Cell-surface proteins are important biomarkers for cell phenotyping, disease diagnosis, therapeutic evaluation, and drug screening. However, their quantitative analysis on intact living cells remains challenging because conventional methods often require cell lysis, fixation, repeated washing, extensive sample processing, or bulky instrumentation. Herein, we developed a modular and reconfigurable cell-surface-to-solution CRISPR-Cas12a platform for wash-free quantitative analysis of cell-surface proteins on intact living cells. Aptamer recognition of extracellularly accessible targets deblocks a DNA activator, thereby activating Cas12a trans-cleavage in solution and converting localized cell-surface recognition into amplified fluorescence while maintaining a low background in the absence of targets. Using EpCAM as a model target, we engineered a split dual-aptamer architecture that enabled cooperative target recognition, efficient activator deblocking, and low-background signal amplification. The platform achieved sensitive EpCAM detection with a limit of detection of 32 fM and enabled live-cell analysis down to 2 cells/μL. It distinguished cell populations with different surface EpCAM levels and quantitatively monitored epithelial-mesenchymal transition-associated changes in cell-surface EpCAM abundance. Coordinated redesign of the target-responsive nucleic acid components extended the platform to PTK7 detection and the analysis of drug-induced cell-surface PTK7 remodeling. Coupling the system to a lateral flow readout enabled portable visual detection. This work establishes a modular and reconfigurable CRISPR-Cas12a sensing strategy for wash-free amplified quantification of cell-surface proteins on living cells, providing a convenient tool for investigating their dynamic remodeling during physiological and pathological processes and therapeutic responses, as well as for drug screening.
Additional Links: PMID-43010518
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43010518,
year = {2026},
author = {Hou, XY and Li, MY and Sun, WB and Wu, SL and Tan, Y and Yang, QF and Li, KD and Li, QN and Zhu, LN and Kong, DM},
title = {Modular Cell-Surface-to-Solution CRISPR-Cas12a Platform for Wash-Free Quantification of Cell-Surface Proteins on Living Cells.},
journal = {Analytical chemistry},
volume = {98},
number = {44},
pages = {31528-31541},
doi = {10.1021/acs.analchem.6c05289},
pmid = {43010518},
issn = {1520-6882},
support = {22293030//National Natural Science Foundation of China/ ; 22474063//National Natural Science Foundation of China/ ; },
mesh = {Humans ; *CRISPR-Cas Systems/genetics ; Aptamers, Nucleotide/chemistry ; *Epithelial Cell Adhesion Molecule/analysis ; *Membrane Proteins/analysis ; },
abstract = {Cell-surface proteins are important biomarkers for cell phenotyping, disease diagnosis, therapeutic evaluation, and drug screening. However, their quantitative analysis on intact living cells remains challenging because conventional methods often require cell lysis, fixation, repeated washing, extensive sample processing, or bulky instrumentation. Herein, we developed a modular and reconfigurable cell-surface-to-solution CRISPR-Cas12a platform for wash-free quantitative analysis of cell-surface proteins on intact living cells. Aptamer recognition of extracellularly accessible targets deblocks a DNA activator, thereby activating Cas12a trans-cleavage in solution and converting localized cell-surface recognition into amplified fluorescence while maintaining a low background in the absence of targets. Using EpCAM as a model target, we engineered a split dual-aptamer architecture that enabled cooperative target recognition, efficient activator deblocking, and low-background signal amplification. The platform achieved sensitive EpCAM detection with a limit of detection of 32 fM and enabled live-cell analysis down to 2 cells/μL. It distinguished cell populations with different surface EpCAM levels and quantitatively monitored epithelial-mesenchymal transition-associated changes in cell-surface EpCAM abundance. Coordinated redesign of the target-responsive nucleic acid components extended the platform to PTK7 detection and the analysis of drug-induced cell-surface PTK7 remodeling. Coupling the system to a lateral flow readout enabled portable visual detection. This work establishes a modular and reconfigurable CRISPR-Cas12a sensing strategy for wash-free amplified quantification of cell-surface proteins on living cells, providing a convenient tool for investigating their dynamic remodeling during physiological and pathological processes and therapeutic responses, as well as for drug screening.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Humans
*CRISPR-Cas Systems/genetics
Aptamers, Nucleotide/chemistry
*Epithelial Cell Adhesion Molecule/analysis
*Membrane Proteins/analysis
RevDate: 2026-11-12
CmpDate: 2026-11-11
Microfluidic Biosensors for the Detection of Foodborne Pathogens: A Comprehensive Review.
Food science & nutrition, 14(11):e72588.
Foodborne pathogen detection in complex foods remains challenging because sample preparation and signal readout can be affected by lipids, proteins, and background microorganisms. This review compares microfluidic biosensors by substrate, fabrication route, sample handling, and optical, electrochemical, or nucleic-acid readout. Published studies demonstrate rapid detection in selected food samples, but reported detection limits cannot be compared without their matrices, units, enrichment steps, and assay times. Laboratory performance also does not establish field readiness. Reproducible manufacture, reagent stability, integrated sample-to-answer operation, and validation in authentic foods remain major translational barriers. Orthogonal readouts, CRISPR-assisted assays, and AI-supported interpretation are promising, but their benefit over simpler methods requires direct comparison and independent validation. Future studies should report matrix-specific recovery and performance, test robustness across sites, and address usability, cost, and regulatory requirements before claiming commercial readiness.
Additional Links: PMID-43010997
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43010997,
year = {2026},
author = {Mao, W and Zhang, L},
title = {Microfluidic Biosensors for the Detection of Foodborne Pathogens: A Comprehensive Review.},
journal = {Food science & nutrition},
volume = {14},
number = {11},
pages = {e72588},
pmid = {43010997},
issn = {2048-7177},
abstract = {Foodborne pathogen detection in complex foods remains challenging because sample preparation and signal readout can be affected by lipids, proteins, and background microorganisms. This review compares microfluidic biosensors by substrate, fabrication route, sample handling, and optical, electrochemical, or nucleic-acid readout. Published studies demonstrate rapid detection in selected food samples, but reported detection limits cannot be compared without their matrices, units, enrichment steps, and assay times. Laboratory performance also does not establish field readiness. Reproducible manufacture, reagent stability, integrated sample-to-answer operation, and validation in authentic foods remain major translational barriers. Orthogonal readouts, CRISPR-assisted assays, and AI-supported interpretation are promising, but their benefit over simpler methods requires direct comparison and independent validation. Future studies should report matrix-specific recovery and performance, test robustness across sites, and address usability, cost, and regulatory requirements before claiming commercial readiness.},
}
RevDate: 2026-11-12
CmpDate: 2026-11-11
CRISPR Technology: From Bench to Bedside Applications.
MedComm, 7(11):e71011.
CRISPR-Cas genome editing represents one of the most transformative advances in modern molecular biology, enabling programmable site-specific genetic modification that has revolutionized functional genomics and precision therapeutic development. Beyond canonical Cas9 nucleases, the CRISPR toolkit has diversified into precision base editors, prime editors, CRISPR-associated transposases, and Cas12/Cas13 RNA-targeting effectors, each with distinct mechanistic properties. Clinically, ex vivo CRISPR therapies for hemoglobinopathies have secured regulatory approval, while base editing, prime editing, and in vivo Chimeric Antigen Receptor (CAR)-T candidates are advancing through trials for a broad spectrum of hematologic, oncologic, and rare genetic disorders. However, existing reviews largely address technical innovation or clinical translation in isolation, lacking a holistic, up-to-date synthesis of the full bench-to-bedside trajectory of CRISPR technology. This review systematically dissects the molecular mechanisms, advantages, and limitations of core CRISPR editing platforms; summarizes pivotal clinical data across hemoglobinopathies, CAR-T immunotherapy, muscular dystrophy, cystic fibrosis, cardiometabolic diseases and rare monogenic diseases; evaluates delivery systems including lipid nanoparticles and viral vectors; and discusses key translational barriers such as off-target genotoxicity and immunogenicity alongside emerging optimization strategies. This work provides a holistic bench-to-bedside framework for CRISPR research, offering critical insights to advance next-generation precision genetic medicine.
Additional Links: PMID-43011237
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43011237,
year = {2026},
author = {Ma, X and Li, L and Sun, Y},
title = {CRISPR Technology: From Bench to Bedside Applications.},
journal = {MedComm},
volume = {7},
number = {11},
pages = {e71011},
pmid = {43011237},
issn = {2688-2663},
abstract = {CRISPR-Cas genome editing represents one of the most transformative advances in modern molecular biology, enabling programmable site-specific genetic modification that has revolutionized functional genomics and precision therapeutic development. Beyond canonical Cas9 nucleases, the CRISPR toolkit has diversified into precision base editors, prime editors, CRISPR-associated transposases, and Cas12/Cas13 RNA-targeting effectors, each with distinct mechanistic properties. Clinically, ex vivo CRISPR therapies for hemoglobinopathies have secured regulatory approval, while base editing, prime editing, and in vivo Chimeric Antigen Receptor (CAR)-T candidates are advancing through trials for a broad spectrum of hematologic, oncologic, and rare genetic disorders. However, existing reviews largely address technical innovation or clinical translation in isolation, lacking a holistic, up-to-date synthesis of the full bench-to-bedside trajectory of CRISPR technology. This review systematically dissects the molecular mechanisms, advantages, and limitations of core CRISPR editing platforms; summarizes pivotal clinical data across hemoglobinopathies, CAR-T immunotherapy, muscular dystrophy, cystic fibrosis, cardiometabolic diseases and rare monogenic diseases; evaluates delivery systems including lipid nanoparticles and viral vectors; and discusses key translational barriers such as off-target genotoxicity and immunogenicity alongside emerging optimization strategies. This work provides a holistic bench-to-bedside framework for CRISPR research, offering critical insights to advance next-generation precision genetic medicine.},
}
RevDate: 2026-11-11
Next-Generation Mycobacterium tuberculosis Diagnostics: A Systematic Review of Molecular, CRISPR, and Biosensor Technologies.
Recent patents on biotechnology pii:BIOT-EPUB-159546 [Epub ahead of print].
INTRODUCTION: TB (tuberculosis) due to Mycobacterium tuberculosis continues to be a significant worldwide health issue. Timely and reliable diagnostic tests will improve treatment outcomes and reduce the spread of disease. Traditional TB diagnostics currently available, such as smear microscopy and culture, have significant limitations with regard to sensitivity and turnaround times, especially for smear-negative cases and for tuberculosis in extrapulmonary locations.
OBJECTIVES: The purpose of this review is to analyze the evolution of TB diagnostics from traditional microbiology to new molecular diagnostic methods (including CRISPR, biosensor technology, and microfluidic methods), including an assessment of their diagnostic testing performance, feasibility, and potential for the future.
METHODS: The systematic narrative review aimed to systematically assess literature published from 2020 to 2025 retrieved from PubMed, Scopus, Web of Science, IEEE Xplore, ScienceDirect, and Google Scholar. The review was carried out according to the PRISMA guidelines and included 89 studies after screening and assessing for eligibility. The data were analysed qualitatively (i.e., through thematic analysis) by comparing data from conventional, molecular, and next-generation diagnostic methods.
RESULTS: Molecular tests (e.g., GeneXpert, Line Probe Assays, PCR, and Whole Genome Sequencing) provide greater sensitivity and specificity than traditional methods and allow for faster diagnosis. Additionally, newer CRISPR-based tests, biosensors, and microfluidic devices hold promise for rapid, portable, point-of-care diagnosis of tuberculosis.
DISCUSSION: The findings indicate that molecular diagnostics improve rapid detection and drug-resistance profiling, while CRISPR and biosensor platforms offer potential for rapid point-of-care testing. However, affordability, infrastructure, clinical validation, and scalability remain important barriers.
CONCLUSION: The use of molecular diagnostic testing, CRISPR technology, biosensors, artificial intelligence, and portable platforms will dramatically enhance existing TB surveillance systems and strategies for controlling the disease globally.
Additional Links: PMID-43012140
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43012140,
year = {2026},
author = {Gomase, VS and Nimje, HM and Kale, S and Midathada, A and Dhamane, SP},
title = {Next-Generation Mycobacterium tuberculosis Diagnostics: A Systematic Review of Molecular, CRISPR, and Biosensor Technologies.},
journal = {Recent patents on biotechnology},
volume = {},
number = {},
pages = {},
doi = {10.2174/0118722083512070261026092440},
pmid = {43012140},
issn = {2212-4012},
abstract = {INTRODUCTION: TB (tuberculosis) due to Mycobacterium tuberculosis continues to be a significant worldwide health issue. Timely and reliable diagnostic tests will improve treatment outcomes and reduce the spread of disease. Traditional TB diagnostics currently available, such as smear microscopy and culture, have significant limitations with regard to sensitivity and turnaround times, especially for smear-negative cases and for tuberculosis in extrapulmonary locations.
OBJECTIVES: The purpose of this review is to analyze the evolution of TB diagnostics from traditional microbiology to new molecular diagnostic methods (including CRISPR, biosensor technology, and microfluidic methods), including an assessment of their diagnostic testing performance, feasibility, and potential for the future.
METHODS: The systematic narrative review aimed to systematically assess literature published from 2020 to 2025 retrieved from PubMed, Scopus, Web of Science, IEEE Xplore, ScienceDirect, and Google Scholar. The review was carried out according to the PRISMA guidelines and included 89 studies after screening and assessing for eligibility. The data were analysed qualitatively (i.e., through thematic analysis) by comparing data from conventional, molecular, and next-generation diagnostic methods.
RESULTS: Molecular tests (e.g., GeneXpert, Line Probe Assays, PCR, and Whole Genome Sequencing) provide greater sensitivity and specificity than traditional methods and allow for faster diagnosis. Additionally, newer CRISPR-based tests, biosensors, and microfluidic devices hold promise for rapid, portable, point-of-care diagnosis of tuberculosis.
DISCUSSION: The findings indicate that molecular diagnostics improve rapid detection and drug-resistance profiling, while CRISPR and biosensor platforms offer potential for rapid point-of-care testing. However, affordability, infrastructure, clinical validation, and scalability remain important barriers.
CONCLUSION: The use of molecular diagnostic testing, CRISPR technology, biosensors, artificial intelligence, and portable platforms will dramatically enhance existing TB surveillance systems and strategies for controlling the disease globally.},
}
RevDate: 2026-11-11
CmpDate: 2026-11-11
Mapping Osteosarcoma Biology With CRISPR/Cas: From Gene Function to Therapeutic Targets.
Cell biology international, 50(11):.
Osteosarcoma is a highly aggressive primary bone malignancy characterized by rapid proliferation, chemoresistance, and early metastasis. Recent advances in CRISPR/Cas (clustered regularly interspaced short palindromic repeats/CRISPR-associated proteins) genome editing have enabled precise targeting of oncogenes, tumor suppressors, and regulators of epigenetic, metabolic, and signaling pathways, providing new insights into osteosarcoma biology. CRISPR-mediated knockout of cell-cycle regulators, including CDK11, impairs proliferation, while restoration of TP53 and suppression of TERT promoter activity inhibits tumor growth. Other line of studies has revealed that chemoresistance mechanisms mediated by ABCB1/MDR1, CD44, ATR, RAD18, and autophagy-related genes have been effectively reversed through CRISPR interventions, restoring sensitivity to cisplatin and doxorubicin. Furthermore, CRISPR applications in immune modulation, such as PD-L1 knockout, may enhance antitumor immunity. Importantly, high-throughput CRISPR screens also may identify essential genes, novel oncogenic drivers, and synthetic lethal targets, thus informing potential precision therapeutic strategies. This review aims to critically summarize CRISPR/Cas-mediated studies in osteosarcoma, focusing on targeting oncogenes and tumor suppressors, overcoming chemoresistance, modulating immune responses, regulating metabolism and autophagy, and identifying essential genes and vulnerabilities, providing a translational framework for precision therapy.
Additional Links: PMID-43012455
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43012455,
year = {2026},
author = {El-Sehrawy, AAMA and Sapaev, I and Nematov, O and Turakulov, R and Bayramdurdi, S and Turaeva, NO and Bainsal, N and Bansal, P and Smerat, A},
title = {Mapping Osteosarcoma Biology With CRISPR/Cas: From Gene Function to Therapeutic Targets.},
journal = {Cell biology international},
volume = {50},
number = {11},
pages = {},
doi = {10.1002/cbin.70233},
pmid = {43012455},
issn = {1095-8355},
mesh = {*Osteosarcoma/genetics/therapy/metabolism ; Humans ; *CRISPR-Cas Systems/genetics ; *Bone Neoplasms/genetics ; Drug Resistance, Neoplasm/genetics ; Gene Editing/methods ; Animals ; Oncogenes ; Autophagy ; },
abstract = {Osteosarcoma is a highly aggressive primary bone malignancy characterized by rapid proliferation, chemoresistance, and early metastasis. Recent advances in CRISPR/Cas (clustered regularly interspaced short palindromic repeats/CRISPR-associated proteins) genome editing have enabled precise targeting of oncogenes, tumor suppressors, and regulators of epigenetic, metabolic, and signaling pathways, providing new insights into osteosarcoma biology. CRISPR-mediated knockout of cell-cycle regulators, including CDK11, impairs proliferation, while restoration of TP53 and suppression of TERT promoter activity inhibits tumor growth. Other line of studies has revealed that chemoresistance mechanisms mediated by ABCB1/MDR1, CD44, ATR, RAD18, and autophagy-related genes have been effectively reversed through CRISPR interventions, restoring sensitivity to cisplatin and doxorubicin. Furthermore, CRISPR applications in immune modulation, such as PD-L1 knockout, may enhance antitumor immunity. Importantly, high-throughput CRISPR screens also may identify essential genes, novel oncogenic drivers, and synthetic lethal targets, thus informing potential precision therapeutic strategies. This review aims to critically summarize CRISPR/Cas-mediated studies in osteosarcoma, focusing on targeting oncogenes and tumor suppressors, overcoming chemoresistance, modulating immune responses, regulating metabolism and autophagy, and identifying essential genes and vulnerabilities, providing a translational framework for precision therapy.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Osteosarcoma/genetics/therapy/metabolism
Humans
*CRISPR-Cas Systems/genetics
*Bone Neoplasms/genetics
Drug Resistance, Neoplasm/genetics
Gene Editing/methods
Animals
Oncogenes
Autophagy
RevDate: 2026-11-11
CmpDate: 2026-11-11
Clustered Regularly Interspaced Palindromic Repeats-Cas Genome-Editing Systems in Filamentous Fungi: Current Tools, Optimization Strategies, and Future Perspectives.
Journal of agricultural and food chemistry, 74(44):34662-34682.
Filamentous fungi are important microbial cell factories for producing antibiotics, organic acids, enzymes, and other valuable products, with broad applications in food, agriculture, and medicine. However, inefficient and imprecise genome editing remains a major bottleneck limiting rational strain engineering. This review summarizes major genome-editing tools in filamentous fungi, including Cre-loxP, TALENs, and CRISPR-Cas systems, with emphasis on their mechanisms, advantages, and limitations. We highlight CRISPR-Cas9 as the predominant platform and discuss optimization strategies involving sgRNA design, engineered Cas9 variants, promoter engineering, AMA1-based replicative plasmids, and ribonucleoprotein delivery. Emerging technologies, including base editing, prime editing, Cas12a, and Mad7, are also discussed for their potential to broaden editing capabilities. Finally, we outline future perspectives focusing on extending the application of existing genome-editing systems in filamentous fungi and discovering novel genome-editing tools from large-scale omics data sets. This review will accelerate the development of filamentous fungi as versatile platforms for biomanufacturing.
Additional Links: PMID-43012712
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43012712,
year = {2026},
author = {Du, R and Wang, W and Xie, J and Li, Y and Wu, N and Xu, Q},
title = {Clustered Regularly Interspaced Palindromic Repeats-Cas Genome-Editing Systems in Filamentous Fungi: Current Tools, Optimization Strategies, and Future Perspectives.},
journal = {Journal of agricultural and food chemistry},
volume = {74},
number = {44},
pages = {34662-34682},
doi = {10.1021/acs.jafc.6c12748},
pmid = {43012712},
issn = {1520-5118},
support = {22378210//National Natural Science Foundation of China/ ; 32603244//National Natural Science Foundation of China/ ; 32603627//National Natural Science Foundation of China/ ; BK20233003//Natural Science Foundation of Jiangsu Province/ ; 23KJA180003//Major Basic Research Project of the Natural Science Foundation of the Jiangsu Higher Education Institutions/ ; },
mesh = {*Fungi/genetics/metabolism ; *Gene Editing/methods/trends ; *CRISPR-Cas Systems ; Genome, Fungal ; Clustered Regularly Interspaced Short Palindromic Repeats ; },
abstract = {Filamentous fungi are important microbial cell factories for producing antibiotics, organic acids, enzymes, and other valuable products, with broad applications in food, agriculture, and medicine. However, inefficient and imprecise genome editing remains a major bottleneck limiting rational strain engineering. This review summarizes major genome-editing tools in filamentous fungi, including Cre-loxP, TALENs, and CRISPR-Cas systems, with emphasis on their mechanisms, advantages, and limitations. We highlight CRISPR-Cas9 as the predominant platform and discuss optimization strategies involving sgRNA design, engineered Cas9 variants, promoter engineering, AMA1-based replicative plasmids, and ribonucleoprotein delivery. Emerging technologies, including base editing, prime editing, Cas12a, and Mad7, are also discussed for their potential to broaden editing capabilities. Finally, we outline future perspectives focusing on extending the application of existing genome-editing systems in filamentous fungi and discovering novel genome-editing tools from large-scale omics data sets. This review will accelerate the development of filamentous fungi as versatile platforms for biomanufacturing.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Fungi/genetics/metabolism
*Gene Editing/methods/trends
*CRISPR-Cas Systems
Genome, Fungal
Clustered Regularly Interspaced Short Palindromic Repeats
RevDate: 2026-11-11
CmpDate: 2026-11-11
Tumor-Specific Gene Editing Enhances Cancer Immunogenicity through Succinate Metabolism-Mediated MHC-I Reprogramming.
Journal of the American Chemical Society, 148(44):48152-48167.
Impaired expression of major histocompatibility complex class I (MHC-I) greatly compromises cytotoxic T-cell-mediated anticancer immunotherapy. Existing MHC-I activation strategies are greatly challenged by poor tumor specificity and off-target toxicity. Herein, we report a dual tumor-specific CRISPR/Cas9 gene editing system that can precisely knock out succinate dehydrogenase subunit C (Sdhc) to activate the MHC-I pathway via epigenetic and transcriptional regulation. A tumor-specific gene editor is first engineered via reversible shielding of sgRNA using an apurinic/apyrimidinic endonuclease 1 (APE1)-responsive, complementary ssDNA, yielding AP-sgRNA with blocked editing activity in normal cells yet completely restored activity in APE1-overexpressing tumor cells. Subsequently, tumor-targeted delivery of AP-sgRNA and Cas9 mRNA (mCas9) is achieved using dibenzocyclooctyne-decorated lipid nanoparticle (DLNP), which upon bioorthogonal click reaction can anchor cancer cells that are prelabeled with azido groups using the unnatural sugar DCL-AAM. Thus, AP-sgSdhc/mCas9@DLNP enables efficient and selective Sdhc editing in tumor cells, leading to epigenetic and transcriptional activation of MHC-antigen processing and presentation genes and thereby provoking robust antitumor efficacy in the B16-OVA melanoma model through enhanced, T cell-mediated immune responses. Moreover, it completely suppressed pulmonary metastasis after combination with aPD-L1 in the 4T1 lung metastasis model. This study provides an enlightened paradigm for precision gene editing and renders a promising mechanism for potentiating cancer immunotherapy.
Additional Links: PMID-43013067
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43013067,
year = {2026},
author = {Yang, H and Zhang, H and Zhao, Z and Ren, Y and Xu, Y and Cai, K and Cheng, J and Liu, X and Chen, Y and Yin, L},
title = {Tumor-Specific Gene Editing Enhances Cancer Immunogenicity through Succinate Metabolism-Mediated MHC-I Reprogramming.},
journal = {Journal of the American Chemical Society},
volume = {148},
number = {44},
pages = {48152-48167},
doi = {10.1021/jacs.6c14840},
pmid = {43013067},
issn = {1520-5126},
support = {52303200//National Natural Science Foundation of China/ ; 52325305//National Natural Science Foundation of China/ ; 52573340//National Natural Science Foundation of China/ ; NA//Collaborative Innovation Center of Suzhou Nano Science and Technology/ ; NA//Higher Education Discipline Innovation Project/ ; NA//Joint International Research Laboratory of Carbon-Based Functional Materials and Devices/ ; },
mesh = {Animals ; Mice ; Humans ; *Gene Editing ; *Succinic Acid/metabolism ; CRISPR-Cas Systems ; *Histocompatibility Antigens Class I/immunology/genetics/metabolism ; Cell Line, Tumor ; },
abstract = {Impaired expression of major histocompatibility complex class I (MHC-I) greatly compromises cytotoxic T-cell-mediated anticancer immunotherapy. Existing MHC-I activation strategies are greatly challenged by poor tumor specificity and off-target toxicity. Herein, we report a dual tumor-specific CRISPR/Cas9 gene editing system that can precisely knock out succinate dehydrogenase subunit C (Sdhc) to activate the MHC-I pathway via epigenetic and transcriptional regulation. A tumor-specific gene editor is first engineered via reversible shielding of sgRNA using an apurinic/apyrimidinic endonuclease 1 (APE1)-responsive, complementary ssDNA, yielding AP-sgRNA with blocked editing activity in normal cells yet completely restored activity in APE1-overexpressing tumor cells. Subsequently, tumor-targeted delivery of AP-sgRNA and Cas9 mRNA (mCas9) is achieved using dibenzocyclooctyne-decorated lipid nanoparticle (DLNP), which upon bioorthogonal click reaction can anchor cancer cells that are prelabeled with azido groups using the unnatural sugar DCL-AAM. Thus, AP-sgSdhc/mCas9@DLNP enables efficient and selective Sdhc editing in tumor cells, leading to epigenetic and transcriptional activation of MHC-antigen processing and presentation genes and thereby provoking robust antitumor efficacy in the B16-OVA melanoma model through enhanced, T cell-mediated immune responses. Moreover, it completely suppressed pulmonary metastasis after combination with aPD-L1 in the 4T1 lung metastasis model. This study provides an enlightened paradigm for precision gene editing and renders a promising mechanism for potentiating cancer immunotherapy.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Animals
Mice
Humans
*Gene Editing
*Succinic Acid/metabolism
CRISPR-Cas Systems
*Histocompatibility Antigens Class I/immunology/genetics/metabolism
Cell Line, Tumor
RevDate: 2026-11-11
CmpDate: 2026-11-12
Prime Editing: Mechanism and Developments.
Methods in molecular biology (Clifton, N.J.), 3099:1-7.
Prime editing is a "search and replace" based genome editing method that can introduce point mutations, insertions, and deletions into DNA at desired sites, making it the editing technique capable of making the most diverse range of edits. Prime editing utilizes a Cas9 nickase fused to a reverse transcriptase to introduce edits encoded by a specially designed DNA oligonucleotide called a prime editing guide RNA (pegRNA). While prime editing has been shown to achieve robust editing in different genomic loci and in different cell types, this technology still has the potential for further optimization and improvement. Many groups have been successful in improving prime editing outcomes by optimizing the design of prime editors and pegRNAs. Additionally, modulating key cellular pathways has also been an effective tool for achieving high levels of editing. Due to its high efficiency and relative safety, prime editing has the potential to transform disease modeling and genomic medicine.
Additional Links: PMID-43015537
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43015537,
year = {2027},
author = {Berry, AM and Costa, BLD and Quinn, PMJ},
title = {Prime Editing: Mechanism and Developments.},
journal = {Methods in molecular biology (Clifton, N.J.)},
volume = {3099},
number = {},
pages = {1-7},
pmid = {43015537},
issn = {1940-6029},
mesh = {*Gene Editing/methods ; Humans ; *CRISPR-Cas Systems ; RNA, Guide, CRISPR-Cas Systems/genetics ; Animals ; },
abstract = {Prime editing is a "search and replace" based genome editing method that can introduce point mutations, insertions, and deletions into DNA at desired sites, making it the editing technique capable of making the most diverse range of edits. Prime editing utilizes a Cas9 nickase fused to a reverse transcriptase to introduce edits encoded by a specially designed DNA oligonucleotide called a prime editing guide RNA (pegRNA). While prime editing has been shown to achieve robust editing in different genomic loci and in different cell types, this technology still has the potential for further optimization and improvement. Many groups have been successful in improving prime editing outcomes by optimizing the design of prime editors and pegRNAs. Additionally, modulating key cellular pathways has also been an effective tool for achieving high levels of editing. Due to its high efficiency and relative safety, prime editing has the potential to transform disease modeling and genomic medicine.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Gene Editing/methods
Humans
*CRISPR-Cas Systems
RNA, Guide, CRISPR-Cas Systems/genetics
Animals
RevDate: 2026-11-12
CmpDate: 2026-11-11
Targeted genomic integration and rearrangement using prime assembly.
Nature, 659(8140):532-541.
Although therapeutic genome editing holds great potential to remedy diverse inherited and acquired disorders, targeted installation of medium-to-large genomic modifications in therapeutically relevant cells remains challenging[1]. Here we develop prime assembly, an approach that permits DNA sequence assembly and integration in human cells leveraging CRISPR-targeted dual flap synthesis. This method enables RNA-programmable site-specific integration of single or double-stranded DNA fragments. Unlike homology-directed repair, prime assembly is similarly active in dividing and non-dividing cells. We applied prime assembly to perform targeted exon recoding, transgene integration and megabase-scale rearrangements, including at therapeutically relevant loci in primary human cells. Prime assembly expands the capabilities of genome engineering by enabling the targeted integration of medium to large-sized DNA sequences without relying on double-stranded DNA donors, nuclease-driven double-strand breaks or cell cycle progression.
Additional Links: PMID-42749803
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid42749803,
year = {2026},
author = {Levesque, S and Kawashima, N and Hwang, GH and Zeng, J and Toskov, V and Barry, T and Mannherz, W and Homfeldt, L and Becerra, B and Schoonenberg, VAC and Pinello, L and Agarwal, S and Bauer, DE},
title = {Targeted genomic integration and rearrangement using prime assembly.},
journal = {Nature},
volume = {659},
number = {8140},
pages = {532-541},
pmid = {42749803},
issn = {1476-4687},
support = {R01 HG013618/HG/NHGRI NIH HHS/United States ; R01 HL165061/HL/NHLBI NIH HHS/United States ; },
mesh = {Humans ; *CRISPR-Cas Systems/genetics ; *Gene Editing/methods ; *Gene Rearrangement/genetics ; Exons/genetics ; DNA/genetics/biosynthesis ; Transgenes/genetics ; *Genome, Human/genetics ; *Genomics ; },
abstract = {Although therapeutic genome editing holds great potential to remedy diverse inherited and acquired disorders, targeted installation of medium-to-large genomic modifications in therapeutically relevant cells remains challenging[1]. Here we develop prime assembly, an approach that permits DNA sequence assembly and integration in human cells leveraging CRISPR-targeted dual flap synthesis. This method enables RNA-programmable site-specific integration of single or double-stranded DNA fragments. Unlike homology-directed repair, prime assembly is similarly active in dividing and non-dividing cells. We applied prime assembly to perform targeted exon recoding, transgene integration and megabase-scale rearrangements, including at therapeutically relevant loci in primary human cells. Prime assembly expands the capabilities of genome engineering by enabling the targeted integration of medium to large-sized DNA sequences without relying on double-stranded DNA donors, nuclease-driven double-strand breaks or cell cycle progression.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Humans
*CRISPR-Cas Systems/genetics
*Gene Editing/methods
*Gene Rearrangement/genetics
Exons/genetics
DNA/genetics/biosynthesis
Transgenes/genetics
*Genome, Human/genetics
*Genomics
RevDate: 2026-11-12
CmpDate: 2026-11-12
Targeting FAK-YAP Signaling Axis Inhibits Tumor Stemness and Overcomes Tumor Resistance to Cuproptosis.
Advanced materials (Deerfield Beach, Fla.), 38(63):.
Cuproptosis has recently been identified as a novel metabolic cell death pathway that holds great promise for cancer therapy. However, cuproptosis resistance developed by tumor cells severely impairs its anticancer efficacy. Here, our study uncovers that the FAK-YAP signaling axis in tumor cells plays important roles in the development of cuproptosis resistance and the promotion of tumor stemness. To therapeutically target this signaling axis, a CRISPR-cuproptosis synergistic nanoplatform (CPLNP@HA) is elaborately designed for targeted co-delivery of a Ptk2 (encoding FAK) CRISPR-Cas9 knockout plasmid to block FAK-YAP signaling axis and Cu-elesclomol (Cu-ES, a cuproptosis inducer) into tumor cells. Mechanistically, CPLNP@HA efficiently silences FAK expression, which subsequently blocks the cuproptosis-induced activation of the FAK-YAP signaling cascade. This intervention not only sustains intracellular copper accumulation to reinforce cuproptosis but also reduces tumor stemness, thereby significantly potentiating the therapeutic outcomes of cuproptosis and activating tumoricidal immunity as evidenced by transcriptomic analysis. In combination with immune checkpoint blockade therapy, CPLNP@HA markedly inhibits tumor development upon rechallenge after surgical resection. Our work establishes FAK-YAP signaling axis as a new therapeutic target to overcome cuproptosis resistance and inhibit tumor stemness, providing a promising combinatorial paradigm to sensitize tumor to cuproptosis and immunotherapy.
Additional Links: PMID-42799341
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid42799341,
year = {2026},
author = {Zhou, H and Wang, YZ and Zhang, SM and Yan, X and Chen, H and Jin, SX and Chen, WH and Zhang, XZ},
title = {Targeting FAK-YAP Signaling Axis Inhibits Tumor Stemness and Overcomes Tumor Resistance to Cuproptosis.},
journal = {Advanced materials (Deerfield Beach, Fla.)},
volume = {38},
number = {63},
pages = {},
doi = {10.1002/adma.75155},
pmid = {42799341},
issn = {1521-4095},
support = {52273301//National Natural Science Foundation of China/ ; 52473145//National Natural Science Foundation of China/ ; 52333004//National Natural Science Foundation of China/ ; 52131302//National Natural Science Foundation of China/ ; 2024DJA011//Hubei Province Science and Technology Innovation Talent Program/ ; //Institutional Animal Care and Use Committee/ ; WP20240086//Animal Experiment Center of Wuhan University/ ; },
mesh = {*Cuproptosis ; *Signal Transduction/drug effects ; Humans ; *Neoplastic Stem Cells/drug effects/metabolism/pathology ; Cell Line, Tumor ; YAP-Signaling Proteins ; Animals ; *Focal Adhesion Kinase 1/metabolism/genetics ; *Transcription Factors/metabolism ; Drug Resistance, Neoplasm/drug effects ; *Adaptor Proteins, Signal Transducing/metabolism ; CRISPR-Cas Systems/genetics ; },
abstract = {Cuproptosis has recently been identified as a novel metabolic cell death pathway that holds great promise for cancer therapy. However, cuproptosis resistance developed by tumor cells severely impairs its anticancer efficacy. Here, our study uncovers that the FAK-YAP signaling axis in tumor cells plays important roles in the development of cuproptosis resistance and the promotion of tumor stemness. To therapeutically target this signaling axis, a CRISPR-cuproptosis synergistic nanoplatform (CPLNP@HA) is elaborately designed for targeted co-delivery of a Ptk2 (encoding FAK) CRISPR-Cas9 knockout plasmid to block FAK-YAP signaling axis and Cu-elesclomol (Cu-ES, a cuproptosis inducer) into tumor cells. Mechanistically, CPLNP@HA efficiently silences FAK expression, which subsequently blocks the cuproptosis-induced activation of the FAK-YAP signaling cascade. This intervention not only sustains intracellular copper accumulation to reinforce cuproptosis but also reduces tumor stemness, thereby significantly potentiating the therapeutic outcomes of cuproptosis and activating tumoricidal immunity as evidenced by transcriptomic analysis. In combination with immune checkpoint blockade therapy, CPLNP@HA markedly inhibits tumor development upon rechallenge after surgical resection. Our work establishes FAK-YAP signaling axis as a new therapeutic target to overcome cuproptosis resistance and inhibit tumor stemness, providing a promising combinatorial paradigm to sensitize tumor to cuproptosis and immunotherapy.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Cuproptosis
*Signal Transduction/drug effects
Humans
*Neoplastic Stem Cells/drug effects/metabolism/pathology
Cell Line, Tumor
YAP-Signaling Proteins
Animals
*Focal Adhesion Kinase 1/metabolism/genetics
*Transcription Factors/metabolism
Drug Resistance, Neoplasm/drug effects
*Adaptor Proteins, Signal Transducing/metabolism
CRISPR-Cas Systems/genetics
RevDate: 2026-11-12
CmpDate: 2026-11-12
Functional double-emulsion droplets enable multiplexed CRISPR quantification of cancer-related miRNAs.
Biosensors & bioelectronics, 317:119361.
Accurate, multiplexed microRNA detection is critical for early cancer diagnosis. We present a droplet-based digital CRISPR/Cas13a platform for simultaneous, amplification-free detection of multiple miRNAs. By integrating double emulsion (DE) microfluidics with programmable crRNAs, the system achieves orthogonal, interference-free readouts, enabling precise absolute quantification in complex biological samples. The assay demonstrates high sequence specificity, robust orthogonality, and consistent performance across target combinations and matrices. Fluorescence-positive droplet counts correlate linearly with input concentrations, allowing quantification of miRNA-21, miRNA-29a, and miRNA-92a with 10 copies/μL representing the lowest concentration experimentally evaluated in this study. The applicability of the platform is further evaluated in a small proof-of-concept cohort of plasma samples from healthy controls and colorectal cancer (CRC) patients. This platform provides an amplification-free approach for multiplexed miRNA quantification and supports further development for clinical biomarker analysis.
Additional Links: PMID-42945784
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid42945784,
year = {2027},
author = {Zhang, Y and Deng, F and Sang, R and Liu, L and Barber, TJ and Goldys, EM and Li, M},
title = {Functional double-emulsion droplets enable multiplexed CRISPR quantification of cancer-related miRNAs.},
journal = {Biosensors & bioelectronics},
volume = {317},
number = {},
pages = {119361},
doi = {10.1016/j.bios.2026.119361},
pmid = {42945784},
issn = {1873-4235},
mesh = {Humans ; *MicroRNAs/genetics/blood/isolation & purification ; *Biomarkers, Tumor/genetics/blood ; *Biosensing Techniques/instrumentation ; *CRISPR-Cas Systems/genetics ; *Colorectal Neoplasms/genetics/blood/diagnosis ; Emulsions/chemistry ; Equipment Design ; },
abstract = {Accurate, multiplexed microRNA detection is critical for early cancer diagnosis. We present a droplet-based digital CRISPR/Cas13a platform for simultaneous, amplification-free detection of multiple miRNAs. By integrating double emulsion (DE) microfluidics with programmable crRNAs, the system achieves orthogonal, interference-free readouts, enabling precise absolute quantification in complex biological samples. The assay demonstrates high sequence specificity, robust orthogonality, and consistent performance across target combinations and matrices. Fluorescence-positive droplet counts correlate linearly with input concentrations, allowing quantification of miRNA-21, miRNA-29a, and miRNA-92a with 10 copies/μL representing the lowest concentration experimentally evaluated in this study. The applicability of the platform is further evaluated in a small proof-of-concept cohort of plasma samples from healthy controls and colorectal cancer (CRC) patients. This platform provides an amplification-free approach for multiplexed miRNA quantification and supports further development for clinical biomarker analysis.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Humans
*MicroRNAs/genetics/blood/isolation & purification
*Biomarkers, Tumor/genetics/blood
*Biosensing Techniques/instrumentation
*CRISPR-Cas Systems/genetics
*Colorectal Neoplasms/genetics/blood/diagnosis
Emulsions/chemistry
Equipment Design
RevDate: 2026-11-08
CmpDate: 2026-11-05
A modular lentiviral system for multiplexed gene perturbation and functional analysis suggests interdependence of hormone receptors in breast cancer growth in vivo.
Life science alliance, 10(1):.
Precise and flexible control of gene expression is essential for dissecting gene function in complex biological systems. Although recent developments in genetic engineering and CRISPR/Cas9 technology have expanded tools for gene activation, suppression, and editing, their application in physiologically relevant models remains challenging, time-consuming, and expensive. Here, we present a modular, doxycycline-inducible vector system that integrates gene overexpression, shRNA-mediated knockdown, and CRISPR/Cas9-mediated regulation within a single, lentivirus-compatible system. The modular design allows rapid exchange of selection markers, epitope tags, and reporters via Gateway cloning, providing broad adaptability across experimental settings. In addition to standard fluorescent and luminescent reporters, the system includes advanced sensors, such as Fucci cell cycle reporters, to enable monitoring of cellular processes. By combining fluorescence barcoding with combinatorial genetic perturbations, the platform supports multiplexed analysis of gene function and genetic interactions through phenotypic characterization by fluorescence imaging or flow cytometry. We demonstrate its utility in vivo with breast cancer intraductal xenografts, which suggest that ER+ breast cancer cells (MCF7) rely on androgen, estrogen, and progesterone receptors for in vivo growth. This versatile gene perturbation system provides tight temporal control, streamlined implementation, and high-content phenotyping capacity facilitating efficient in vitro and in vivo studies while reducing the use of animals in in vivo validation experiments. It thus expands the experimental repertoire for dynamic, multigene interrogation in complex systems.
Additional Links: PMID-42988560
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid42988560,
year = {2027},
author = {Alam, S and Matvienko, D and Boström, J and Pires, MJ and Papadimitropoulou, A and Eshtad, S and Sanjiv, K and Qian, H and Valerie, NC and Brisken, C and Altun, M},
title = {A modular lentiviral system for multiplexed gene perturbation and functional analysis suggests interdependence of hormone receptors in breast cancer growth in vivo.},
journal = {Life science alliance},
volume = {10},
number = {1},
pages = {},
pmid = {42988560},
issn = {2575-1077},
mesh = {Humans ; Female ; *Lentivirus/genetics ; *Breast Neoplasms/genetics/metabolism/pathology ; Animals ; CRISPR-Cas Systems/genetics ; Receptors, Estrogen/metabolism/genetics ; Mice ; Genetic Vectors/genetics ; MCF-7 Cells ; Receptors, Progesterone/metabolism/genetics ; Gene Expression Regulation, Neoplastic ; Cell Line, Tumor ; Receptors, Androgen/metabolism/genetics ; Cell Proliferation/genetics ; },
abstract = {Precise and flexible control of gene expression is essential for dissecting gene function in complex biological systems. Although recent developments in genetic engineering and CRISPR/Cas9 technology have expanded tools for gene activation, suppression, and editing, their application in physiologically relevant models remains challenging, time-consuming, and expensive. Here, we present a modular, doxycycline-inducible vector system that integrates gene overexpression, shRNA-mediated knockdown, and CRISPR/Cas9-mediated regulation within a single, lentivirus-compatible system. The modular design allows rapid exchange of selection markers, epitope tags, and reporters via Gateway cloning, providing broad adaptability across experimental settings. In addition to standard fluorescent and luminescent reporters, the system includes advanced sensors, such as Fucci cell cycle reporters, to enable monitoring of cellular processes. By combining fluorescence barcoding with combinatorial genetic perturbations, the platform supports multiplexed analysis of gene function and genetic interactions through phenotypic characterization by fluorescence imaging or flow cytometry. We demonstrate its utility in vivo with breast cancer intraductal xenografts, which suggest that ER+ breast cancer cells (MCF7) rely on androgen, estrogen, and progesterone receptors for in vivo growth. This versatile gene perturbation system provides tight temporal control, streamlined implementation, and high-content phenotyping capacity facilitating efficient in vitro and in vivo studies while reducing the use of animals in in vivo validation experiments. It thus expands the experimental repertoire for dynamic, multigene interrogation in complex systems.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Humans
Female
*Lentivirus/genetics
*Breast Neoplasms/genetics/metabolism/pathology
Animals
CRISPR-Cas Systems/genetics
Receptors, Estrogen/metabolism/genetics
Mice
Genetic Vectors/genetics
MCF-7 Cells
Receptors, Progesterone/metabolism/genetics
Gene Expression Regulation, Neoplastic
Cell Line, Tumor
Receptors, Androgen/metabolism/genetics
Cell Proliferation/genetics
RevDate: 2026-11-07
CmpDate: 2026-11-05
From immunity to identity to exaptation: RNA-based self/non-self discrimination across cellular life.
BMC immunology, 27(1):.
Distinguishing self from non-self is a universal imperative of life, where such discrimination at RNA level is both evolutionarily rational and urgently required to maintain homeostasis. Across kingdoms, organisms have evolved distinct yet convergent strategies to achieve this goal. Animals broadly employ A-to-I mRNA editing and other modifications as self-tags; plants and fungi mainly rely on RNA interference, spatial segregation, and m[6]A methylation; and prokaryotes utilize CRISPR-Cas immunity as a programmable analog of self-recognition. Despite their efficacy, these systems harbor intrinsic vulnerabilities that viruses might exploit through mimicry and modification theft, perpetuating a dynamic host-pathogen arms race. During evolution, these defense mechanisms might be exapted for new roles in hosts: A-to-I editing diversified proteomes, and m[6]A methylation became a global regulator of mRNA fate. Together, these observations reveal that mechanisms born from conflict might be repurposed to drive molecular innovation, linking self-recognition, adaptation, and the evolution of complexity.
Additional Links: PMID-42989096
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid42989096,
year = {2026},
author = {Xie, Q and Ma, L and Wang, Z and Duan, Y and Cao, Q},
title = {From immunity to identity to exaptation: RNA-based self/non-self discrimination across cellular life.},
journal = {BMC immunology},
volume = {27},
number = {1},
pages = {},
pmid = {42989096},
issn = {1471-2172},
support = {2026TC089//Chinese Universities Scientific Fund/ ; },
mesh = {Animals ; Humans ; RNA Editing ; RNA Interference ; RNA Methylation ; *RNA, Messenger/genetics ; CRISPR-Cas Systems ; Host-Pathogen Interactions/immunology ; *RNA/genetics/immunology ; Epitranscriptome ; },
abstract = {Distinguishing self from non-self is a universal imperative of life, where such discrimination at RNA level is both evolutionarily rational and urgently required to maintain homeostasis. Across kingdoms, organisms have evolved distinct yet convergent strategies to achieve this goal. Animals broadly employ A-to-I mRNA editing and other modifications as self-tags; plants and fungi mainly rely on RNA interference, spatial segregation, and m[6]A methylation; and prokaryotes utilize CRISPR-Cas immunity as a programmable analog of self-recognition. Despite their efficacy, these systems harbor intrinsic vulnerabilities that viruses might exploit through mimicry and modification theft, perpetuating a dynamic host-pathogen arms race. During evolution, these defense mechanisms might be exapted for new roles in hosts: A-to-I editing diversified proteomes, and m[6]A methylation became a global regulator of mRNA fate. Together, these observations reveal that mechanisms born from conflict might be repurposed to drive molecular innovation, linking self-recognition, adaptation, and the evolution of complexity.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Animals
Humans
RNA Editing
RNA Interference
RNA Methylation
*RNA, Messenger/genetics
CRISPR-Cas Systems
Host-Pathogen Interactions/immunology
*RNA/genetics/immunology
Epitranscriptome
RevDate: 2026-11-07
CmpDate: 2026-11-06
Development of a One-Step RT-LAMP-CRISPR/Cas12b Assay for Rapid On-Site Detection of Dabie Bandavirus.
ACS omega, 11(43):66547-66556.
Severe fever with thrombocytopenia syndrome (SFTS), caused by Dabie bandavirus (DBV), has rapidly spread to multiple countries worldwide since its discovery in 2009, posing a serious threat to global public health security. SFTS is a tick-borne disease, and people living in mountainous and hilly areas are at increased risk of infection, which highlights the urgent need for rapid, accurate, and field-applicable diagnostic strategies for DBV. In this study, LAMP primers and CRISPR sgRNA were designed based on the conserved region of the DBV L segment. A one-pot, one-step molecular assay integrating reverse transcription loop-mediated isothermal amplification (RT-LAMP) with CRISPR/Cas12b technology was established after systematic optimization of key parameters. The assay operates under isothermal conditions at 60 °C, delivering results within 40 min. Analytical evaluation demonstrated a limit of detection of 25.6 RNA copies per reaction. No cross-reactivity was observed with Hantaan virus, Seoul virus, Chikungunya virus, Japanese encephalitis virus, Dengue virus, and Zika virus. Clinical validation using 42 specimens showed complete concordance with gold-standard qRT-PCR, achieving 100% sensitivity (30/30) and 100% specificity (12/12). For point-of-care application, fluorescence visualization was incorporated into the CRISPR/Cas-based detection workflow, enabling straightforward result interpretation. This integrated RT-LAMP-CRISPR/Cas12b platform provides rapid and specific detection of DBV through a simplified workflow that does not require complex instrumentation, supporting its potential application in resource-limited environments.
Additional Links: PMID-42992074
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid42992074,
year = {2026},
author = {Guo, J and Wu, T and Qiao, Q and Zhu, X and Zhao, K and Cui, L and Huo, X and Ge, Y},
title = {Development of a One-Step RT-LAMP-CRISPR/Cas12b Assay for Rapid On-Site Detection of Dabie Bandavirus.},
journal = {ACS omega},
volume = {11},
number = {43},
pages = {66547-66556},
pmid = {42992074},
issn = {2470-1343},
abstract = {Severe fever with thrombocytopenia syndrome (SFTS), caused by Dabie bandavirus (DBV), has rapidly spread to multiple countries worldwide since its discovery in 2009, posing a serious threat to global public health security. SFTS is a tick-borne disease, and people living in mountainous and hilly areas are at increased risk of infection, which highlights the urgent need for rapid, accurate, and field-applicable diagnostic strategies for DBV. In this study, LAMP primers and CRISPR sgRNA were designed based on the conserved region of the DBV L segment. A one-pot, one-step molecular assay integrating reverse transcription loop-mediated isothermal amplification (RT-LAMP) with CRISPR/Cas12b technology was established after systematic optimization of key parameters. The assay operates under isothermal conditions at 60 °C, delivering results within 40 min. Analytical evaluation demonstrated a limit of detection of 25.6 RNA copies per reaction. No cross-reactivity was observed with Hantaan virus, Seoul virus, Chikungunya virus, Japanese encephalitis virus, Dengue virus, and Zika virus. Clinical validation using 42 specimens showed complete concordance with gold-standard qRT-PCR, achieving 100% sensitivity (30/30) and 100% specificity (12/12). For point-of-care application, fluorescence visualization was incorporated into the CRISPR/Cas-based detection workflow, enabling straightforward result interpretation. This integrated RT-LAMP-CRISPR/Cas12b platform provides rapid and specific detection of DBV through a simplified workflow that does not require complex instrumentation, supporting its potential application in resource-limited environments.},
}
▼ ▼ LOAD NEXT 100 CITATIONS
ESP Quick Facts
ESP Origins
In the early 1990's, Robert Robbins was a faculty member at Johns Hopkins, where he directed the informatics core of GDB — the human gene-mapping database of the international human genome project. To share papers with colleagues around the world, he set up a small paper-sharing section on his personal web page. This small project evolved into The Electronic Scholarly Publishing Project.
ESP Support
In 1995, Robbins became the VP/IT of the Fred Hutchinson Cancer Research Center in Seattle, WA. Soon after arriving in Seattle, Robbins secured funding, through the ELSI component of the US Human Genome Project, to create the original ESP.ORG web site, with the formal goal of providing free, world-wide access to the literature of classical genetics.
ESP Rationale
Although the methods of molecular biology can seem almost magical to the uninitiated, the original techniques of classical genetics are readily appreciated by one and all: cross individuals that differ in some inherited trait, collect all of the progeny, score their attributes, and propose mechanisms to explain the patterns of inheritance observed.
ESP Goal
In reading the early works of classical genetics, one is drawn, almost inexorably, into ever more complex models, until molecular explanations begin to seem both necessary and natural. At that point, the tools for understanding genome research are at hand. Assisting readers reach this point was the original goal of The Electronic Scholarly Publishing Project.
ESP Usage
Usage of the site grew rapidly and has remained high. Faculty began to use the site for their assigned readings. Other on-line publishers, ranging from The New York Times to Nature referenced ESP materials in their own publications. Nobel laureates (e.g., Joshua Lederberg) regularly used the site and even wrote to suggest changes and improvements.
ESP Content
When the site began, no journals were making their early content available in digital format. As a result, ESP was obliged to digitize classic literature before it could be made available. For many important papers — such as Mendel's original paper or the first genetic map — ESP had to produce entirely new typeset versions of the works, if they were to be available in a high-quality format.
ESP Help
Early support from the DOE component of the Human Genome Project was critically important for getting the ESP project on a firm foundation. Since that funding ended (nearly 20 years ago), the project has been operated as a purely volunteer effort. Anyone wishing to assist in these efforts should send an email to Robbins.
ESP Plans
With the development of methods for adding typeset side notes to PDF files, the ESP project now plans to add annotated versions of some classical papers to its holdings. We also plan to add new reference and pedagogical material. We have already started providing regularly updated, comprehensive bibliographies to the ESP.ORG site.
ESP Picks from Around the Web (updated 28 JUL 2024 )
Old Science
Weird Science
Treating Disease with Fecal Transplantation
Fossils of miniature humans (hobbits) discovered in Indonesia
Paleontology
Dinosaur tail, complete with feathers, found preserved in amber.
Astronomy
Mysterious fast radio burst (FRB) detected in the distant universe.
Big Data & Informatics
Big Data: Buzzword or Big Deal?
Hacking the genome: Identifying anonymized human subjects using publicly available data.